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1 Introduction
1.1 Nervous System
The vertebrate nervous system consists of two parts, the central nervous system (CNS)
and the peripheral nervous system (PNS). The CNS is formed by the brain and spinal
cord, while the PNS consists of the remaining neuronal tissue in the body. The brain is
located in the head and protected by meninges covering its entire surface. The brain is
subdivided into five parts: telencephalon, diencephalon, mesencephalon, metencephalon
and myelencephalon. It contains cavities, the ventricles, filled with cerebrospinal fluid
(CSF). These ventricles are connected with each other and the spinal cord (Bear et al.,
2006).
The brain tissue consists of different cell-types, e.g. neurons, glial cells, endothelial
cells and ependymal cells. Murine brains contain around 71x106 neurons which form
a complex network with around 1011 synapses between cells (Herculano-Houzel et al.,
2006). Glia make up 65% of the mouse brain (Allen and Barres, 2009). Optically two
different nerve tissues can be distinguished. White matter is highly myelinated and grey
matter is less myelinated and also consists of unmyelinated neurons.
The different parts of the brain can be further subdivided into distinct regions which
fulfil specific functions. This study focused on the thalamus and hippocampus, which
will be explained in further detail below.
1.1.1 Thalamus
The thalamus is part of the diencephalon, each hemisphere contains a thalamus. They
are located subcortically in the centre of the brain, close to the third ventricle (Bear et
al., 2006). The thalamus relays all information to the cortex and is therefore also called
the gate to consciousness (Crick and Koch, 2003). Still, the thalamus is also involved in
information processing and not only a relay station (Sherman and Guillery, 2002).
The thalamus is subdivided into several nuclei. First order nuclei fulfil different functions
in somatosensory information transduction to the cortex, while higher order nuclei relate
information between different cortical areas. First order nuclei receive information from
different inputs, e.g. visual, auditive and sensory information (Grant et al., 2012).
In this study, glial cells in the ventrobasal thalamus (VB) were studied. This region
is subdivided into the ventral posterior lateral (VPL) and the ventral posterior medial
(VPM) nuclei. It is a first order nucleus and receives input from the whiskers. These
13
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Figure 1.1 Thalamocortical circuits in the adult mouse brain. The line in the inset (brain
outline on top) indicates the slice orientation of the large section containing thalamocortical projections.
The coronal schematic slice depicts the signalling pathways between the ventrobasal thalamus (VB) and
somatosensory cortex. The VB receives synaptic input from the brain stem via the ascending pathway.
Thalamic neurons (red) relay information to layer 4 of the primary somatosensory cortex S1 (light
pink) and the cortex signals back from layer 6 to the VB (light green). The axons pass through
the internal commissure (ic). Both thalamo-cortical (TC) and cortico-thalamic (CT) neurons have
synaptic connections with GABAergic neurons in the reticular thalamic nucleus (RTN), establishing
inhibitory feedback and feedforward circuits to the VB (orange). Additionally, signals from layer 5 of
the somatosensory cortex signal (dark green) to the posterior thalamic nucleus (Po), a higher order
nucleus, which in turn projects (dark blue) to another cortical area, e.g. S2 (light blue). Str, striatum;
GP, globus pallidus. From Grant et al., 2012.
signals arrive in distinct areas termed barreloids, corresponding to barrels in the cortex
(Van Der Loos, 1976; Haidarliu and Ahissar, 2001; Lo´pez-Bendito and Molna´r, 2003).
The VB is therefore integrated in the trigeminal pathway, sending sensory information
via the brain stem to the thalamus and finally to the cortex (Bosman et al., 2011).
The VB receives synaptic input from the ascending pathway, also called lemniscal path-
way (Fig. 1.1). This pathway terminates on the dendritic arbor of VB neurons which
have excitatory glutamatergic synapses (Ralston, 1969). The VB nuclei contain relay
neurons projecting to the somatosensory cortex, mainly to layer 4 via the thalamo-
cortical (TC) pathway (Agmon and Connors, 1991). The VB contains a somatotopic
map of the whisker field as observed in the cortex (Erzurumlu et al., 2010). The relay
neurons reside completely in one barreloid with their dendrites during early develop-
ment, but starting around postnatal (p) day p18 they extend dendritic processes into
14
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neighbouring barreloids (Zantua et al., 1996). The axons extend through the retic-
ular thalamic nucleus (RTN) and the internal capsule to reach the cortex. TC neu-
rons make synapses on RTN neurons. GABAergic neurons in the RTN have an in-
hibitory effect on VB neurons by closing an inhibitory feedback loop. Cortical neu-
rons from layer 6 send information back to the VB via cortico-thalamic (CT) projec-
tions which also make synapses on RTN neurons (Bourassa et al., 1995; Pinault, 2011;
Grant et al., 2012), thereby providing an inhibitory feedforward circuit. In the VB they
make synapses on distal dendrites of relay neurons (Grant et al., 2012).
The thalamus does not only contain excitatory glutamatergic synapses and inhibitory
GABAergic synapses, but also electrical synapses in the RTN nucleus throughout life
(Landisman and Connors, 2005; Niculescu and Lohmann, 2013; Lee et al., 2014). Elec-
trical synapses were never observed in VB neurons after p12 (Lee et al., 2010).
The thalamus is highly interconnected with other brain regions and its normal function
is crucial for somatosensory information processing in the brain. Thalamic dysfunc-
tions have been associated with schizophrenia and absence epilepsies (Cope et al., 2009;
Pinault, 2011).
1.1.2 Hippocampus
The hippocampus is part of the cortex and located in the medial temporal lobe. The
name is derived from the Greek word for seahorse, because of its structure resembling
a seahorse. Similar to the thalamus, the hippocampus is a paired structure with a
hippocampus in each hemisphere. The hippocampus is subdivided in several regions:
Cornu Ammonis (CA) 1 to CA3 and the dentate gyrus (DG). The CA regions are further
subdivided in several layers. The stratum (st.) pyramidale (pyr.) contains the somata
of pyramidal neurons, stretching their axons in the st. oriens. On the other side of st.
pyr. the dendrites extend into the st. radiatum (rad.). The next layer is the st. lacuno-
sum moleculare. While excitatory pyramidal neurons reside with their somata in the
st. pyr., the other layers contain inhibitory interneurons and several types of glial cells.
The dentate gyrus has a typical V-shape and contains the neuronal granular cell layer,
the inside is called the hilus and the outer layer is the st. moleculare (Fig. 1.2; Amaral
and Witter, 1989). The innermost layer of the granule cell layer, the subgranular zone
(SGZ), is one of the neurogenic niches in the adult brain, containing neural stem cells
which continuously form new neurons (Seri et al., 2001).
The hippocampus has a well characterized neuronal signalling circuit, the trisynaptic
excitatory pathway, shown in Figure 1.2. Synaptic input from the entorhinal cortex ar-
rives in the dentate gyrus and is propagated by mossy fibres to CA3 pyramidal neurons.
Schaffer collaterals from CA3 neurons project on dendrites of CA1 pryamidal neurons
in st. radiatum. The axons of CA1 neurons signal back to the entorhinal cortex (Deng
et al., 2010).
The hippocampus is involved in learning and memory such as episodic and spatial mem-
ory. On a cellular level long lasting changes in synaptic transmission, called synaptic
15
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Figure 1.2 Anatomy and neuronal circuit of the hippocampus. The small inset depicts the
localization of the hippocampus in the murine brain. The hippocampus receives synaptic input from
the entorhinal cortex (EC) via the dentate gyrus (DG). Mossy fibres from the DG signal on CA3
neurons which in turn send information via the Schaffer collaterals to CA1 pyramidal neurons. Their
axons stretch into st. oriens in direction to the EC. The small image illustrates the localization of the
hippocampus in the rodent brain. LPP, lateral perforant pathway; MPP, medial perforant pathway.
From Deng et al., 2010.
plasticity, were correlated with memory formation. Rodents exposed to hippocampus-
related learning tasks displayed long lasting changes of synaptic strength (Martin and
Morris, 2002). The hippocampus is also involved in emotional behaviour. The emo-
tional status influences adult neurogenesis in the SGZ (Deng et al., 2010). Furthermore,
reduced adult neurogenesis impaired learning, the integration of newly formed neurons
is therefore essential for memory formation (Martin and Morris, 2002).
1.2 Glial cells in the brain
The brain consists of different cell-types. In addition to neurons, glia are important for
normal brain functions. These cells were discovered by Rudolf Virchow in the mid-1800s
and first administered a supportive role in the brain. Their name is derived from the
Greek word for glue (Virchow, 1846; Barres, 2008). Today the importance of glia in
the brain is widely recognized (Nedergaard et al., 2003; Barres, 2008; Lee et al., 2012;
Herculano-Houzel, 2014). Glial cells are divided into two subgroups, microglia and
macroglia. The latter group is further subdivided into astrocytes, oligodendrocytes,
NG2 cells and ependymal cells.
16
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1.2.1 Microglia
Microglia are the immune cells of the CNS resembling macrophages found in other
tissues. They have a small cell soma and several processes to continuously scan their
surroundings. They are present in all brain regions and are activated by inflammation
or lesions (Rock et al., 2004). Activation leads to morphological changes including a
more ramified structure. Furthermore, microglia migrate to the lesion site, proliferate
and remove toxic substances and debris by phagocytosis (Amat et al., 1996; Sierra et al.,
2013). Activated microglia in vitro display functional gap junction channels formed by
connexin43, in the brain activated microglia contain increased connexin43 protein levels
(Eugen´ın et al., 2001). The presence of functional gap junction channels could not be
confirmed in situ: Microglia never displayed tracer coupling to other cells irrespective
of their activation status (Richter et al., 2014; Wasseff and Scherer, 2014).
1.2.2 Ependymal cells
Ependymal cells have a cuboidal shape and line the walls of the ventricles. They evolve
from radial glia cells and have motile cilia for propulsion of the cerebrospinal fluid (CSF).
Furthermore, they play a role in brain homoeostasis by exchange of molecules with the
CSF (Spassky et al., 2005). A special subgroup of ependymal cells are the tanycytes
which line the floor of the third ventricle. These cells extend long processes to the
hypothalamus possibly propagating signals from the CSF to CNS neurons and another
process to blood vessels (Langlet, 2014). They are chemosensitive and modulate neuronal
activity to regulate brain energy balance, and are involved in energy homoeostasis by
regulating metabolic signalling to the hypothalamus (Langlet, 2014).
1.2.3 Astrocytes
Astrocytes are abundantly present throughout the brain. The name is derived from their
star-like morphology. They have a ramified structure with fine processes, their morphol-
ogy becomes increasingly complex with brain architecture. Furthermore, with increasing
brain complexity the ratio of astrocytes per neuron increases (Nedergaard et al., 2003;
Allaman et al., 2011).
Astrocytes are close interaction partners at the blood-brain-barrier and play a role in
the gliovascular network. Endothelial cells line the walls of the vasculature which are en-
wrapped by astrocytic endfeet to take up water, ions and metabolites from the blood and
release toxic substances, excess water and ions into the blood (Nedergaard et al., 2003;
Strohschein et al., 2011). Additionally, they control the blood flow in the brain and are
involved in angiogenesis, the formation of new blood vessels (Haydon and Carmignoto,
2006; Wang and Bordey, 2008). Astrocytes are therefore important for brain homoeosta-
sis, and express a variety of transporters and channels in their endfeet like aquaporins,
K+ channels, glucose transporters (GluT) and connexins (Wang and Bordey, 2008).
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Anatomical studies revealed that astrocytes reside in the brain in a non-overlapping
manner contacting each other with their processes (Bushong et al., 2002). Neighbouring
cells are connected with each other via gap junction channels (GJC) and thereby form a
network. In the hippocampus this network is established during early postnatal devel-
opment (Schools et al., 2006). Gap junction channel mediated networks will be further
described in section 1.4.
Electrophysiological analysis revealed a passive current pattern in whole-cell recordings.
Interestingly, astrocytes lacking GJC have a passive current pattern like pap junction
(GJ)-coupled astrocytes (Wallraff et al., 2006). The current pattern reflects the high
density of K+ channels, inward-rectifying K+ (Kir) and two-pore domain K+ (K2P )
channels (Kang et al., 1998; Wallraff et al., 2004; Seifert et al., 2009). In addition, their
membrane potential is close to the K+ equilibrium in the brain, around -80 to -90 mV
(Nedergaard et al., 2003; Wang and Bordey, 2008). A role in spatial K+ buffering was
already postulated in the 1960s for astrocytes and confirmed by several studies indicat-
ing K+ diffusion in the astroglial network and cell swellings in case of non-functional
networks (Orkand et al., 1966; Wallraff et al., 2006; Pannasch et al., 2011).
Astrocytes closely interact with neurons at synapses which led to the concept of the tri-
partite synapse (Araque et al., 1999; Agulhon et al., 2008; Pannasch and Rouach, 2013).
They enwrap synapses with their processes and take up neurotransmitters like gluta-
mate and GABA from the synaptic cleft and express glutamate transporters (Matthias
et al., 2003). Astrocytes respond to glutamate with increased [Ca2+]i levels mediated
by G-protein coupled receptors like mGluR5 in VB astrocytes (Nedergaard et al., 2003;
Parri et al., 2010). Furthermore, they express the enzyme glutamine synthetase (GS)
to transform glutamate into glutamine (Norenberg, 1979; Nedergaard et al., 2003). As-
trocytes also release gliotransmitters like D-serine, ATP and glutamate and are active
partners in neuronal activity in addition to uptake of neurotransmitters (Henneberger
et al., 2010; Sahlender et al., 2014).
Glutamine synthetase is one of the widely used astrocyte markers (Coulter and Eid,
2012). Further examples for classical astrocyte markers are glial fibrillary acidic pro-
tein (GFAP), the calcium binding protein S100β and aldehyde dehydrogenase 1 family,
member L1 (Aldh1L1) also known as 10-formyltetrahydrofolate dehydrogenase (FDH)
(Cahoy et al., 2008; Wang and Bordey, 2008). GFAP is expressed by hippocampal as-
trocytes, but not in the thalamus, while S100β was described in both thalamic and
hippocampal astrocytes (Frassoni et al., 2000; Matthias et al., 2003; Muneoka et al.,
2012). Aldh1L1 was found to be enriched in astrocytes in a transcriptome analysis, and
suggested to be a universal astrocyte marker throughout the brain (Cahoy et al., 2008).
In summary, astrocytes fulfil a variety of functions which are essential for brain ho-
moeostasis and thus for normal brain function.
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1.2.4 Oligodendrocytes and NG2 cells
Oligodendrocytes are the third macroglial cell-type in the brain. They have few ’oligo’
branches extending from the cell soma and are the myelinating cells of the CNS. Schwann
cells fulfil the same function in the PNS. In contrast to astrocytes they do not contact
blood vessels.
Interfascicular oligodendrocytes enwrap neuronal axons with their processes and thereby
insulate the axon. Myelination starts during postnatal development in a region depen-
dent manner with a peak expression of myelin proteins during the third postnatal week
(Verity and Campagnoni, 1988; Fuss et al., 2000). The myelin sheath is an extension of
the cell membrane and consists of several membrane layers. The cell membrane is a lipid
bilayer and in the myelin sheath additionally contains glycosphingolipids, sulphatides like
O4 and galactolipids. The cytoplasm is extruded from these layers. Additionally, it con-
tains proteins like myelin basic protein (MBP), phospholipoprotein (PLP), 2’,3’-cyclic
nucleotide 3’-phosphodiesterase (CNPase) and also connexins. The axon is not entirely
enwrapped, but in between consecutive myelinated parts it has direct contact to the
extracellular space at the nodes of Ranvier.
Another class of oligodendrocytes are non-myelinating perineuronal oligodendrocytes.
These cells are located in apposition to neuronal cell bodies in grey matter like cortex.
They express CNPase and GS, but no glutamate transporters like GLAST or GLT1 and
might play a role in metabolic support (Takasaki et al., 2010).
Mature myelinating oligodendrocytes are typically identified by their expression of myelin
proteins CNPase, MBP and PLP (Cahoy et al., 2008; Jahn et al., 2009). The develop-
ment of oligodendrocytes has been widely studied and differentiation stages are distin-
guished by changes in morphology and marker expression.
During early development precursors express several transcription factors like Olig1,
Olig2, and Sox10 which regulate cell proliferation and development. Oligodendrocyte
precursors express NG2 and platelet derived growth factor receptor α (PDGFαR) and
later differentiate into myelinating cells in the juvenile brain (Karram et al., 2008;
Nishiyama et al., 2009; Trotter et al., 2010). NG2 (nerve-glia antigen 2) cells were
discovered in the 1980s by Stallcup using antibodies against the chondroitin sulphate
proteoglycan 4 (CSPG4; Stallcup, 1981. Still, some of these NG2 expressing cells reside
in the mature brain and are synaptically innervated by neurons (Bergles et al., 2000;
Jabs et al., 2005). The expression of Ca2+ permeable (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid) (AMPA) receptors was confirmed in hippocampus and thalamus
(Seifert and Steinha¨user, 1995; Parri et al., 2010). In the adult brain in white matter
Olig2 expressing precursors differentiate into myelinating oligodendrocytes, while in grey
matter these cells persist as NG2 cells (Dimou et al., 2008). The role of these cells in the
mature brain remains elusive. Interestingly, NG2 cells seem to scan their environment
with their highly motile processes and respond to synaptic input with local Ca2+ ele-
vations (Haberlandt et al., 2011). The NG2 protein is a transmembrane protein which
might play a role in stabilizing Neuron-NG2 synapses. However, employing NG2 knock-
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out mice this effect could not be confirmed, even though an earlier study showed that
NG2 and AMPA receptors are clustered intracellularly by glutamate receptor interaction
protein (GRIP; Stegmu¨ller et al., 2003; Passlick et al., 2014). NG2 cells are sometimes
referred to as the fourth macroglial cell-type, as not all of these cells differentiate into
oligodendrocytes.
Oligodendrocytes express a set of connexins which is different from astrocyte connex-
ins. As mentioned before, oligodendrocytes comprise connexin channels in their myelin
sheath (see above). Additionally, oligodendrocytes form a gap junction network in white
matter which also contain NG2 cells (Maglione et al., 2010; Tress et al., 2012) and will
be further described in section 1.4.
1.2.5 RG-like cells
Radial-glia like cells (RG-like cells) are neural stem cells in the adult brain. These cells
reside in neurogenic niches in the subventricular zone of the lateral ventricle and the SGZ
of the DG (Doetsch et al., 1999; Seri et al., 2001). RG-like cells have a characteristic
morphology with their cell soma located in the SGZ and a long process stretching through
the granule cell layer (Filippov et al., 2003b). These cells proliferate and thereby generate
new neural precursor cells which differentiate into neurons (Seri et al., 2001; Doetsch,
2003). RG-like cells have astrocyte-like properties, e.g. they express GFAP and gap
junction proteins and are coupled to neighbouring cells (Seri et al., 2001; Kunze et al.,
2009). Functional analysis revealed a localization dependent presence of AMPA receptors
on their processes, glutamate transporters on the soma and gamma-aminobutyric acid
(GABAA) receptors on the entire cell surface (Renzel et al., 2013). This is in contrast to
hippocampal astrocytes which do not express AMPA receptors but comprise glutamate
transporters (Matthias et al., 2003).
Like radial glia in the embryonic brain, RG-like cells serve as a scaffold for migrating
neural precursors during differentiation (Frassoni et al., 2000; Elias et al., 2007). Radial
glia trans-differentiate into astrocytes when migration is completed in contrast to RG-
like cells (Schmechel and Rakic, 1979; Doetsch, 2003; Kimelberg, 2004). Recent results
indicate a role in memory and learning for newly generated neurons (Deng et al., 2010).
1.3 AMPA and GABAA receptors in glial cells
For a long time astrocytes were thought to be passive cells located between neurons.
They display a passive current pattern in response to de- and hyperpolarizing voltage
steps. Today we know that astrocytes express a variety of channels despite their passive
current pattern. These channels are either ionotropic receptors leading to ion flux over
the membrane or metabotropic receptors that activate second messengers and thereby
induce a signalling cascade in the cell.
VB astrocytes express a variety of receptors like histamine receptors, AMPA (GluA1),
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NMDA (NR2B), GABAA, group I mGluRs and group II mGluA2+3 receptors (Parri et
al., 2001; Parri and Crunelli, 2002). Neuronal synaptic activity leads to [Ca2+]i increases
in thalamic astrocytes by activating mGluAs on astrocytes (Pirttimaki and Parri, 2012).
Additionally, VB astrocytes display spontaneous Ca2+ oscillations in young mice at p4,
which decrease until p14. Interestingly, these oscillations have pacemaker properties at
a frequency of 0.019Hz (Parri and Crunelli, 2001).
AMPA receptors are ionotropic receptors activated by glutamate. They are transmem-
brane channels expressed by neurons and glial cells (Burnashev et al., 1992). There are
four different AMPA receptor subunits GluA1, GluA2, GluA3 and GluA4. The presence
of the GluA2 subunit and its RNA-editing at the Q/R-site is responsible for the Ca2+ im-
permeability. The subunits exist in two splice isoforms known as ”flip” and ”flop” which
differ in a small sequence of the extracellular loop prior to the fourth transmembrane re-
gion. Splice isoforms along with a second RNA-editing site, the R/G-site, influence chan-
nel gating kinetics. Four of these subunits form an ion channel (Burnashev et al., 1992;
Bear et al., 2006; Guzman and Jonas, 2010). In response to neurotransmitter activation
the channel opens and permits the influx of the cations Na+, K+ and Ca2+, the latter
only in the absence of the GluA2 subunit.
Astrocytes respond to glutamate application with inward currents (Steinha¨user et al.,
1994). In cerebellar Bergmann glia functional AMPA receptors display high Ca2+ per-
meabilities and do not express the GluA2 subunit (Burnashev et al., 1992; Mu¨ller et al.,
1992). Loss of AMPA receptors induce retraction of processes from synapses and have
severe consequences on a behavioural level by impaired motor performance (Saab et al.,
2012). In the supraoptic nucleus of the hypothalamus two distinct types of astrocytes
were observed. One type lacks AMPA receptors and glutamate uptake and the second
type expresses glutamate transporters (Matyash and Kettenmann, 2010).
In the murine hippocampus distinct cell-types were observed according to their gluta-
mate currents. Cells displaying a complex current pattern, known as NG2 cells, express
AMPA receptors, while passive astrocytes express glutamate transporters (Matthias et
al., 2003; Seifert et al., 2003). These observations were confirmed by a study in the rat
hippocampus analysing astrocytes termed variable-rectifying astrocytes and NG2 cells
termed outward-rectifying astrocytes (Zhou and Kimelberg, 2001).
The group of glutamate receptors includes NMDA and kainate receptors in addition
to AMPA receptors. Astrocytes lack NMDA receptors in most brain regions. Only in
cortical astrocytes and Bergmann glia functional NMDA receptors were reported which
display a weaker Mg2+ block compared to neuronal NMDA receptors (Wang and Bor-
dey, 2008; Matyash and Kettenmann, 2010). Kainate receptors are not expressed by
astrocytes (Porter and McCarthy, 1997).
GABAA receptor channels are composed of 5 subunits, usually 2 α-, 2 β- and 1 γ- or δ-
subunit. Every subunit is encoded by related genes. There are 6 different α-, 3 β-, 3 γ-
and 1 δ- genes (Kandel et al., 2012). These gene transcripts are differentially expressed
in a region dependent manner and are developmentally regulated. The α3 mRNA was
found to be highly expressed in the RTN, while in the ventral posterior nucleus α1, α4,
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β2 and δ were the predominating mRNAs. In hippocampal pyramidal cells and granule
cells in the dentate gyrus express high levels of many GABAA mRNAs, but completely
lack α4 expression (Wisden et al., 1992). During embryonal and early postnatal devel-
opment the expression pattern in the cortex and thalamus differs from adult brain. In
young animals the α2, α3, α5 and β3 were prominently expressed and then downregu-
lated before being replaced by other gene transcripts (Laurie et al., 1992). The presence
of the γ2 subunit is a characteristic feature of synaptic GABAA receptors in neurons as
well as in NG2 cells (Passlick et al., 2013). Activation of these channels allows influx of
the anions Cl− and HCO−3 . This induces a depolarization in young neurons and a hyper-
polarization in mature neurons due to the increasing expression of the KCl cotransporter
KCC2 (Stein et al., 2004), thereby providing an inhibitory effect in neurons. Astrocytes
do not make synapses with other cells and lack this subunit. Furthermore, they lack the
neuron-specific KCC2 and respond to GABA with a depolarization (Stein et al., 2004;
Matyash and Kettenmann, 2010).
In contrast to glutamate receptor currents all astrocytes express GABAA receptor cur-
rents. Bergmann glia cells display developmentally regulated GABAA receptor expres-
sion with a peak at p7-10 (Matyash and Kettenmann, 2010). Also astrocytes in the
hippocampus and supraoptic nucleus always display GABAA receptors as well as RG-
like cells. Furthermore, both in mouse and rat, NG2 cells and astrocytes express these
receptors (Steinha¨user et al., 1994; Zhou and Kimelberg, 2001; Passlick et al., 2013;
Renzel et al., 2013).
1.4 Connexin gap junction channels
Vertebrates express connexin (Cx) gap junction proteins which are a class of transmem-
brane proteins. There are different types of connexins which are distinguished by their
molecular weight, e.g. Cx30 has a molecular weight of 30 kDaltons (kDa; Beyer et al.,
1989). Another nomenclature involves gene names which are grouped in families (α,
β, γ, etc.) defined by sequence homology of the different connexins and length of the
cytoplasmic C-terminus (So¨hl et al., 2001). There are 21 known connexins in humans
and 20 connexins in mouse with a molecular weight between 23 to 62 kDa and 23 to
57 kDa respectively. 11 connexins were found in nervous tissue (Willecke et al., 2002;
So¨hl and Willecke, 2003; Giaume et al., 2010).
Six connexin subunits form a hemichannel in the cell membrane, known as connexon.
By rearrangement of the connexin proteins the channel can be closed (Willecke et al.,
2002). Two adjacent hemichannels form a gap junction channel (GJC) to connect
the cytoplasm of two cells. Several GJC assemble and thereby form a GJ plaque
(Fig.1.3A). The GJC can be formed by two connexons of the same connexin type,
termed homotypic channels, or by connexons of two different connexins forming a het-
erotypic channel. Additionally, one hemichannel can be formed by one or several types
of connexin proteins. Homomeric hemichannels are formed by one type of connexin
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and heteromeric channels contain different connexin proteins (Willecke et al., 2002;
Goldberg et al., 2004). Connexins have four transmembrane domains, two extracellular
loops, one intracellular loop and the N- and C-terminal tails located in the cytoplasm.
Sequences are partially highly conserved, like the cysteine residues required for extracel-
lular disulfide bonds, or variable, like the length of the C-terminus or the length of the
extracellular loops (Fig. 1.3B; Rozental et al., 2000; Willecke et al., 2002). A crystal
structure analysis by Maeda et al. (2009) of the Cx26 GJC revealed the ultrastructure of
the channel. All transmembrane domains are helices. The N-terminal helices form the
channel wall and are therefore responsible for channel permeability for small molecules,
e.g. the Cx26 GJC has a diameter of 14 A˚ at its smallest site (Maeda et al., 2009).
GJC are selectively permeable regarding molecular weight, shape, net charge and the
resulting interactions with the connexins forming the channel (Goldberg et al., 2004;
Giaume et al., 2010). The pore domain connects the cytoplasm of two adjacent cells and
allows the diffusion of small molecules below 1-1.2 kDa in size (Laird, 2006; Giaume et
al., 2010). Extensive in vitro studies have been performed using different tracers to anal-
yse connexon and GJC permeability for these molecules (Elfgang et al., 1995; Yum et al.,
2007; Ahn et al., 2008; Orthmann-Murphy et al., 2007b; Magnotti et al., 2011b). In the
brain GJC are important for exchange of second messengers (cAMP, IP3), ions (K
+, Na+,
Ca2+), water and metabolites (glucose, lactate) among others (Holthoff and Witte, 2000;
Niermann et al., 2001; Rouach et al., 2002; Bedner et al., 2006; Wallraff et al., 2006;
Rouach et al., 2008; Giaume et al., 2010).
The length of the C-terminus is highly variable between connexins (see above) and con-
tains several phosphorylation sites and binding sites for cytoplasmic matrix proteins,
e.g. Zona occludens (ZO)-1, ZO-2, α- and β-tubulin (Laird, 2006). The phosphory-
lation of serine or tyrosine amino acids by mitogen-acitvated protein kinase (MAPK),
protein kinase A (PKA), protein kinase C (PKC), v- and c-src kinases modulates the
life cycle of connexins and gating properties of GJC (Lampe and Lau, 2000; Laird, 2006;
Solan and Lampe, 2014). Interestingly, the lifetime of connexins is very short and
highly regulated in an activity dependent manner by phosphorylation and binding to
tight-junction associated proteins ZO-1 and ZO-2. The latter are involved in GJ assem-
bly and stabilization in the membrane (Duffy et al., 2002; Laird, 2006).
Connexins are expressed in different organs, among others in heart, liver and brain. Fur-
thermore, their expression is developmentally regulated, region dependent and cell-type
specific (Dermietzel et al., 1989; Willecke et al., 2002; Nagy et al., 2004; Theis et al.,
2005). Most cell-types express several connexins, e.g. astrocytes express Cx26, Cx30
and Cx43, while oligodendrocytes express a different set of connexins: Cx29, Cx32 and
Cx47 (Nagy et al., 2003; Bedner et al., 2012). A specific connexin is expressed by several
cell-types, e.g. in the brain Cx43 is expressed by astrocytes, leptomeningeal cells and
ependymal cells (Laird, 2006).
Connexin hemichannels, which connect the cytoplasm with the extracellular space, were
observed in many cells (Willecke et al., 2002; Goodenough and Paul, 2003). Un-
der physiological conditions these hemichannels are mostly closed. Additionally, cells
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Figure 1.3 Gap junction plaque topology and connexin structure. (A) Gap junction plaques
consist of several gap junction channels between two adjacent cells which are formed by connected
hemichannels. Six connexins form a hemichannel. Gap junction channels consisting of one connexin
type are homomeric/homotypic (1), when composed of different connexins they are termed heteromeric
(2), and in case of two connected hemichannels of different connexins heterotypic (3). (B) Connexins
have 4 transmembrane domains, two extracellular loops, one intracellular loop and the N- and C-
terminal tails on the cytoplasmic side. Extracellular disulphide bonds are highly conserved, in addition,
several connexins contain phosphorylation sites on their C-terminal tail. From So¨hl et al., 2005.
also contain another channel protein in mammals, termed pannexins, which show sub-
stantial homology to innexins found in invertebrates (Goodenough and Paul, 2003;
Giaume et al., 2010). They might be involved in gliotransmitter release and open in
response to physiological and pathophysiological stimuli (Bennett et al., 2012; Orellana
and Stehberg, 2014).
Several human diseases are associated with connexin mutations and mouse models have
been generated to study modifications or complete loss of connexin (Willecke et al.,
2002; Laird, 2006; Giaume et al., 2010). Loss of Cx26 leads to non-syndromic deafness
and in some cases to alterations in the skin (Cohen-Salmon et al., 2002; Laird, 2006).
Several Cx32 mutations lead to X-linked Charcot-Marie-Tooth disease, a neuropathy
affecting the PNS by demyelination (Willecke et al., 2002; Menichella et al., 2003).
Oculodentodigital dysplasia (ODDD) is a disease caused by mutations in the human Gja1
gene, coding for Cx43, and includes abnormalities of the fingers, toes, eyes, face and teeth
(Laird, 2006; Dobrowolski et al., 2008). Recessive mutations of Cx47 lead to Pelizaeus-
Merzbacher-like disease, a progressive leukodystrophy involving hypomyelination and
spasticity by loss-of-function mutations (Orthmann-Murphy et al., 2007a; Tress et al.,
2011). Connexin expression and proper GJ formation is therefore crucial for normal
brain function.
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1.4.1 Astrocyte connexins
Astrocytes express three connexins: Cx26, Cx30, and Cx43, which are not expressed
by oligodendrocytes or neurons in the CNS (Rash et al., 2001; Nagy and Rash, 2003).
Glial cells have >100x more GJC than neurons. Considering the spatial anatomical
domains of astrocytes and assuming a uniform distribution of these GJC on the cell
surface, most interastrocytic (A/A) junctions must be autologous (Rash et al., 1998;
Bushong et al., 2002; Nagy and Rash, 2003). Most likely these reflexive GJC fa-
cilitate homoeostasis between different cellular compartments (Grosche et al., 1999;
Rouach et al., 2002). GJC with neighbouring cells are mostly located at the endfeet
of astrocytes enwrapping blood vessels and at their fine processes (Giaume et al., 2010).
Functional studies in several brain regions revealed that astrocyte networks selectively
overlap with neuronal functional entities (Houades et al., 2006; Houades et al., 2008;
Roux et al., 2011). Furthermore, these networks adapt to changes in neuronal activity
and are required for normal brain function (Rouach et al., 2008; Pannasch et al., 2012).
Cx26 is expressed in astrocytes and leptomeninges in the CNS and in the inner ear. It
has been widely studied due to its mutations causing a non-syndromic deafness (Rash
et al., 2001; Willecke et al., 2002). Cx26-deficient mice die early in embryogenesis
due to impaired transplacental glucose uptake (Gabriel et al., 1998). In the brain
Cx26 was detected around blood vessels, in leptomeninges and in astrocytes and has
a perivascular, sub-pial and subependymal localization (Mercier and Hatton, 2001).
Cx26 shows subcellular colocalization with Cx30 and Cx43. GJCs between astrocytes
containing Cx26 and Cx30 are often found near neuronal processes (Nagy et al., 2001;
Rash et al., 2001). Furthermore, Cx26 was detected in GJ plaques together with Cx32
(Nagy et al., 2001; Rash et al., 2001). Cx26 is differentially expressed with highest
levels during embryonal development and early postnatal life and decreasing thereafter
in the brain (Dermietzel et al., 1989; Nagy et al., 2001). In the adult brain high lev-
els of Cx26 were observed in the thalamus, while in the hippocampus only low levels
and in the cortex no Cx26 was detected apart from leptomeninges (Nagy et al., 2001;
Nagy et al., 2011). A study employing Cx26+/LacZ mice did not confirm astrocytic Cx26
expression, though the reporter was found in leptomeninges in the brain and in other
organs (Filippov et al., 2003a). Cx26 is highly homologous to Cx30 and in some studies
antibodies cross-reacting with Cx30 were applied, overestimating Cx26 expression in the
brain (Orthmann-Murphy et al., 2008). The Gjb2 locus is located near the Gjb6 (Cx30)
locus on chromosome 14 (Willecke et al., 2002; Boulay et al., 2013).
Cx30 is also found in astrocytes, but in contrast to Cx26, it is only expressed dur-
ing postnatal development starting from the second postnatal week (Dahl et al., 1996;
Kunzelmann et al., 1999). It is located near blood vessels and expressed by ependymal
cells and leptomeningeal cells in addition to astrocytes (Kunzelmann et al., 1999). Mu-
tations of Cx30 were thought to induce deafness due to observations in a Cx30 knock-out
mouse line. These mice were affected by the additional loss of Cx26 due to the prox-
imity of the genes on one chromosome (Teubner et al., 2003; Lynn et al., 2011). A
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recently generated new knock-out mouse was healthy and hearing was normal (Boulay
et al., 2013). The expression level of Cx30 is lower in the hippocampus compared
to Cx43, the third connexin expressed by astrocytes (Gosejacob et al., 2011). Func-
tional analysis employing the tracer biocytin revealed a differential impact on network
formation of 22% or around 50% reduction in network size (Gosejacob et al., 2011;
Pannasch et al., 2014). Furthermore, Cx30 is not expressed by white matter astro-
cytes and is selectively higher permeable for cations over anions (Nagy et al., 1999;
Nagy et al., 2004; Yum et al., 2007). Expression levels of Cx30 in the cerebellum
and thalamus are higher compared to hippocampus (Nagy et al., 1999; Gosejacob et
al., 2011). Cx30 plays a role in astrocytic glutamate transport and thereby influences
synaptic transmission (Pannasch et al., 2014). Immunohistochemical analysis revealed
colocalization with Cx43 (Kunzelmann et al., 1999; Nagy et al., 1999).
Cx43 is widely expressed throughout the body, and because of its crucial role in heart
function many studies were performed on expression and regulation of Cx43 (Yamamoto
et al., 1990; Lampe and Lau, 2000; Laird, 2006). Cx43 expression in the brain is up-
regulated during embryonal development and remains high through adulthood (Der-
mietzel et al., 1989). The Gja1 gene is located on chromosome 10 and is also ex-
pressed by leptomeningeal cells and ependymocytes in the brain (Rash et al., 2001;
Willecke et al., 2002). Loss of Cx43 in hippocampal astrocytes leads to a 50% de-
crease in network size, spreading depression in neurons and to an increase in Cx30
protein levels (Theis et al., 2003; Degen et al., 2012). Loss of both Cx30 and Cx43
leads to complete uncoupling of astrocytes in the hippocampus, dysmyelination and
vacuolizations (Wallraff et al., 2006; Lutz et al., 2009; Pannasch et al., 2011). Further-
more, spatial K+ buffering, metabolite transport and neurotransmitter clearance are im-
paired leading to increased synaptic transmission and spontaneous epileptiform activity
amongst others. Hippocampal astroglial networks modulate extracellular homoeosta-
sis and thereby influence synaptic strength (Wallraff et al., 2006; Rouach et al., 2008;
Pannasch et al., 2011).
Radial glia-like cells are neuronal precursors which reside in neurogenic niches in the
adult brain. These cells have astrocyte like properties and express Cx30 and Cx43, dele-
tion of both connexins resulted in uncoupled RG-like cells in the subgranular zone of the
dentate gyrus (Kunze et al., 2009; Liebmann et al., 2013). Recently, it was shown that
Cx30 expression is not required for adult neurogenesis, but Cx43 is important (Liebmann
et al., 2013). In addition, connexins have a non-channel function influencing migration
of neuronal precursors (Elias et al., 2007).
In conclusion, astrocytes express Cx26, Cx30 and Cx43 in vivo to form gap junctions
and establish a glial network whose function is closely linked to neuronal activity.
1.4.2 Oligodendrocyte connexins
Oligodendrocytes express a specific set of connexins that differs from astrocytes: Cx29,
Cx32 and Cx47 (Dermietzel et al., 1989; Rash et al., 2001; Altevogt et al., 2002;
26
Introduction
Nagy and Rash, 2003). Interestingly, in freeze-fracture replica immunogold labelling
analysis interoligodendrocytic (O/O) junctions were rarely or not at all observed (Massa
and Mugnaini, 1982; Rash et al., 2001; Kamasawa et al., 2005). Gap junction plaques on
oligodendrocytes were connected to astrocytes or established autologous junctions be-
tween cell membrane layers (Rash et al., 2001; Nagy and Rash, 2003; Nagy et al., 2004;
Kamasawa et al., 2005).
Cx29 was never located in gap junction plaques between cells, but rather in autolo-
gous junctions between different layers of the myelin sheath close to nodes of Ranvier
in the adult brain, but also at the cell soma (Li et al., 2002; Nagy and Rash, 2003;
Nagy et al., 2003; Nagy et al., 2004; Kamasawa et al., 2005; Ahn et al., 2008). The Gje1
gene on chromosome 5 is expressed from the first postnatal week and is gradually upreg-
ulated until adulthood (So¨hl et al., 2001; Willecke et al., 2002; Nagy et al., 2003). The
expression is restricted to neural tissue in PNS Schwann cells and CNS oligodendrocytes
(Altevogt et al., 2002; Nagy et al., 2004). Functional analysis of gap junction networks
in white matter revealed no decrease in network size upon loss of Cx29 which confirms
the non-intercellular gap junction localization of Cx29 (Maglione et al., 2010). Western
blot analysis revealed high expression levels in the thalamus and lower expression in the
hippocampus and cortex, probably accounting for the differences in myelination in these
brain regions (Nagy et al., 2003). In the myelin sheath Cx29 was found to colocalize
with Cx32, the second oligodendrocytic connexin (Nagy et al., 2004).
Several studies located Cx32 on oligodendrocyte somata, initial processes and in the
myelin sheath (Nagy et al., 2003; Nagy et al., 2004; Kamasawa et al., 2005). It is
especially located at Schmidt-Lantermann incisures, between paranodal loops close to
nodes of Ranvier and in the outermost layer of myelin, but not in compact myelin and
rarely at A-O junctions (Scherer et al., 1995; Nagy et al., 2004; Kamasawa et al., 2005).
In contrast, in the PNS Cx32 was only observed between myelin layers of Schwann
cells (Scherer et al., 1995; Menichella et al., 2006). Expression of the Gjb1 -encoded
Cx32 is only detected during postnatal development starting from the second postnatal
week and is not restricted to neural tissue (Dermietzel et al., 1989; Nelles et al., 1996).
Loss of Cx32 in mice did not induce any neurological disorders (Nelles et al., 1996;
Scherer et al., 1998). Functional studies in white matter areas revealed no impact of
Cx32 on glial network size (Maglione et al., 2010). In vitro studies revealed restricted
passage of anions through Cx32 GJC (Goldberg et al., 2004). In the outer myelin layers
Cx32 was found together with Cx47 (Kamasawa et al., 2005).
Initial studies revealed Cx47 expression mainly in neural tissue, especially in neurons
(Teubner et al., 2001). Cx47 is encoded by the Gja12 gene on chromosome 11. Fur-
ther analysis detected Cx47 only in oligodendrocytes, but not in neurons, and confirmed
the mainly neural tissue expression (Menichella et al., 2003; Odermatt et al., 2003;
Kamasawa et al., 2005). Cx47 was mainly localized on the soma of oligodendrocytes
and on the outer surface of the myelin sheath, most likely at A-O junctions (Menichella
et al., 2003; Nagy et al., 2003). In functional studies employing tracer diffusion, loss
of Cx47 had a strong impact on network size. Additional loss of Cx32 led to un-
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coupled oligodendrocytes (Maglione et al., 2010). Furthermore, loss of Cx47 induced
morphological alterations in the CNS including vacuolizations between the axon fi-
bre and the myelin sheath (Menichella et al., 2003; Odermatt et al., 2003). Cx47
is therefore highly important for myelination. It is upregulated together with myeli-
nating proteins, first detected around p10 and highly expressed until p30, while in
adult mice expression levels are lower (Menichella et al., 2003). Additionally, loss
of Cx47 is accompanied by loss or relocation of other glial connexins in the brain,
but not by upregulation of other oligodendrocyte connexins (Odermatt et al., 2003;
Li et al., 2008). In conclusion, connexin expression in oligodendrocytes is important for
normal myelination and homoeostasis in the brain (Kamasawa et al., 2005; Maglione et
al., 2010).
1.4.3 Neuronal connexins
Neurons communicate with each other via chemical or electrical synapses. Gap junc-
tion channels in neurons form electrical synapses which play an important role dur-
ing the prenatal phase of neurogenesis (Kunze et al., 2009; Niculescu and Lohmann,
2013). At this early stage of development a simple communication method is required
to coordinate proliferation, migration and positioning of the neurons in the neocor-
tex (Montoro and Yuste, 2004). Chemical synapses mainly develop during postna-
tal development, when neuronal circuits are established, and might be better suited
for neuronal communication in adulthood (Montoro and Yuste, 2004; Niculescu and
Lohmann, 2013; Pereda, 2014). Brain maturation involves synaptic pruning, unneces-
sary chemical synapses are eliminated during this process. Electrical synapses aid in
this process and also microglia are involved in synaptic pruning (Paolicelli et al., 2011;
Pereda, 2014).
Even though most electrical synapses disappear during postnatal development, some
electrical synapses persist throughout life in several brain regions (Connors and Long,
2004). For formation of these synapses neurons express mainly Cx36 and Cx45 which
are differentially regulated (Belluardo et al., 2000; Kru¨ger et al., 2000). Cx36 expres-
sion starts during late embryogenesis and increases within the first postnatal week,
before it slightly declines, but is still expressed throughout life (Bittman et al., 2002;
Maxeiner et al., 2003). The Cx36 gene Gja9 is located on chromosome 2 (So¨hl and
Willecke, 2003).
In contrast, Cx45 is embryonally expressed with a peak expression in the second post-
natal week and is downregulated afterwards in most brain regions. In adulthood, Cx45
expression has been observed only in the thalamus, CA3 region of the hippocampus,
the molecular layer of the cerebellum and layers II and VI in the parieto-occipital and
entorhinal cortex (Kru¨ger et al., 2000; Maxeiner et al., 2003). The Gja7 gene is located
on chromosome 11 and its expression parallels the astrocytic Cx26 expression pattern
during development (Maxeiner et al., 2003; So¨hl and Willecke, 2003).
Though chemical synapses replace electrical synapses in most brain regions, interneurons
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in the cortex and RTN neurons in the thalamus remain highly connected in the adult
brain, while in the VB electrical synapses were only found before the end of the second
postnatal week (Niculescu and Lohmann, 2013). Starting in the second postnatal week
these electrical synapses are replaced and a disynaptic circuit including RTN neurons is
established (Lee et al., 2010).
These gap junctions are not exclusively found between neurons, but also between neurons
and astrocytes in the juvenile cortex and locus ceruleus (Alvarez-Maubecin et al., 2000;
Bittman et al., 2002). In the cortex these gap junctions were asymmetric, therefore
dye transfer was observed only from astrocytes to neurons at p7 and developmentally
reduced already at p14 (Bittman et al., 2002).
Connexin expression is abundant in neurons and their precursors and developmentally
downregulated during maturation of the brain.
1.4.4 Heterotypic gap junction channels between glial cells
Gap junction channels were first thought to be exclusively formed between cells of the
same type. Freeze fracture studies in the early 1980s revealed that GJC also occur be-
tween astrocytes and oligodendrocytes in the white matter of the cat brain (Massa and
Mugnaini, 1982). These gap junctions were mainly observed on oligodendrocyte somata,
initial processes and the uncompacted outermost myelinating processes (Massa and Mug-
naini, 1982; Nagy and Rash, 2003). These channels were expected to be heterotypic as
astrocytes and oligodendrocytes express a different set of connexins (Orthmann-Murphy
et al., 2008).
In vitro studies in HeLa and N2A cells confirmed the function of GJC between as-
trocytic and oligodendrocytic connexons, though not all combinations are permeable.
The following combinations produced functional channels in HeLa cells: 26/26, 30/30,
43/43, 32/32, 47/47, 26/30, 26/32, 30/32, 30/47 and 43/47 (Elfgang et al., 1995;
Yum et al., 2007; Magnotti et al., 2011b). Connexins 32/47, 26/47 and 32/43 do not
form heterotypic channels and Cx29 does not form intercellular channels (Altevogt and
Paul, 2004; Ahn et al., 2008; Magnotti et al., 2011b). The in vitro study employing
N2A cells confirmed most of these data, but opposite to the above mentioned results
no functional heterotypic channels were observed for connexins 30/43 and 30/47, the
latter is in contrast to findings in HeLa cells (Orthmann-Murphy et al., 2007b). In
conclusion, the cell culture studies suggested that functional channels between astro-
cytes and oligodendrocytes are formed by connexins 30/32 and 43/47 (Nagy et al., 2003;
Orthmann-Murphy et al., 2007b). An immunohistochemical study in the spinal cord
proposed functional channels formed by 26/32, 30/47 and 43/47 (Altevogt and Paul,
2004).
Heterotypic channels were intensively studied as it was thought that oligodendrocytes do
not form GJC with each other and are connected via astrocytes (Massa and Mugnaini,
1982; Nagy et al., 2004). Even though in cell culture oligodendrocyte connexins proofed
to form functional channels (see above). Functional analysis in the corpus callosum
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confirmed the presence of direct GJC between oligodendrocytes (Maglione et al., 2010;
Wasseff and Scherer, 2011), while in the cortex these GJC did not exist (Wasseff and
Scherer, 2011). Furthermore, the in vivo studies suggested Cx47 to be the most im-
portant connexin in white matter for astrocyte-oligodendrocyte GJCs as loss of Cx47
abolished panglial networks as revealed by biocytin diffusion (Maglione et al., 2010).
The study by Wasseff and Scherer (2011) employed Sulforhodamine-B and found Cx32
to be more important for network size. These discrepancies most likely reflect the GJC
selectivity for different dyes.
Several studies demonstrated the subcellular relocation of connexins, when one connexin
is deleted in cells. Loss of Cx32 reduced Cx30 and Cx26 on oligodendrocyte somata in
several brain regions, while Cx43 and Cx47 were not affected (Nagy et al., 2003). Like-
wise loss of Cx30 leads to relocation of Cx32 (Lynn et al., 2011).
Loss of one connexin usually leads to a mild phenotype with only minor morphological
changes in the brain (Dere et al., 2003; Menichella et al., 2003; Odermatt et al., 2003;
Theis et al., 2003; Sargiannidou et al., 2009). In contrast, double knock-out (DKO) of
two connexins usually leads to severe phenotypes and partial mortality. Several DKO
lines were generated of which the 30/43 and 43/47 DKO were reported to be viable
with modest changes in brain morphology (Wallraff et al., 2006; Lutz et al., 2009;
Kunze et al., 2009; Magnotti et al., 2011a). Three other DKOs, one lacking oligo-
dendrocyte connexins 32/47, and two combinations impairing panglial coupling by lack
of 30/47 and 32/43 displayed severe changes in brain morphology, especially in myeli-
nated areas, but also grey matter areas (Menichella et al., 2003; Odermatt et al., 2003;
Menichella et al., 2006; Magnotti et al., 2011a; Tress et al., 2012). Morphological
changes involved alterations in myelin structure including vacuolizations, astrogliosis
and microglia activation. These alterations lead to severe phenotypes. The 32/43 DKO
displayed absence-like seizure activity and sensorimotor impairments (Magnotti et al.,
2011a). Interestingly, not all 30/47 DKOs were affected by early mortality and surviving
animals displayed intact oligodendrocyte networks and elevated Cx32 levels, although
astrocyte-oligodendrocyte connections were lost.
A recent study demonstrated that ablation of Cx43 destabilizes Cx47 in the oligoden-
drocyte membrane by alterations in Cx47 phosphorylation (May et al., 2013), which
explains the similarities of the phenotype in Cx32/43 compared to Cx32/47 DKOs.
Loss of oligodendrocyte connexins led to myelin vacuolizations, axon loss, reduced oligo-
dendrocyte numbers and as a consequence to action tremors (Menichella et al., 2003;
Odermatt et al., 2003; Menichella et al., 2006). In these mice, oligodendrocyte coupling
to neighbouring astrocytes and oligodendrocytes is abolished (Maglione et al., 2010;
Wasseff and Scherer, 2011).
The described alteration in mice lacking two connexins indicate that the cells are not
able to compensate for the lack of more than one connexin. Along with the observed
severe phenotypes, there is strong evidence that glial networks are required for normal
brain function.
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1.5 Neuron-Glia Network Interaction
Glial cells were regarded as the glue between neurons for a long time. This view has
changed dramatically with the advances in neuroscience over the past years. Normal
brain function relies on several functions fulfilled by glia, like neurotransmitter uptake,
metabolite supply, ion homoeostasis and gliotransmitter release (Giaume and Theis,
2010; Allaman et al., 2011). Recent publications demonstrated the importance of glial
networks for metabolite transport and K+ buffering which are impaired in mice lacking
glial networks leading to neuronal dysfunctions (Wallraff et al., 2006; Rouach et al., 2008;
Fu¨nfschilling et al., 2012; Lee et al., 2012; Tress et al., 2012).
The role of glia in K+ buffering was first described in amphibia by Orkand et al. (1966).
The localization of astrocytes contacting blood vessels with their endfeet and extend-
ing their processes to nodes of Ranvier and into the synaptic cleft makes them ideal
partners in ion homoeostasis. On their endfeet they have Kir4.1 and aquaporin4 chan-
nels to expel K+ ions and water into the capillaries (Rash, 2010; Strohschein et al.,
2011). The extracellular K+ concentration is tightly regulated ([K+]e 2-3 mM) and
low compared to the intracellular K+ concentration ([K+]i 135 mM). Already slight
increases in extracellular K+ concentrations lead to neuronal epileptic discharges (Wall-
raff et al., 2006). Impaired K+ buffering was observed in the hippocampus of mice
with a disrupted astroglial network and led to cell swellings (Wallraff et al., 2006;
Pannasch et al., 2011). The mechanism of K+ buffering is still under debate. As
the first studies were performed on unmyelinated axons of amphibians, the postulated
Orkand model cannot be easily transferred to myelinated axons. In this model as-
trocytes take up K+ from the extracellullar space which is released by neurons. In
contrast, in the CNS of higher order vertebrates it was observed that K+ is released at
nodes of Ranvier and in addition in the internodal space, the latter is not accessible
for astrocytes (Rash, 2010). In the myelin Cx29 hemichannels and voltage gated Kv1
channels are located closely together in the adaxaonal membrane, especially at juxta-
paranodal sites (Altevogt et al., 2002; Nave, 2010). K+ siphoning involves oligoden-
drocytes in addition to astrocytes which directly contact the outermost myelin sheath
(see above). The myelin swellings and vacuolizations observed in X-linked Charcot-
Marie-Tooth disease, Pelizaeus-Merzbacher-like disease and Cx32/47 DKO mice further
support a role of oligodendrocytes in K+ buffering (Orthmann-Murphy et al., 2008;
Rash, 2010).
Interestingly, there is not only an effect of glial cells on neuron function, but neuronal
activity shapes glial networks. Elevated extracellular K+ and glutamate levels increas
astroglial GJ communication in the cortex (Enkvist and McCarthy, 1994). Further-
more, neuronal activity reinforced the diffusion of bioactive molecules in the astroglial
network, like glucose, but not biocytin (Rouach et al., 2008). Interestingly, this effect
involves neuronal AMPA receptors, but not astrocytic glutamate transporters. Further-
more, hippocampal astrocytes are devoid of AMPA receptors (Matthias et al., 2003;
Wallraff et al., 2004; Giaume and Theis, 2010). Blocking neuronal activity reduced net-
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work size by influencing Cx30 GJC (Roux et al., 2011). This observation was further
confirmed by elevated Cx30 levels in the brain of animals living in enriched environments
(Rampon et al., 2000).
Increasing neuronal activity requires higher energy supply to the brain. Compared to
body weight the brain is just a small organ, but it is responsible for 20% of the oxygen
and energy consumption (Giaume et al., 2010). Interestingly, during high neuronal ac-
tivity glucose uptake is not increased in neurons, but in astrocytes in the mouse barrel
cortex (Chuquet et al., 2010). Moreover, astrocytic endfeet cover 99.7% of the capillar-
ies and metabolites can be easily transported in the glial network to sites of neuronal
energy demand (Barros, 2013). Astrocytic localization between neurons and blood ves-
sels favours a role in metabolite transport as it was shown for ion homoeostasis. In
complex nervous systems astrocytes are more abundant and obtained a more complex
morphology (Nedergaard et al., 2003; Barros, 2013). The GJ network can supply energy
to neurons also over long distances and might therefore be crucial for neuronal survival
during hypoglycaemia or ischaemia (Giaume et al., 2010). The model of energy supply
to neurons was first described by Pellerin and Magistretti (1994) as the astrocyte-neuron
lactate shuttle (ANLS; Fig. 1.4). According to this model astrocytes produce lactate
in response to neuronal activity at glutamatergic synapses. Glutamate is taken up by
astrocytes and activates the Na+/K+-ATPase which requires ATP. For this purpose glu-
cose is taken up by astrocytes from the blood vessels and metabolised to lactate by
glycolysis and ATP production is increased. Lactate is then transported into the synap-
tic bouton and serves as an energy source in the neuron to sustain its function (Pellerin
and Magistretti, 1994; Pellerin and Magistretti, 2012). Several studies summarized in
Pellerin and Magistretti (2012) support the ANLS model.
In addition to the use of lactate by neurons, other molecules are under debate as pos-
sible nutrients, like pyruvate and ketone bodies like β-hydroxybutyrate which can also
be transported to neurons (Morrison et al., 2013). A study in the optic nerve indeed
confirmed that neuronal activity can be maintained for a long time by adding glucose,
lactate or pyruvate, partially glutamine, but not β-hydroxybutyrate to the extracellular
solution (Brown et al., 2001).
Studies on metabolic pathways in the brain confirmed that neurons outsourced glycol-
ysis to astrocytes which is most likely a protection against oxidative stress for neurons.
Furthermore, glycogen storage is fulfilled by astrocytes which produce lactate in case of
energy demands which protects neurons during hypoglycemia (Brown and Ransom, 2007;
Barros, 2013). Disruption of this energy supply chain via the ANLS pathway from as-
trocytes to neurons leads to severe brain dysfunction and amnesia (Suzuki et al., 2011).
The astrocytic network plays an important role in metabolite transport. Impaired diffu-
sion leads to neuronal synaptic depression during exogenous glucose deprivation in the
hippocampus (Rouach et al., 2008; Escartin and Rouach, 2013).
Different cell-types in the CNS express distinct transporters for glucose and lactate
uptake. Neurons express glucose transporter 3 (GluT3) and monocarboxylate trans-
porter 2 (MCT2), while astrocytes express GluT1 and MCT4, and oligodendrocytes
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Figure 1.4 Astrocyte-Neuron Lactate Shuttle. The ANLS model was introduced in the middle of
the 1990s. It depicts the influence of glutamatergic neuronal signalling at synapses (1) and axonal action
potential propagation (2) on astrocyte glycolysis in grey matter. Glutamate clearance by astrocytes from
the synaptic cleft activates glial Na+/K+-ATPase (5). The increased ATP demand induces glycolysis
(6) and lactate production (7) in astrocytes which is released into the extracellular space and taken
up by neurons for energy supply (4) and metabolised in neuronal mitochondria (3). From Pellerin and
Magistretti, 2012.
were found to express GluT1 and MCT1 (Tekko¨k et al., 2005; Barros and Deitmer, 2010;
Lee et al., 2012). During neuronal activity GluTs are activated in astrocytes, but not
in neurons (Barros and Deitmer, 2010; Chuquet et al., 2010). In contrast, lactate trans-
port by neuronal MCT2 is favoured over other MCTs (Barros and Deitmer, 2010).
Several studies focusing on lactate transport in the brain identified oligodendrocytes
as important partners in energy supply. The direct contact of axons with the myelin
of Schwann cells in the PNS and oligodendrocytes in the CNS is required for nutrient
transport. MCTs are located directly at these contact sites in the adjacent membranes.
The observed differences compared to the ANLS model most likely reflect the distinct
functional organization. The ANLS model focuses on energy supply to synapses, while
the above stated studies focused on energy supply to myelinated axons. Astrocyte con-
tact to axons is limited by myelination. In the brain 99% of the axon surface is covered
by myelin (Morrison et al., 2013). In addition, this also limits the axonal contact to the
extracellular space for metabolite uptake. The study by Fu¨nfschilling et al. (2012) iden-
tified oligodendrocytes as a source of lactate for white matter axons which is provided
by aerobic glycolysis. The role of astrocytes remained elusive, but oligodendrocytes do
not have direct contacts to blood vessels. It is unclear whether the glucose is taken
up from the extracellular space via GluT1 or received via gap junctions from astro-
cytes. Interestingly, MCT1 expression in oligodendrocytes was crucial for energy supply
to axons: lack of MCT1 caused severe axonopathies and was motorneuron toxic (Lee
et al., 2012). Overall energy demands are higher in grey matter compared to white
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matter (Amaral et al., 2013). It is therefore likely that astrocytes are a prime source
of lactate at glutamatergic synpases in grey matter, while myelinated axons receive
nutrients from oligodendrocytes (Pellerin and Magistretti, 1994; Suzuki et al., 2011;
Fu¨nfschilling et al., 2012; Lee et al., 2012). Summarizing, the ANLS model and the
oligodendrocyte-axon interactions in brain metabolism indicate that normal brain func-
tion requires a functional panglial rather than only an astrocytic network (Amaral et
al., 2013; Morrison et al., 2013).
Neuronal synapses are enwrapped by astrocytic processes which led to the concept of
the tripartite synapse (Araque et al., 1999; Perea et al., 2009). Astrocytes regulate
neuronal excitability and synaptic transmission, thereby modulating synaptic plastic-
ity (Perea et al., 2009). They release vesicles and gliotransmitter like D-serine, ATP
and glutamate at synapses (Mothet et al., 2005; Bezzi et al., 2004; Perea et al., 2009;
Henneberger et al., 2010; Sahlender et al., 2014). Furthermore, astrocytes respond
to neuronal signalling with Ca2+ waves in their syncytium, though the propagation
mechanism via GJ or extracellular signalling pathways is still under debate (Neder-
gaard et al., 2003; Haydon and Carmignoto, 2006; Pirttimaki and Parri, 2012). Also
the already mentioned glutamate uptake from the synaptic cleft is an important func-
tion. Astrocytes express GS to convert glutamate to glutamine. The glutamine is
then transported to neurons for synaptic transmitter production (Allaman et al., 2011;
Amaral et al., 2013). Indeed the amino acid neurotransmitters glutamate, GABA and
aspartate are made from astrocytic glutamine (McKenna, 2011; Amaral et al., 2013).
The glutamate shuttle was discovered over 40 years ago (van den Berg and Garfinkel,
1971) and GS expression in glia was revealed by several studies shortly after (Martinez-
Hernandez et al., 1977). GS expression is not confined to astrocytes, but we know
for more than 25 years that also oligodendrocytes express GS (D’Amelio et al., 1987;
Cammer, 1990; Miyake and Kitamura, 1992). Indeed, in the presence of unmyelinated
axons oligodendrocytes take up glutamate by glutamate transporter 1 (GLT1; DeSilva
et al. (2009)).
The astroglial interactions at the synapse also involve connexins. In a recent study it was
shown that Cx30 has a non-GJ function for process extension into synapses. In Cx30
knock-out mice astrocytes displayed increased glutamate uptake by extending their pro-
cesses into the synaptic cleft, thereby decreasing excitatory synaptic transmission and
impairing synaptic plasticity due to glutamate clearance (Pannasch et al., 2014). Inter-
estingly, mice lacking astroglial connexins Cx30 and Cx43 displayed increased synaptic
transmission and impaired long term plasticity by reduced glutamate and K+ clearance
(Pannasch et al., 2011).
In summary, neurons and glial cells form a functional entity in the brain.
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2 Aim of the Study
Over the past decades glial cells have been extensively studied in several brain regions.
Increasing evidence supports the active role of glia in brain function and the view of glial
heterogeneity. The thalamus is known as the ”gate to conciousness” and many studies
focused on its neuronal functions. The present study aimed at increasing our knowledge
about thalamic glia and their physiological role in brain function in comparison to hip-
pocampal glial cells. This gave the rationale in my thesis to focus on the following four
questions:
(i) Analysis of glial network properties in the ventrobasal thalamus.
Astrocytes are connected with each other via gap junction channels and thereby form
an extensive network. Unexpectedly, thalamic astrocytes seemed to be devoid of gap
junction channels (Parri et al., 2001). Employing transgenic and connexin knock-out
mice, the first part of the study aimed at characterizing glial networks during develop-
ment and identifying the connexins involved in network formation and their cell-type
composition in the ventrobasal thalamus.
(ii) Characterization of glial cells in the thalamus and hippocampus.
In the mature ventrobasal thalamus only low expression of GFAP, a classical astrocyte
marker in the hippocampus, was observed.(Frassoni et al., 2000). This study aimed at
characterizing protein expression in thalamic glial cells in comparison to hippocampal
glia by immunohistochemical analysis.
(iii) What is the functional role of glial networks in the thalamus?
Gap junction channels are permeable for many molecules like metabolites, second mes-
sengers and ions (Giaume et al., 2010). The thalamus relays all sensory information
to the cortex and neuronal activity requires sufficient energy supply. It was a goal of
this study to establish a method to analyse the influence of glial networks and poten-
tial glial energy supply on corticothalamic signalling employing field potential recordings.
(iiii) Analysis of ionotropic receptor expression in thalamic astrocytes.
Astrocytes express several receptors for neurotransmitters and respond to neuronal ac-
tivity (Matyash and Kettenmann, 2010). The present study aimed at characterizing
the expression pattern of ionotropic AMPA and GABAA receptor subunits in thalamic
astrocytes using single-cell RT-PCR analysis.
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3 Materials
3.1 Chemicals
Chemicals were purchased from Abcam (Cambridge, UK), Abbott (Illinois, USA), Ap-
plichem (Darmstadt, Germany), BelaPharm Medistar (Ascheberg, Germany), Biorad
(Mu¨nchen, Germany), Biostatus (Shepshed, UK), Carl Roth (Karlsruhe, Germany), cp
pharma (Burgdorf, Germany), Dianova (Hamburg, Germany), Invitrogen (Darmstadt,
Germany), Linde (Pullach, Germany), Merck (Darmstadt, Germany), Millipore (Darm-
stadt, Germany), Polysciences (Warrington, USA), New England Biolabs (Frankfurt,
Germany), Promega (Madison, USA), Qiagen (Hilden, Germany), Roche (Mannheim,
Germany), Sigma-Aldrich (Mu¨nchen, Germany), Thermo Fisher Scientific (Waltham,
USA) and Tocris (Bristol, UK). PCR Primers were ordered from Eurofins MWG (Ebers-
berg, Germany).
Chemicals
2-Mercaptoethanol
2-NBDG
50 bp ladder
100 bp DNA ladder
Agarose 1000
Aqua polymount
Acetic acid
Acrylamide solution (Rotiphorese Gel30)
APS
BAPTA
Biocytin
BSA
Boric acid
Bromophenol blue
CaCl2
Carbogen
CepetorKH
DEPC-water
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Draq5
D-AP5
dNTPs
EDTA
EGTA
Ethanol
Ethidium bromide
First strand buffer
Glucose
Glutaraldehyde
Glycine
Glycerol
HEPES
Hoechst 33258
Isoflurane
Isopropanol
KCl
Ketamine
K-Gluconate
L.A.B. Solution
Low Molecular Weight DNA ladder
Methanol
MgCl2
MgSO4
Milk powder
Na2-ATP
Na-Azide
NaCl
Na-deoxycholate
NaHCO3
NaH2PO4
NaOH
NBQX
Nonidet-P40
NGS
Novex Sharp Protein Standard
Paraformaldehyde
Picrotoxin
Protease and phosphatase single use inhibitor
Proteinase K
Random hexanucleotide primer
Restore Western Blot stripping buffer
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Restriction enzymes
RNase inhibitor
Roti-Load buffer (4x)
SR101
Sterile water
Streptavidin-Cy2
Streptavidin-Cy3
Streptavidin-Cy5
Streptavidin-A647
Sucrose
Tris
Tris-Base
Tris-Cl
TritonX-100
TTX
Tween-20
TEMED
Xylariem
Kits
GoScript reverse transcriptase (Promega)
GoTaq flexi DNA polymerase (Promega)
MinElute PCR Purification Kit (Qiagen)
Platinum Taq polymerase (Invitrogen)
Pierce BCA protein assay Kit (Thermo Fisher Scientific)
SuperSignal West Dura extended duration substrate (Thermo Fisher Scientific)
Taq polymerase (Invitrogen)
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3.2 General materials
Borosilicate Glass Science Products, Hofheim, Germany
Coverslips, Object slides Engelbrecht, Edermu¨nde, Germany
Disposable pipettes Roth, Karlsruhe, Germany
Glass pipettes Brand, Wertheim, Germany
Gloves Ansell, Staffordshire, UK
Instant adhesive Uhu, Bu¨hl, Germany
Kimtech Kimberley Clark
Needles and Syringes BD, Franklin Lakes, USA
Parafilm Pechiney Plastic Packaging, Chicago, USA
Plastic pasteur pipettes Roth, Karlsruhe, Germany
Pipettman Gilson, Middleton, USA
PVDF membrane Millipore, Schwalbach, Germany
Razor blade Wilkinson, Bucks, UK
Reaction tubes, Well plates Sarstedt, Nu¨mbrecht, Germany
Surgical instruments Fine Science Tools, Heidelberg, Germany
Syringe filters 4 mm Thermo Fisher Scientific, Waltham, USA
Tape Leukoplast, Hamburg, Germany
Tips, Tubes Greiner Bio-One, Frickenhausen, Germany
Venofix Braun, Melsungen, Germany
Whatman paper Whatman International, Maidstone, UK
3.3 Software
GeneTools Synoptics, Cambridge, UK
Igor Pro Wave Metrics, Portland, USA
ImageJ NIH, Maryland, USA
Inkscape The Inkscape Team
LAS AF Leica Microsystems, Wetzlar, Germany
MC Stimulus II Multi Channel Systems, Reutlingen, Germany
MetaVue Molecular Devices, Sunnyvale, USA
Tida Heka, Lambrecht, Germany
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3.4 Equipment
Amplifier DPA-2F npi, Tamm, Germany
Amplifier DPA-2FS npi, Tamm, Germany
Axiophot Carl Zeiss, Gttingen, Germany
Centrifuges Eppendorf, Wesseling, Germany
Eclipse E600FN microscope Nikon, Tokyo, Japan
DIC camera Cohu, Poway, USA
EPC-7 Heka, Lambrecht, Germany
EPC-800 Heka, Lambrecht, Germany
Fluorescence lamp Nikon, Tokyo, Japan
GeneGnome XRQ Synoptics, Cambridge, UK
Heat block VWR, Darmstadt, Germany
HERAEUS Fresco17 centrifuge Thermo Fischer Scientific, Bonn, Germany
IPC pump Ismatec, Wertheim, Germany
ITC-16 computer interface Heka, Lambrecht, Germany
Leica SP5 LSM Leica Microsystems, Wetzlar, Germany
Leica SP8 LSM Leica Microsystems, Wetzlar, Germany
Leica TCS NT confocal Leica Microsystems, Wetzlar, Germany
LIH 1600 Heka, Lambrecht, Germany
Micromanipulator, electric Luigs und Neumann, Ratingen, Germany
Micromanipulator MHW-3, hydraulic Narishige, Japan
MC Stimulus II Multi Channel Systems, Reutlingen, Germany
Microwave Severin, Germany
Mini-Protean 3 Cell Biorad Mu¨nchen, Germany
Mini-Trans blot Cell Biorad Mu¨nchen, Germany
MyCycler, Thermal cycler Biorad, Mu¨nchen, Germany
Oscilloscope HM 507 Hameg, Mainhausen, Germany
pH meter Mettler Toledo, Giessen, Germany
Pipette puller P-2000 Sutter Instruments, Hofheim, Germany
Pipette puller PP-830 Narishige, Japan
Shaking water bath Memmert GmbH, Schwabach, Germany
Table top small centrifuge VWR, Darmstadt, Germany
SEC-05LX npi, Tamm, Germany
SM1, SM5 control box Luigs und Neumann, Ratingen, Germany
STG-2004 Multi Channel Systems, Reutlingen, Germany
STG-4004 Multi Channel Systems, Reutlingen, Germany
Vibration isolation platform LW 3036B-OPT Newport, Irvine, USA
Vibratome VT1200S Leica, Nussloch, Germany
Vortexer VWR, Darmstadt, Germany
Weight balance Sartorius group, Go¨ttingen, Germany
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3.5 Antibodies
Primary Antibodies
Epitope Species Type Dilution Company
Aldh1L1 mouse mc 1:25 Abcam
β-Gal rabbit pc 1:400 Molecular Probes
Cx30 rabbit pc 1:250 Zymed-Invitrogen
Cx43 rabbit pc 1:5,000 Sigma
GFAP rabbit pc 1:750 Dako
GFP mouse mc 1:500 Invitrogen
GFP chicken pc 1:600 Abcam
GS mouse mc 1:200 Millipore
GS mouse mc 1:1,000 Transduction Laboratories
Iba1 mouse mc 1:400 WAKO
Olig2 rabbit pc 1:1,000 Millipore
NeuN mouse mc 1:200 Chemicon
NG2 rabbit pc 1:100 Millipore
S100β mouse mc 1:250 Abcam
α-Tubulin mouse mc 1:20,000 Sigma
Secondary Antibodies
Antibody Species Dilution Company
anti-mouse-A488 goat 1:500-600 Molecular Probes
anti-rabbit-A488 goat 1:500 Molecular Probes
anti-chicken-A488 goat 1:500 Molecular Probes
anti-mouse-A594 goat 1:500 Molecular Probes
anti-rabbit-A594 goat 1:500 Molecular Probes
anti-mouse-A647 goat 1:500 Molecular Probes
anti-rabbit-A647 goat 1:500 Molecular Probes
anti-mouse-HRP goat 1:10,000 GE healthcare
anti-rabbit-HRP goat 1:10,000 GE healthcare
Streptavidine Conjugates
Streptavidin-Cy2 1:100
Streptavidin-Cy3 1:300
Streptavidin-Cy5 1:200
Streptavidin-A647 1:600
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3.6 PCR primers
Cx26-E3
5’-ACAGGATTGGGAGTCTAGAAG-3’
Cx26-E5
5’-TTTGTCTACTCTGTAGCTGTG-3’
Cx26-A5
5’-ACAGAAATGTGTTGGTGATGG-3’
Nestin-Cre us
5’-TCCCTTCTCTAGTGCTCCACGTCC-3’
Nestin-Cre ds
5’-TCCATGAGTGAACGAACCTGGTCG-3’
3.7 RT-PCR primers
Gene Sequence Product length/
GeneBank Acc.#
Alpha se 5’-AACATGACMAYGCCMAAYAAGCT-3’ 554 bp
Alpha as 5’-GCATARCAGACAGCWATRAACCA-3’
α1 nested se 5’-CCAGCCCGTTCAGTGGTTGTA-3’ 180 bp
α1 nested as 5’-GCACGGCAGATATGTTTGAAT-3’ NM 010250
α2 nested se 5’-TTACAATGCTTCTGACTCCGTTCA-3’ 306 bp
α2 nested as 5’-CGRGCACTGATRCRWARGGT-3’ NM 008066
α3 nested se 5’-CTTGGGAAGAACAAATCTGTGGA-3’ 305 bp
α3 nested as 5’-CGRGCACTGATRCRWARGGT-3’ NM 008067
α4 nested se 5’-ACCAAAGGCCCTGAGAAGTCA-3’ 308 bp
α4 nested as 5’-CGRGCACTGATRCRWARGGT-3’ NM 010251
α5 nested se 5’-GCTGGAGGATGATGGCACACTTCT-3’ 208 bp
α5 nested as 5’-GTTGAGCCTGGAGCCATCTTCTG-3’ NM 176942
Beta se 5’-CTGGATGARCAAAACTGYAC-3’ 443 bp
Beta as 5’-ACAAAGACAAARCAWCCCAT-3’
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Gene Sequence Product length/
GeneBank Acc.#
β1 nested se 5’-ATGGAGGAGAGGGAGCAGTAACT-3’ 358 bp
β1 nested as 5’-CAGCCCATGAGATAGATGTCAATC-3’ NM 008069
β2/3 nested se 5’-GGCGYGGCGRTGACAAKGC-3’ 307 bp
β2/3 nested as 5’-TCCCGRAGGTGRGTGTTGAT-3’ NM 008070,
NM 008071
Gamma se 5’-ATTTGGATTCCAGACACYWTCTT-3’ 392 bp
Gamma as 5’-AAGTAGCCCATTCTTCKRCTCAG-3’
γ1 nested se 5’-CGCCTGCTGCGGATTTG-3’ 180 bp
γ1 nested as 5’-CACAGAGGGCTTTTTCCACTTGT-3’ NM 010252
γ2 nested se 5’-AAAAMRGCTGAGGCTCACTGGAT-3’ 211 bp
γ2 nested as 5’-AACTGCGCTTCCATTGATAAACA-3’ NM 177408
γ3 nested se 5’-AAAAMRGCTGAGGCTCACTGGAT-3’ 272 bp
γ3 nested as 5’-CTGAGGCCCATGAAGTCAAACTGA-3’ NM 008074
Delta se 5’-ATGGCGCCAGGGCAATGAATG-3’ 424 bp
Delta as 5’-GTGGAGGTGATGCGGATGCTGTAT-3’
δ1 nested se 5’-TATGCCCGAAACTTCCGACCAG-3’ 308 bp
δ1 nested se 5’-AAAATCACCCCATCAGGCTGTAGG-3’ NM 008072
AMPA-R se 5’-GGATCMACWAAAGARTTYTTCA-3’ 412 bp
AMPA-R as 5’-TCAGGCTSAGRGCACTSGTCT-3’
GluA1 se 5’-GTGTTTGTTCGGACCACAGAG-3’ 275 bp
NM 001113325
GluA2 se 5’-GTGAGGACTACGGCAGAAGGAGTA-3 260 bp
GluA2 as 5’-TCGTACCACCATTTGTTTTTCA-3’ NM 001083806
GluA3 se 5’-AGCTGATGGGGTAGCCCGAGTTC-3’ 258 bp
NM 016886
GluA4 se 5’-AGAGCCATCTGTGTTCACTA-3’ 285 bp
NM 019691
GluA1, 3, 4 as 5’-TCMCCTTTATCGTACCACCATTT-3’
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Gene Sequence Product length/
GeneBank Acc.#
S100β se 5’-AGGCCATGGTTGCCCTCATTGAT-3’ 246 bp
S100β se 5’-ACTCATGGCAGGCCGTGGTCA-3’
S100β nested se 5’-TACTCCGGGCGAGAGGGTGACAA-3’ 186 bp
S100β nested as 5’-GGCGACGAAGGCCATGAACTCC-3’ NM 009115
3.8 Restriction enzymes
Enzyme Restriction site Incubation Company
BsaHI 5’- GRCGYC -3’ 37◦C NEB
TspRI 5’- NNCASTGNN -3’ 37◦C NEB
MseI 5’- TTAA -3’ 37◦C NEB
HpaI 5’- GTTAAC -3’ 37◦C NEB
3.9 Solutions and buffers
3.9.1 Solutions for electrophysiology
Preparation solution
NaCl 87 mM
KCl 2.5 mM
NaH2PO4 1.25 mM
NaHCO3 25 mM
MgCl2 7 mM
CaCl2 0.5 mM
Glucose 25 mM
Sucrose 75 mM
and pH 7.4 adjusted with carbogen (95% O2/5% CO2)
Artificial cerebrospinal fluid (ACSF)
NaCl 126 mM
KCl 3 mM
MgSO4 2 mM
CaCl2 2 mM
Glucose 10 mM
NaH2PO4 1.25 mM
NaHCO3 26 mM
and pH 7.4 adjusted with carbogen (95% O2/5% CO2)
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Intracellular standard solution
KCl 130 mM
MgCl2 2 mM
CaCl2 0.5 mM
BAPTA 5 mM
HEPES 10 mM
Na2-ATP 3 mM
pH 7.28
Intracellular K-gluconate solution
K-gluconate 130 mM
MgCl2 1 mM
Na2-ATP 3 mM
HEPES 20 mM
EGTA 10 mM
pH 7.2
supplemented with the tracer
0.5% biocytin or
14.6 mM 2-NBDG
3.9.2 Solutions and buffers for immunohistochemistry
Phosphate buffered saline (10x)
NaCl 1.5 mM
KCl 2.7 mM
Na2HPO4 8.3 mM
NaH2PO4 1.7 mM
dissolved in dH2O
pH 7.4
PBS with sodium azide
NaN3 0.01% (w/v)
dissolved in 1x PBS
PFA solution
Paraformaldehyde 4% (w/v)
dissolved in 1x PBS
Blocking solution
NGS 10% (v/v)
TritonX-100 2-0.5% (v/v)
diluted in 1x PBS
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Antibody solution
NGS 2% (v/v)
TritonX-100 0.1% (v/v)
diluted in 1x PBS
Blocking solution for biocytin
NGS 10% (v/v)
BSA 5% (v/v)
TritonX-100 2% (v/v)
diluted in 1x PBS
Antibody solution for biocytin visualization
NGS 2% (v/v)
BSA 2% (v/v)
TritonX-100 0.1-0.5% (v/v)
diluted in 1x PBS
Hoechst nuclei staining solution
Hoechst 1% (v/v)
diluted in dH2O
Draq5 nuclei staining solution
Draq5 0.1% (v/v)
diluted in 1x PBS
3.9.3 Buffers for SDS-PAGE gel
Contents Stacking gel Resolving gel
2 x gels a` 1.5 mm (4%) (10%) (12%)
Rotiphorese gel 30 1.3 ml 10.5 ml 12 ml
Stacking gel (pH 6.8) 2.5 ml - -
Resolving gel (pH 8.8) - 7.5 ml 7.5 ml
dH2O 6.2 ml 12 ml 10.5 ml
TEMED 6 µl 18 µl 18 µl
APS (10%) 60 µl 180 µl 180 µl
3.9.4 Solutions and buffers for Western blotting
Phosphatase inhibitor
Thermo Fisher phosphatase inhibitor cocktail 100x
dissolved in protein lysis buffer
46
Materials
Protein lysis buffer (modified RIPA buffer)
Tris-base 50 mM
NaCl 150 mM
Nonidet P-40 (NP40) 0.5% (v/v)
Na-deoxycholate 0.5% (w/v)
TritonX-100 1% (v/v)
sterile-filtered, pH 7.5
APS stock buffer
Ammonium persulfate 10% (w/v)
dissolved in dH2O
SDS stock buffer
Sodium dodecyl sulfate 10% (w/v)
dissolved in dH2O
Stacking gel buffer
Tris-base 0.5 M
SDS stock buffer 0.4% (v/v)
sterile-filtered, pH 6.8
Resolving gel buffer
Tris-base 1.5 M
SDS stock buffer 0.4% (v/v)
sterile-filtered, pH 8.8
Laemmli sample buffer (4x)
Tris-HCl 62.5 mM
SDS stock buffer 3% (v/v)
Glycerol 10% (v/v)
Bromophenol blue 0.01% (w/v)
2-Mercaptoethanol 5% (v/v)
dissolved in dH2O, pH 6.8
SDS running buffer (1x)
Tris-base 0.25 M
Glycine 1.92 M
SDS stock buffer 1% (v/v)
dissolved in 5 l dH2O, pH 8.3
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Transfer buffer (5x)
Tris-HCl 50 mM
Tris-Base 0.1 M
Glycine 0.8 M
dissolved in 2 l dH2O, pH 8.3
Transfer buffer (1x)
Transfer buffer (5x) 20% (v/v)
Methanol 20% (v/v)
diluted in dH2O
Washing blot buffer
Tris-HCl 8.5 mM
Tris-Base 1.7 mM
NaCl 50 mM
Tween 20 0.05%(v/v)
dissolved in 2 l dH2O, pH 6.3
Blocking buffer
Milk powder 5% (w/v)
dissolved in washing blot buffer
3.9.5 Solutions and buffers for molecular analysis
Laird-Lysis-Buffer
Tris-HCl 100 mM
NaCl 200 mM
EDTA 5 mM
SDS 0.2% (w/v)
diluted in dH2O, pH 8.5
Proteinase K
Proteinase K 4 µl of 20 mg/ml stock
dissolved in 500 µl Laird-Lysis -Buffer
TBE (10x)
Tris-Base 1 M
Boric acid 0.83 M
EDTA 10 mM
Ethidium bromide
Ethidium bromide 10% (10 mg/ml)
diluted in 1x TBE
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3.10 Animals
Maintenance and handling of animals used in this study was according to local govern-
ment regulations. Mice were kept under standard housing conditions with 12 h/12 h
dark-light cycle, food and water ad libitum. All measures were taken to minimize the
number of animals used.
3.10.1 Cx26fl/fl:Nestin-Cre mice
Since Cx26 is essential for embryonal development, mice with brain-specific deletion
of Cx26 were generated using a conditional knock-out strategy (Cohen-Salmon et al.,
2002). A constitutive deletion of Cx26 is lethal at embryonal day E11 due to decreased
transplacental glucose uptake (Gabriel et al., 1998). Deletion of Cx26 in the mouse brain
was achieved by taking advantage of the Cre/loxP system. The coding region of exon 1
of the Gjb2 gene is flanked by two loxP sites in Cx26fl mice. A Cre recombinase under
the control of the rat Nestin promoter was used to delete the floxed (fl) deoxyribonucleic
acid (DNA) sequence resulting in the deletion of Cx26 in Nestin-Cre expressing cells
(Tronche et al., 1999; Nagy et al., 2011). Nestin is a type VI intermediate filament
mainly expressed in neural progenitor cells (Zimmerman et al., 1994).
3.10.2 Cx30LacZ/LacZ mice
Cx30-deficient mice were generated by Teubner et al. (2003). In these mice the Cx30
(Gjb6 ) coding region has been replaced by a LacZ reporter sequence which is there-
fore expressed under control of Cx30 gene regulatory elements. The LacZ-encoded β-
galactosidase contains a nuclear localization signal and can be visualized by immuno-
histochemistry. Due to the gene targeting strategy these mice were reported to be deaf,
most likely due to decreased expression of Cx26, whose gene is located in close proximity
to the Gjb6 locus (Lynn et al., 2011). Analysis of reporter expression in mouse brain
revealed region-dependent reporter expression (Gosejacob et al., 2011).
3.10.3 Cx43ECFP knock-in mice
The Cx43ECFP mouse line expresses the reporter enhanced cyan fluorescent protein
(ECFP) under the control of the Cx43 (Gja1 ) promoter (Degen et al., 2012). A global
knock-out of Gja1 is lethal due to morphological disturbances of the right ventricular
outflow tract (Reaume et al., 1995). Therefore the Cx43ECFP knock-in mouse line was
generated by breeding Cx43fl(ECFP) mice, with PGK-cre mice (Lallemand et al., 1998).
Mice are always heterozygous, due to lethality of homozygous animals and the reporter
is expressed in all Cx43-expressing cells of the body. Immunohistochemical analysis
confirmed astrocyte-specific ECFP expression in the mouse brain (Degen et al., 2012).
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3.10.4 Cx30LacZ/LacZ;Cx43fl/fl:hGFAP-Cre mice
Cx30/43 double knock-out (DKO) animals were obtained by breeding Cx30LacZ mice
with Cx43fl(LacZ) and hGFAP-Cre mice (Theis et al., 2001; Theis et al., 2003; Zhuo et
al., 2001). These mice express LacZ instead of Cx30 in all cells of the body. Addition-
ally, Cx43 is deleted in all GFAP-expressing cells (e.g. astrocytes and radial glia-like
cells) in the CNS and express LacZ under the control of the Gja1 promoter. Loss of
these two connexins in the mouse brain leads to a complete disruption of astrocyte gap
junction-mediated coupling and, as a consequence to impaired spatial K+ buffering and
spontaneous epileptic activity (Wallraff et al., 2006).
3.10.5 Cx30LacZ/LacZ;Cx43flG138R/flG138R:Nestin-Cre mice
This mouse line was generated by breeding Cx30LacZ mice with Cx43G138R mice and
additionally Nestin-Cre mice to study effects of Cx43 variants on radial glia-like cell net-
works. The Cx43G138R line is a mouse model for Oculodentodigital dysplasia (ODDD),
a disease caused by mutations in the human Gja1 gene, coding for Cx43 protein. The
clinical manifestations include abnormalities of the fingers, toes, eyes, face and teeth
(Dobrowolski et al., 2008). The human Cx43G138R point mutation was inserted into
the wild-type (wt) mouse Gja1 gene and the resulting Cx43G138R/+ mice showed all
phenotypes known for ODDD in human patients. The conditional knock-out using a
Nestin-Cre mouse line allowed for the neurally restricted expression of the point muta-
tion (Tronche et al., 1999). The Cre recombinase activity led to deletion of the loxP-
flanked Cx43-wt region and at the same time to the expression of a Cx43G138R-internal
ribosomal entry site (IRES)- enhanced green fluorescent protein (EGFP) cassette under
the control of the Gja1 regulatory elements (Dobrowolski et al., 2008).
3.10.6 Cx30LacZ/LacZ;Cx43fl/K258stop:hGFAP-Cre mice
This mouse line is the result of cross-breeding four mouse lines, the Cx30LacZ, the
Cx43fl(LacZ), the hGFAP-Cre and the Cx43K258stop (Theis et al., 2001; Zhuo et al.,
2001; Teubner et al., 2003; Maass et al., 2004) mouse line. The Cx43K258stop mice ex-
press a C-terminally truncated Cx43 protein in place of the full-length protein, in which
Cx43 is lacking the last 125 amino acid residues of the cytoplasmic C-terminal domain.
Due to a defect of the epidermal barrier more than 97% of the homozygous Cx43K258stop
mice die shortly after birth (Maass et al., 2004). Surprisingly, former studies showed
that decreasing the Cx43K258stop gene dosage rescued the lethal epidermal phenotype
(Maass et al., 2007), hence Cx43K258stop mice were crossed with mice heterozygous for
a conditional Gja1 knock-out allele. Therefore, we raised Cx43fl/K258stop:hGFAP-Cre
heterozygous mice carrying one Cx43K258stop allele and a Cx43fl(LacZ) allele which is
deleted in the CNS by virtue of the hGFAP-Cre transgene to investigate the effect of
truncated Cx43 in adult neurogenesis.
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3.10.7 Cx30LacZ/LacZ;Cx47EGFP/EGFP mice
This double knock-out mouse line is the result of breeding the Cx30LacZ mouse line
with Cx47EGFP mice (Teubner et al., 2003; Odermatt et al., 2003). Both the deletion
of Cx30 and Cx47 Gjc2 occurs in all cells of the body. The Cx47 single knock-out is
viable, fertile and shows no behavioural abnormalities. Closer morphological analysis
of the brains confirmed oligodendrocyte-specific Cx47-EGFP expression and revealed
vacuolizations in the myelin (Odermatt et al., 2003). Combining the two mouse lines
lacking an astroglial connexin and an oligodendroglial connexin should disrupt panglial
networks (Tress et al., 2012). Indeed, this could be confirmed in white matter, where
no tracer spread from oligodendrocytes to astrocytes was detected in biocytin-labelled
networks. Further analysis of these double knock-outs revealed that 40% of the mice
die between p42 and p90. They display extensive astrogliosis, microglia activation and
myelin malformations with vacuolizations (Tress et al., 2012).
3.10.8 hGFAP-EGFP mice
The transgenic mouse line hGFAP-EGFP expresses the reporter EGFP under the control
of the human GFAP promoter (Nolte et al., 2001). Transgenic mice were generated in
a FVB/N background, an inbred mouse strain with good reproductive performance
and therefore well suited to generate transgenic mice by micro-injection into oocytes.
An additional advantage of this mouse line are the consistently large litters (Taketo et
al., 1991). GFAP is the major intermediate filament in mature astrocytes, but is also
expressed by other cells, e.g. in the PNS by Schwann cells (Jessen and Mirsky, 1985). In
the CNS of these mice GFAP-expressing cells are EGFP labelled. In many brain regions
good overlap of EGFP and GFAP immunostaining was observed and the cells had a
typical astrocyte morphology. In the thalamus strong EGFP expression was observed,
despite the absence of GFAP-labelling (Nolte et al., 2001; Frassoni et al., 2000). Analysis
of membrane currents in acute brain slices revealed EGFP expression in two cell-types,
astrocytes and NG2 cells (Wallraff et al., 2004).
3.10.9 PLP-GFP mice
The PLP-GFP mouse line is a transgenic line generated to identify mature myelinat-
ing oligodendrocytes in living tissue. This mouse line has a C57/Bl6 background and
expresses the green fluorescent protein under the control of a PLP promoter (Fuss et
al., 2000). The protein PLP is a myelin protein and is specifically expressed in myeli-
nating oligodendrocytes, although there is a known splice variant (DM-20) expressed in
pre-myelinating oligodendrocytes (Trapp et al., 1997). Analysis of GFP expression con-
firmed that reporter expression in this mouse line is confined to terminally differentiated
oligodendrocytes. Furthermore GFP is located in the cytoplasm and not in the myelin
sheets, due to deletion of the localization signal (Fuss et al., 2000).
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4.1 Electrophysiology
4.1.1 Preparation of acute brain slices
For preparation of acute brain slices, animals were anaesthetized with Isoflurane, killed
by decapitation and the brains were quickly removed. Horizontal slices for whole cell
patch clamp experiments were obtained by cutting off the cerebellum and a small part
of the dorsal cortex. The brain was then glued dorsally on a specimen holder. Slice
thickness was 200 µm for whole-cell patch clamp experiments. Field potentials (FP) were
recorded in 300 µm thick slices with a 30◦ angle with the horizontal plane. Therefore
the cerebellum was cut off and the brain was split along the midline. The hemisphere
was laid on a plastic block with an angle of 30◦ onto its midline cutting edge and a small
piece of the dorsal brain was cut off, afterwards the hemispheres were glued dorsally on
a specimen holder.
The brains were placed in ice cold preparation solution bubbled with carbogen (95%
O2/5% CO2). Using a vibratome, horizontal slices containing the ventrobasal nuclei of
the thalamus and the hippocampus were obtained. Slices were stored at 35◦C for 20 min,
cooled down to room temperature and transferred into ACSF bubbled with carbogen.
For some experiments slices were incubated in ACSF supplemented with 1 µM SR101
at 35◦C for 20 min and subsequently transferred to ACSF at room temperature. The
composition of the solutions is described in section 3.9.1.
4.1.2 Electrophysiology setup
The electrophysiological experiments employing tracer diffusion were performed in a
recording chamber of a patch clamp setup. A slice was placed in the chamber and
held in place with nylon threads glued onto a U-shaped platinum wire. The recording
chamber was mounted on a holder that could be manually moved in x- and y-directions.
Tissue visualization was achieved with an upright microscope E600FN (Nikon) equipped
with an infrared DIC at 4x magnification (Nikon). The microscope was equipped with
a motorized focus and a DIC camera (Cohu). Additionally, a 60x immersion objective
(Nikon) was used to identify individual cells for experiments. Fluorescent light of de-
fined wavelength was applied to identify fluorescent astrocytes or oligodendrocytes. A
detailed list of the equipment can be found in section 3.4.
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The bath chamber was continuously perfused with carbogenized ACSF at room temper-
ature by a peristaltic pump at 1-2 ml/min. The microscope was placed on a vibration
isolation platform (Newport) to ensure stable measurements and placed inside a Faraday
cage for electric shielding.
A hydraulically controlled micromanipulator MHW-3 (Narishige) was used to move the
recording pipette which was connected to the head stage of the patch clamp amplifier.
Currents were recorded in the voltage clamp mode employing an EPC-7 patch clamp
amplifier and monitored by TIDA software (HEKA). Data were sampled at 6-30 kHz
and filtered at 3-10 kHz.
Pipettes were fabricated from borosilicate glass and had a resistance of 2-6 MΩ when
filled with internal solution. The recording electrode was a teflon-coated silver wire with
a chlorinated tip. The reference electrode consisted of a silver/silver chloride pellet.
For extracellular recordings an electrically-driven micromanipulator was available to
position the recording pipette connected to a bridge amplifier (SEC-05LX, npi). The
bipolar stimulation electrode was positioned with the hydraulically controlled microma-
nipulator and connected to a stimulation generator (Multi Channel Systems).
For some experiments patch clamp technique and confocal laser scanning microscopy
were combined. Therefore another patch clamp setup was used. In brief, the setup was
equipped with an LSM SP5 (Leica) and electrically-driven micromanipulators. Currents
were recorded using an EPC-800 patch clamp amplifier (HEKA).
4.1.3 Whole-cell patch clamp recording
The cells were electrophysiologically characterized by patch clamp technique (Neher and
Sakmann, 1976). In brief, cells were approached with a patch pipette filled with internal
solution. Obstruction of the pipette tip was prevented by applying overpressure while
approaching the cell. When reaching the cell membrane the overpressure was immedi-
ately removed and low pressure was applied to obtain a close contact between the pipette
tip and the cell membrane which is called the cell-attached mode. It is characterized
by a high resistance above 1 GΩ and also known as Gigaseal. Next, short pulses of low
pressure were applied to disrupt the cell membrane and obtain the whole-cell configura-
tion.
Voltage clamp experiments were performed on cells identified by endogenous fluores-
cence or staining with the astrocyte marker SR101 (Nimmerjahn et al., 2004; Kafitz
et al., 2008). All cells were analysed in whole-cell voltage clamp mode. Therefore the
amplifier compares the resting potential of a patched cell with the selected holding po-
tential. By current injection the cell is kept at its desired holding potential whenever
the resting membrane differs from the holding potential. The current recorded by the
amplifier represents the current flow over the cell membrane. Input and series resistance
were regularly checked by applying 10 mV pulses for 50 ms (Fig. 4.1A). For analysis
10 traces were averaged and analysed using a custom made Igor Pro tool written by
Ronald Jabs. In brief, the current at the beginning of the 10 mV pulse was used to
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Figure 4.1 Whole cell patch clamp analysis. (A) 10 mV pulses of 50 ms duration were applied
every 10 min to monitor the access resistance and electrophysiological properties of the patched cell.
(B) Circuit diagram of the whole cell mode, Rs originates at the pipette tip and Rm depends on the
cell membrane properties, e.g. ion channel types and their density. The capacity Cm depends on the
membrane surface area (1 µF/cm2). (C) Stimulation protocol applying de- and hyperpolarizing voltage
steps between -160 mV to +20 mV for 50 ms to identify cell-types, 10 mV increment.
calculate the series resistance, a measure for the access quality. The constant current
after decline of the capacitive current was used to calculate the membrane resistance, see
the circuit diagram in Figure 4.1B. The series resistance was calculated by the equation
Rs=∆U/I(t0) and the membrane resistance was obtained by Rm=∆U/I(t1)-Rs.
The holding potential was -80 mV. During the 20 min experiments the membrane poten-
tial was monitored and all cells with a membrane potential above -60 mV were excluded
from analysis. Cells were electrophysiologically identified by applying voltage steps be-
tween -160 mV to +20 mV, as shown in Figure 4.1C.
Intracellular solutions were based on a K-gluconate solution causing a liquid junction
potential which was compensated during measurements by adjusting the holding poten-
tial. Tracer filling with biocytin or 2-NBDG was performed for 20 min. Afterwards,
slices were fixed in 4% PFA in 1x PBS, pH 7.4 at 4◦C. Slices used for fluorescent glucose
analysis with 2-NBDG were not fixed as the 2-NBDG is not PFA fixable.
In some experiments cells were harvested for subsequent RT-PCR analysis. These cells
were morphologically and electrophysiologically characterized and extracted from the
tissue under optical supervision. The internal pipette solution was a standard KCl-
solution. The harvested cytoplasm in the tip of the pipette was transferred into a tube
with DEPC-water and immediately frozen in liquid N2.
4.1.4 Extracellular field potential recordings
Field potentials were recorded in 300 µm thick horizontal slices tilted 30◦ to the horizon-
tal plane (Fig. 4.2A). Synaptic stimulation of the corticothalamic pathway was achieved
with a computer-controlled constant current isolated stimulator (STG4004 and 2004)
and bipolar electrodes. Stimulation electrode and field potential recording pipette were
placed several 100 µm away from each other. The bipolar electrode was placed in the
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internal capsule and field potentials were recorded in the ventrobasal thalamus (Fig.
4.2B) with a SEC05-LX (npi). The bridge balance was adjusted and the capacity was
compensated. Stimulation responses of the corticothalamic pathway were obtained by
applying stimuli of 100 µs duration as a train of 5 stimuli at 20 Hz. Train stimuli were
repeated every 15 s and resulted in stable responses. Furthermore the afferent synaptic
input parameters allowed for long term recordings without inducing LTP or LTD, but
to monitor the direct synaptic effects of the stimulation. The stimulation intensity was
set to 80% of the maximally elicited postsynaptic responses.
Recorded field potentials were characterized by application of synaptic blockers and the
sodium channel blocker tetrodotoxin (TTX). The receptor antagonist 2,3-dihydroxy-
6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) was applied to block AMPA
receptors and D-2-amino-5-phosphonopentanoate (D-AP5) blocked NMDA receptors.
Picrotoxin-supplemented (100 µM) ACSF was used during the entire experiment to
block GABAA receptor channels. At the end of every experiment TTX (0.5 µM) was
applied to block action potentials and for artefact compensation for subsequent field
potential analysis. After a 10-20 min baseline recording, either synaptic activity was
blocked by bath application of synaptic blockers (10 µM NBQX and 20 µM D-AP5) or
glucose deprivation was induced by wash-in of ACSF without glucose. Control experi-
ments of glucose deprivation were always performed on slices from the same animal in
Picrotoxin-supplemented ACSF. A scheme of the experimental procedure is shown in
Fig. 4.2C, D.
Data analysis was performed with a custom made tool written by Ronald Jabs using
Igor Pro software. Field potential traces were averaged as sets of 10 recordings and
the corresponding TTX file was subtracted to eliminate stimulation artefacts. Three
parameters were analysed, the delay of the popspike, the slope and the amplitude of
the postsynaptic field potential (Fig. 4.2E). The slope of the postsynaptic potential was
obtained by linear regression using all data points between two points of measurement
on the descending slope of the postsynaptic potential. Using the custom made Igor
Pro tool these two points were manually set on the recorded trace, the first one on the
recorded maximum peak after the popspike and the second point was set close before
reaching baseline levels again (Fig. 4.2E). All data points between the measuring points
were included to make a linear fit of the postsynaptic potential. The amplitude of the
popspike was measured from the fitted line to the peak amplitude, therefore a third
measuring point was manually positioned on the peak of the popspike (Fig. 4.2E). This
third point was also used to measure the delay of the popspike after the stimulation time
point (Fig. 4.2E). The acquired data sets were analysed for changes over time during
blocker application or glucose deprivation. The postsynaptic response after the third
stimulus in a train of five stimuli was compared between all experiments.
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Figure 4.2 Field potential recordings in the ventrobasal thalamus. (A) Coronal section of a
mouse brain, the cutting plane at a 30◦ angle with the horizontal plane is indicated by a red line. The
plane contains the cortex (CO), the internal capsule (IC), the reticular thalamic nucleus (RTN) and
the ventrobasal thalamus (VB). Additionally, the hippocampus (HC) is displayed and a cross indicating
the slice orientation (bottom). Modified after Mouse Brain Atlas, mbl.org. (B) Scheme of a horizontal,
30◦ tilted brain slice. The corticothalamic pathway is indicated by a green neuron, additionally the
thalamocortical pathway is shown in blue and the GABAergic neurons of the reticular thalamic nucleus
(RTN) are displayed in brown colour. Modified after Grant et al., 2012. (C and D) Time lines of the
experimental protocols applied for synaptic blocker analysis (C) and the glucose deprivation experiments
(D). (E) Scheme depicting the FP analysis by a custom made Igor Pro tool, by placing three measuring
points on the trace (grey circles). The parameters slope, amplitude and delay (dashed grey lines) of the
postsynaptic response were analysed.
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4.2 Confocal and 2-photon microscopy of acute slices
Electrophysiological recordings combined with 2-NBDG diffusion were imaged online
employing a Leica SP5 laser scanning microscope (LSM) equipped with an infrared ultra-
short-pulse laser. Before starting the patch clamp experiment, stacks of optical sections
were obtained with a continuous wave laser to visualize the SR101+ astrocytes and the
PLP-GFP+ cells in the ventrobasal thalamus. One SR101+ astrocyte was patched and
dialysed with 2-NBDG for 20 min. Employing the infrared laser, it was possible to
separate the 2-NBDG fluorescence from the GFP signal. Therefore 2-photon absorption
was achieved by excitation of the fluorochromes with femtosecond pulses of infrared light
with repetition rates of 80 MHz. The wave length for the excitation was adjusted for
best signal to noise ratio: GFP/SR101 710 nm (1.15 W). Reflected and transmitted
light was collected with two channel non-descanned detectors in each light pathway.
For GFP/SR101 signals reflected emission light was separated with a FITC-TRITC
filter cube. Volumes of 258.33x258.33x28-33 µm3 were scanned with a resolution of
1024x1024x29-34 pixels. Images of 2-NBDG diffusion were acquired 3 min and 20 min
after patching the astrocyte. Combining the continuous wave laser images acquired
before patching the astrocyte and the 2-NBDG filled network images, the number of
PLP-GFP+ cells and SR101+ cells filled with 2-NBDG were quantified.
4.3 Immunohistochemistry
4.3.1 Tissue preparation
Mice were deeply anaesthetized by intraperitoneal injection of 80 mg/kg Ketamine hy-
drochloride and 1.2 mg/kg Medetomidine hydrochloride and transcardially perfused with
30-50 ml 1x PBS followed by 30-50 ml 4% PFA. Brains were removed, postfixed overnight
in 4% PFA and washed the next day with 1x PBS.
Brains were prepared as described in section 4.1.1 and cut on a vibratome VT1200S
(Leica) into horizontal slices (40 µm) in 1x PBS at 4◦C and stored in 1x PBS with
sodium azide at 4◦C for subsequent staining.
4.3.2 Staining
Brain slices were stained to visualize tracer filled networks and for characterization of
cell-types in the VB compared to hippocampal CA1 region.
The tissue was stained using a free floating method in 24-well plates. Slices were per-
meabilized and blocked for 2-4 h at room temperature in 1x PBS containing 0.5-2%
TritonX-100 and 10% normal goat serum (NGS). The first antibodies were incubated in
1x PBS containing 0.1% TritonX-100 and 2% NGS at 4◦C overnight on a shaker, some
antibodies were incubated at room temperature overnight. The next day slices were
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washed 3 times for 10 min in 1x PBS and incubated with the corresponding secondary
antibodies in the antibody solution for 1.5 h at room temperature on a shaker. After-
wards slices were washed again 3 times for 10 min and incubated with Hoechst (1:100 in
dH2O) or Draq5 (1:1000 in 1x PBS) for nuclei staining. After a final washing step slices
were mounted on object slides with Aquapolymount for further confocal or fluorescence
microscopy analysis. See section 3.9.2 for a detailed list of the solutions.
Biocytin was visualized with Streptavidin-Cy3, -Cy2, -Cy5 or -A647 applied in the stain-
ing protocol above. Additionally, for the immunohistochemical analysis of the biocytin
injected cells 2-5% bovine serum albumin (BSA) was added to the blocking and antibody
solutions, secondary antibodies were incubated for 2 h at room temperature.
The applied antibodies are listed in section 3.5, for double and triple immunostainings
suitable first and corresponding secondary antibodies were used.
4.3.3 Microscopy
Immunofluorescence stainings were analysed by microscopy. Images were acquired at
a 1 µm interval using either a fluorescence microscope Axiophot employing MetaVue
software or confocal LSMs Leica TCS NT or Leica SP8. Fluorescence image resolution
was 2084x2084 pixels and LSM images were acquired at 1024x1024 pixels. Tracer filled
networks were imaged employing a 20x objective. For colocalization studies confocal
images were acquired. Cell type analysis in different brain areas was performed on image
stacks of 500x500x10-15 µm3 volumes. Aldh1L1 analysis was performed on 290x290x15
µm3 volumes. The images obtained were analysed using Fiji software and Figures were
edited using Inkscape.
4.3.4 Data analysis
The immunohistochemical stainings were quantified to assess the protein expression pro-
file and to further characterize glial cells in different brain regions. The number of cells
expressing one or more proteins were counted and cell densities were calculated. All
quantification results were counted by two different persons, by myself and another per-
son namely Sebastian Ebert, Ina Fiedler, Simon Ho¨ft or Anja Matijevic. Glial networks
were analysed by counting manually all tracer filled cells using the Fiji plugin Cell-
Counter. Cells were identified by their morphology and soma size. In some experiments
co-labelling of biocytin and antibody stainings was assessed by counting co-labelled cells.
Characterization of cell-types in the thalamus and hippocampus were performed on three
image stacks with identical volumes from three mice each, a total of nine images were
quantified. All cells of interest in the image were counted and analysed for colocalization
with cell-type markers, subsequently cell densities were calculated. Data are displayed
as mean ± SEM and were statistically analysed by analysis of variance (ANOVA) and
post-hoc Tukey. Differences between means were regarded as significant at p<0.05 (∗);
p<0.01 (∗∗).
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4.4 Protein chemistry
4.4.1 Tissue lysis
Western blot analysis of connexin expression was performed using wild-type C57/Bl6J
mice. Animals were sacrificed by cervical dislocation, and the brains were immediately
isolated. Brain tissue samples of hippocampus and thalamus were isolated, transferred
into a tube and frozen in liquid N2. The tissue samples were stored at -80
◦C or immedi-
ately lyzed in protein lysis buffer supplemented with protease and phosphatase inhibitor
single-use cocktail (100 µl/10 ml). The tissue samples were homogenized with a pestle,
then disrupted with a prechilled 27 gauge needle and supersonic slat until homogeneous
and incubated on ice for 30 min. Samples were centrifuged for 30 min at 13,000x g
at 4◦C and the supernatants were transferred into new tubes. Total protein content
was assayed with bicinchoninic acid (BCA) using 5 µl of each sample, according to the
manufacturer’s instructions.
4.4.2 SDS-PAGE and Western blot
Connexin protein analysis was performed using sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE), therefore 30-50 µg of total protein per lane was used.
With this method, proteins are separated in a polyacrylamide gel according to their size,
smaller molecules travel faster than larger proteins through the acrylamide pores. Po-
tential charge interferences were excluded by adding SDS; the dodecyl sulfate surround
the proteins with an equal negative charge.
Lysates were mixed with Laemmli sample buffer and denatured by heat-incubation for
10 min at 65◦C before they were shortly centrifuged at 4◦C. Proteins were separated
with standard 10% or 12% SDS-PAGE under denaturing conditions for 1-1.5 h at 60
mA. To estimate the protein size, Novex Sharp Protein Standard was loaded along with
the samples and lysate of a Cx30LacZ/LacZ ;Cx43fl/fl:hGFAP-Cre mouse was loaded as a
negative control for antibody specificity.
Polyvinylidene difluoride (PVDF) membranes were used for electroblotting of separated
proteins for 2 h at 500 mA running condition. The electric field was applied vertically
to the gel and allowed the transfer of proteins from the gel to the membrane. The pro-
teins adhere to the membrane by hydrophobic and polar interactions. Membranes were
blocked with 5% milk powder in Tris-buffered saline (TBS) containing 0.05% Tween-20
and incubated overnight at 4◦C on a rotator with primary antibodies: rabbit polyclonal
anti-Cx43CT (1:5,000), rabbit polyclonal anti-Cx30 (1:250) and mouse monoclonal anti-
α-tubulin (1:10,000). Secondary antibodies used: goat-anti-mouse- horse radish perox-
idase (HRP) conjugate (1:10,000) and goat-anti-rabbit-HRP conjugate (1:10,000). All
antibodies, including secondary antibodies, were diluted in 5% milk powder in TBS con-
taining 0.05% Tween-20. Equal loading of the lanes was confirmed by α-tubulin staining
of the same membrane.
For stripping, Pierce Restore stripping buffer was used for all blots for 20 min at room
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temperature. Membranes were usually re-blocked after stripping for 2 h at room tem-
perature. For visualisation of HRP, the SuperSignal West Dura substrate was used and
chemiluminescence was detected with the GeneGnome digital documentation system.
SDS-PAGE and Western blotting were performed by Jiong Zhang.
4.4.3 Data analysis
Raw data analysis and densitometry were performed with GeneTools quantification soft-
ware (Synoptics). After subtracting the background ratio for each band, the intensity of
the target proteins was normalized to the values from their α-tubulin loading controls,
respectively. For each sample the mean of two blots was calculated. The normalized val-
ues of control samples were set to 100%. Data are given as mean ± SEM. The statistical
analysis employed the Mann-Whitney U -test, differences between means were regarded
as significant at p<0.05 (∗); p<0.01 (∗∗). Data analysis was performed by Jiong Zhang.
4.5 Molecular biology
4.5.1 DNA extraction
Genomic DNA was obtained from small tail tips of 3 weeks old mice. Samples were
incubated in 300 µl Laird buffer supplemented with Proteinase K (20 U/ml) at 55◦C
overnight in a water bath. The next day lysates were vortexed and centrifuged at 13,000
rpm for 10 min at room temperature. The supernatant was transferred to a new tube and
the DNA was precipitated by adding 300 µl isopropanol and gently mixing the solutions.
After another centrifugation step at 13,000 rpm for 10 min at room temperature the
supernatant was discarded. The DNA pellet was washed in 70% ethanol (500 µl) and
centrifuged again at 13,000 rpm for 10 min at room temperature. The supernatant was
discarded and the DNA pellet was air dried for 1 h and dissolved in 50 µl of ddH2O.
The genomic DNA was subsequently used for routine genotype analysis with different
primers.
4.5.2 Polymerase chain reaction
DNA samples were amplified by polymerase chain reaction (PCR). The method relies
on several thermal cycling reactions for melting, primer annealing and subsequent repli-
cation of the target DNA. Primers were designed to bind at the 3’-end of the sense
and antisense strands of the DNA sequence to be amplified. Employing a heat-stable
Taq polymerase the DNA strands were amplified by elongation of the primers in 5’-3’
direction. This enzyme was originally isolated from the bacterium Thermus aquaticus.
The following Tables 4.1, 4.2 and 4.3 show the PCR mix and the applied PCR protocols
for genotyping animals of the Cx26fl/fl:Nestin-Cre mouse line; the presence of a floxed
Cx26 was detected by Cx26fl PCR, a successful excision of the gene was verified by
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analysis with Cx26del PCR and the presence of a Cre recombinase gene was detected
by Nestin-Cre PCR. The total volume of the PCR mix was 24 µl and 1-2 µl DNA were
added.
Table 4.1 Cx26fl PCR and protocol
PCR mix Volume [µl]
ddH2O 11.3
PCR buffer 5x 5
MgCl2 (25 mM) 2.5
Primer E3 (10 pmol/µl) 2
Primer E5 (10 pmol/µl) 2
dNTP (each 10 mM) 1
Taq polymerase 0.2
Step Temp. [◦C] Time [min] Cycles
1 94 5 1
2 94 0:45 2-4 35x
3 63 0:45
4 72 0:45
5 72 7 1
6 8 ∞ 1
Table 4.2 Cx26del PCR and protocol
PCR mix Volume [µl]
ddH2O 11.3
PCR buffer 5x 5
MgCl2 (25 mM) 2.5
Primer E3 (10 pmol/µl) 2
Primer A5 (10 pmol/µl) 2
dNTP (each 10 mM) 1
Taq polymerase 0.2
Step Temp. [◦C] Time [min] Cycles
1 94 5 1
2 94 0:45 2-4 35x
3 55 0:45
4 72 2:20
5 72 7 1
6 8 ∞ 1
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Table 4.3 Nestin-Cre PCR and protocol
PCR mix Volume [µl]
ddH2O 14.8
PCR buffer 5x 5
MgCl2 (25 mM) 2
Primer Nestin-Cre us (25 pmol/µl) 0.5
Primer Nestin-Cre ds (25 pmol/µl) 0.5
dNTP (each 10 mM) 1
Taq polymerase 0.2
Step Temp. [◦C] Time [min] Cycles
1 95 5 1
2 94 0:30 2-4 34x
3 62 0:50
4 72 1:30
5 72 10 1
6 8 ∞ 1
4.5.3 Agarose gel electrophoresis
The PCR products were separated by agarose gel electrophoresis. The cDNA samples
were separated by their size and charge, therefore a 1.5% agarose gel containing 0.8 µg/ml
ethidium bromide was prepared. Due to the phosphate groups negatively charged DNA
moved to the anode and the migration velocity was proportional to their molecular
mass. Ethidium bromide was added to visualize the DNA under ultraviolet light; it
intercalates double stranded DNA. Gel electrophoresis was performed at 110 V for 0:45-
1 h. At the same time, a 100 bp DNA ladder was run along with the samples to estimate
the molecular size of the amplified DNA fragments.
4.5.4 Single-cell RT-PCR
Reverse transcription
Thalamic astrocytes in p9-12 old hGFAP-EGFP mice were electrophysiologically char-
acterized. After recording, the cytoplasm of individual cells was harvested under micro-
scopic control and cytoplasm and pipette solution (3 µl) was expelled into a thin-walled
reaction tube filled with 3 µl DEPC-water. The cytoplasm was frozen in liquid N2 and
stored at -20◦C until reverse transcription (RT) was performed. For single-strand cDNA
synthesis 5.5 µl RT-PCR mix (Tab. 4.4) was added to the tubes (final volume about 10
µl). The reaction was performed at 37◦C for 1 h. All experiments employing single-cell
mRNA were performed by Gerald Seifert.
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Table 4.4 Reverse transcription mix
RT Mix Volume [µl]
First strand buffer 2
MgCl2 (25 mM) 1
dNTPs (4x 2.5 mM) 1
Random hexamer primer (1 mM) 0,5
RNasin RNase inhibitor (40 U/µl) 0.5
GoScript reverse transcriptase (160 U/µl) 0.5
Multiplex PCR
A multiplex 2-round single-cell PCR was performed with primers for either GluA1-4
AMPA receptors subunits or α-, β-, γ- and δ-GABAA receptor subunits respectively,
together with the housekeeping gene S100β. The sequences of the primers are shown in
section 3.7. The first PCR was performed after adding first round PCR mix to the RT
product (final volume 50 µl); the PCR mix and protocol are shown in Table 4.5.
An aliquot (2 µl) of the PCR product was used as template for the second PCR em-
ploying nested, subunit-specific primers as shown in section 3.7. Furthermore a nested
PCR for the astrocyte housekeeping gene S100β was performed. The conditions were
the same as described for the first round, with addition of dNTPs and a Platinum Taq
polymerase. Products were identified by gel electrophoresis using the Low Molecular
Weight DNA ladder (New England Biolabs).
Specificity of primers was tested with total mRNA prepared from freshly isolated mouse
brain. For optimization, a 2-round RT-PCR was performed with 2 ng of total RNA and
primers as described above. The primers for the targets were located on different exons
to prevent amplification of genomic DNA. Omission of the RT-enzyme and substitution
of template by bath solution served as negative controls for RT and PCR amplification.
Restriction digest of PCR products
The splice variants flip and flop of the AMPA recepors were discriminated by restriction
digest of PCR products. Therefore the second PCR (GluA1-4) was repeated. The PCR
product was purified using the MinElute PCR Purification Kit (Qiagen), and dissolved
in 30 µl H2O. Eight µl of the PCR product were incubated with restriction enzymes (10
U, 6 h, 37◦C, total volume 15 µl). cDNA fragments were analysed by gel electrophoresis
(3% Agarose 1000) using a 50 bp ladder. The PCR products for GluA receptors were
digested by the splice variant-specific restriction endonucleases BsaHI (cut GluA1 flip,
yielding a 230 bp and a 45 bp fragment), TspRI (GluA2 flip 210 and 50 bp; GluA3 flip,
208 and 50 bp; and GluA4 flip, 235 and 50 bp), MseI (GluA1 flop, 221 and 64 bp; GluA4
flop, 207, 64 and 14 bp) and HpaI (GluA2 flop, 192 and 68 bp; GluA3 flop, 181 and 77
bp). See also section 3.8 for restriction enzyme properties.
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Table 4.5 First round PCR and protocol
PCR Mix Volume µl
dH2O 29
PCR buffer 5
MgCl2 (50 mM) 2.5
Primers receptor se (10 pmol/µl) 1
Primers receptor as (10 pmol/µl) 1
Primers S100β se (10 pmol/µl) 0.5
Primers S100β as (10 pmol/µl) 0.5
Taq polymerase (5 U/µl) 0.5
Step Temp. [◦C] Time [min] Cycles
1 94 0:25 1-3 5x
2 49 2
3 72 0:25
4 94 0:25 4-6 45x
5 49 0:45
6 72 0:25
7 72 7 1
8 4 ∞ 1
Table 4.6 Nested PCR and protocol
PCR Mix Volume [µl]
dH2O 37
PCR buffer 5
MgCl2 (50 mM) 2.5
dNTPs (4x 2.5 mM) 1
Primer nested se (10 pmol/µl) 1
Primer nested as (10 pmol/µl) 1
Platinum Taq polymerase (5 U/µl) 0.5
Step Temp. [◦C] Time [min] Cycles
1 94 0:25 1-3 5x
2 54 2
3 72 0:25
4 94 0:25 4-6 30x
5 54 0:45
6 72 0:25
7 72 7 1
8 4 ∞ 1
64
5 Results
Astroglial networks have been extensively studied in the hippocampus, but little is known
about glial cells in the thalamus. In a study by Parri et al. (2001) thalamic astrocytes
displayed no Lucifer yellow diffusion to neighbouring cells. The apparent absence of
an astroglial network was an unexpected observation and questioned the concept of an
astroglial network throughout the brain.
The thalamus consists of several nuclei with different functions in sensory information
processing. In this study, all experiments were performed in the ventrobasal thalamus,
specifically the VPL and VPM nuclei to avoid potential regional effects. The ventrobasal
thalamus plays an important role in transduction of somatosensory information from the
whiskers to the somatosensory cortex (Haidarliu and Ahissar, 2001).
5.1 Properties of thalamic astroglial networks
Astrocytes are connected with each other via GJC in many brain regions (Wallraff et
al., 2006; Houades et al., 2008; Roux et al., 2011). In the first set of experiments, the
size of these GJN was analysed in the ventrobasal thalamus during mouse development.
Therefore, a single astrocyte was patched using a pipette solution supplemented with
biocytin, a tracer small enough to diffuse through GJC. Biocytin was chosen over Lucifer
yellow as it diffuses further into the network (Rouach et al., 2008). The extent of tracer
diffusion after 20 min filling was analysed to assess network sizes.
In Figure 5.1A and B two exemplary GJN in hGFAP-EGFP mice are displayed. The
patched cells were electrophysiologically characterized and displayed large passive cur-
rent patterns typical for astrocytes (Fig. 5.1A1, B1; Wallraff et al., 2006). Subsequent
tracer visualization revealed large networks which displayed a round shape as shown in
Figure 5.1A2 or an elongated shape (Fig. 5.1B2). The lateral part of the ventrobasal
thalamus contains densely packed myelinated fibre tracts. Tracer spread from the astro-
cyte into myelin fibres was observed in several cases (see inset in Figure 5.1B2).
Developmental analysis was performed at four different time points from young to adult
mice. Thalamic astrocytes filled with biocytin always revealed large GJN which in-
creased between early juvenile and two weeks old animals (p9-11, 84 ± 13 cells; p13-15,
111 ± 8 cells; p35-56, 108 ± 11 cells; p90-120, 95 ± 8 cells; tested by ANOVA and
post-hoc Tukey’s test, p<0.01 (∗∗); Fig. 5.1C). The p9-11 cells were patched by Anna
Beinhauer; 10 of 20 cells at p13-15, 6 of 14 cells at p35-56 and cells at p90-120 were
patched by Simon Ho¨ft (see also Griemsmann et al., 2014).
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Figure 5.1 Astroglial networks in the ventrobasal thalamus have distinct properties. (A,
B) Representative examples of tracer-filled networks after patching an EGFP fluorescent astrocyte in
hGFAP-EGFP mice. (A1, B1) Current patterns of astrocytes induced by de- and hyperpolarization of
the membrane between -160 and +20 mV evoked a passive current pattern in whole-cell voltage clamp
mode (10 mV increment, holding potential -80 mV). Scale bar, 10 ms, 5 nA. (A2, B2) Biocytin always
spread from the initial cell into neighbouring cells and revealed large glial networks. In some cases the
tracer also diffused into myelinated fibre tracts, see higher magnification of boxed area in the inset in
B2. Scale bar, 50 µm. (C) Quantification of network sizes at different time points. The average GJN
size was constant after the second postnatal week (mean ± SEM). (D) Analysis of the influence of the
widely used fluorescent dye SR101 on GJNs revealed no influence on network sizes. Asterisks indicate
statistical significance. Number of experiments is given in parentheses. See also Griemsmann et al.,
2014.
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The red fluorescent dye sulforhodamine 101 (SR101) is an efficient and reliable astrocyte
marker, but it also affects neuronal activity (Nimmerjahn et al., 2004; Kafitz et al., 2008;
Kang et al., 2010). Furthermore, it was still unclear whether SR101 influences astrocyte
network sizes. To answer this question, brain slices were incubated with SR101 and
GJNs compared with those observed in slices without dye incubation (Fig. 5.1D). Tracer
coupling in the thalamus was not influenced by SR101 staining (SR101 incubation,
113 ± 8 cells, n = 12; control, 106 ± 12 cells, n = 8; ANOVA; see also Griemsmann et
al., 2014). SR101 proved to be a reliable astrocyte marker in the thalamus.
In conclusion, astrocytes in the ventrobasal thalamus form glial networks via gap junction
channels which are already fully developed at p13-15. The astrocyte marker SR101 does
not influence network sizes which is therefore a valuable tool for further experiments.
5.2 Connexin expression in astrocytes
5.2.1 The impact of Cx30 and Cx43 on astroglial networks
The first part of the present study employing biocytin as a tracer revealed large glial
networks in the thalamus (Section 5.1). Astrocytes express three different connexin
isoforms: Cx26, Cx30 and Cx43. In the hippocampus Cx43 is the main GJ protein
and loss of Cx30 was reported to have a minor or equal influence (Wallraff et al., 2006;
Gosejacob et al., 2011; Theis and Giaume, 2012; Pannasch et al., 2014). The impact
of Cx26 expression on networks sizes has not been analysed so far in mice lacking this
connexin. It was of special interest which connexins are involved in the formation of GJC
in thalamic glial networks. Therefore, further experiments were performed employing
connexin knock-out mice at the age p30-60 which applies for all following experiments,
if not stated otherwise. Experiments performed in the institute employing heterozygous
Cx43ECFP/+ mice revealed that a moderate proportion of the cells express ECFP in
thalamic GJNs (Griemsmann et al., 2014). In addition, transcript levels of Cx30 mRNA
were increased in thalamic samples in sqRT-PCR analysis compared to hippocampus of
wild-type mice (Griemsmann et al., 2014), indicating that Cx43 plays a less important
role in the thalamus. Still, the functional role of Cx30 in the thalamus remained elusive.
The impact of this isoform on thalamic coupling was investigated in Cx30kiLacZ mice, in
which the coding region of the Cx30 gene was replaced by the reporter LacZ (Teubner
et al., 2003). Thalamic astrocytes were filled with biocytin and displayed a strong
decrease in coupling by 73% compared to littermate controls (Cx30+/+, 81 ± 6 cells,
n = 17; Cx30LacZ/LacZ , 22 ± 3 cells, n = 15; Fig. 5.2A1−3, B1), employing ANOVA and
post-hoc Tukey’s test (p<0.01 (∗∗)). Even complete uncoupling was observed in 25% of
the cells (n = 5 of 20; Fig. 5.2A3, B2; see also Griemsmann et al., 2014) which differed
from control littermates employing X 2-test (p<0.05 (∗)). In Cx30LacZ/LacZ mice the
tracer-filled cell was always brightly fluorescent with a few or no weakly fluorescent cells
around it. The tracer barely diffused into neighbouring cells.
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Figure 5.2 Functional analysis of the gap junction protein Cx30 in the thalamus. (A) Confo-
cal images show biocytin diffusion in the thalamus of Cx30+/+ mice (A1) and Cx30
LacZ/LacZ littermates
(A2 and A3). Tracer-filled cells in Cx30
LacZ/LacZ mice were connected to few (A2) or no neighbouring
cells (A3). The initial cell was always brightly fluorescent with weakly labelled neighbouring cells. (B1)
Network sizes were strongly decreased (by -73%) in Cx30LacZ/LacZ vs. Cx30+/+ mice. (B2) Percentage
of injected cells which were coupled to at least one other cell and thereby formed a network (black)
versus injected uncoupled cells (grey). (C) Additional deletion of Cx43 in astrocytes abolished coupling
of the cells (C1). Only in 2 cases residual networks were observed (C2). (D) Summary of the network
analysis in Cx30/43 DKO mice. UC, uncoupled cells; C, coupled cells. Asterisks indicate statistical
significance. Number of experiments is given in parentheses. Scale bar, 20 µm. See also Griemsmann
et al., 2014.
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The observed difference between thalamic and hippocampal networks regarding the
importance of Cx30 for GJN formation, led to the question whether an additional
deletion of Cx43 would completely abolish coupling as observed in the hippocampus
(Wallraff et al., 2006). Tracer-filled astrocytes in mice deficient for Cx30 and Cx43
(Cx30/43 DKO) revealed complete disruption of inter-cellular gap junctions in 16 out
of 18 biocytin-filled thalamic SR101+ cells in contrast to Cx30+/+ and Cx30LacZ/LacZ
mice (X 2-test, p<0.05 (∗)). Tiny networks (8 ± 6 cells) were only observed in two ex-
periments (Fig. 5.2C1−2, D). Some cells were patched by Simon Ho¨ft (5 of 16 uncoupled
and 1 of 2 coupled cells; see also Griemsmann et al., 2014).
In conclusion, astrocytic coupling in the adult thalamus is mediated predominantly by
Cx30. The additional deletion of Cx43 leads to a complete disruption of the glial net-
work, though the residual coupling in some cases might involve a third connexin, e.g.
Cx26.
5.2.2 Molecular analysis of Cx30 and Cx43 expression
The functional analysis revealed distinct properties of astroglial networks in the thala-
mus compared to the hippocampus. In the following experiments these two brain regions
were analysed for developmental differences in connexin expression on protein level in
C57/Bl6 mice.
Western blot analysis revealed differential connexin expression between brain regions,
additionally, proteins were developmentally up-regulated (Fig. 5.3A1−2, B1−2). Two age
groups were compared: p14, when Cx30 expression increases (Kunzelmann et al., 1999)
and p53 which is in the age group of tracer-filled mice. Western blots were performed
by Jiong Zhang and statistically analysed employing Mann-Whitney U -test, p<0.05 (∗),
p<0.01 (∗∗). Cx30 protein levels increased more than threefold during this period in
the thalamus, while in the hippocampus Cx30 increased twofold between age groups. In
young mice Cx30 protein levels were equal. Cx43 increased twofold in the hippocampus
and thalamus. Protein amounts were equal between brain regions in adult mice, but
differed at p14. In summary, in the adult brain Cx30 protein levels are higher in the
thalamus, while Cx43 protein content does not differ (Fig. 5.3A2, B2; see also Griems-
mann et al., 2014). These data corroborate the important role of Cx30 in the thalamus.
On a cellular level connexin expression was further analysed by reporter gene analysis
in Cx43ECFP/+;Cx30LacZ/+ mice. Experiments were performed only in the thalamus,
as the reporter LacZ is not expressed in the hippocampus of these mice (Fig. 5.3C;
Gosejacob et al., 2011). Quantification was performed on 3 image stacks in 3 different
mice, therefore a total of 9 images were quantified by two persons each (see also Sec-
tion 4.3.4). The Cx30-β-Gal signal contains a nuclear localization signal and antibody
staining revealed abundant expression in the thalamus (Fig. 5.3C1). Cx43-ECFP
+ cells
were visualized in green (Fig. 5.3C2), in the overlay co-expressing cells appear yellow,
but also some single-labelled cells were observed (Fig. 5.3C3).
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Figure 5.3 (previous page) Protein expression of Cx30 and Cx43. (A1) Cx30 protein levels
analysed by Western blot in the thalamus (TH) and hippocampus (HC) of C57/Bl6 mice at two different
time points. Cx30 protein levels increased between p14 and p53 and were higher in the adult thala-
mus. A Cx30/43 DKO mouse was used as negative control and α-tubulin as a loading control. (A2)
Normalised protein levels confirmed the increase of Cx30 levels during development with a stronger
upregulation in the thalamus. (B1) Western blot analysis of Cx43 in wild-type mice. The different
phosphorylation status led to two bands in adult mice. (B2) Cx43 protein levels, which were normalised
to α-tubulin levels, were higher in the juvenile hippocampus than in thalamus. Protein levels increased
during development and were equal between brain regions at p53. (C) Immunohistochemical analysis of
reporter gene expression in mice heterozygous for Cx30LacZ/+ (C1) and for Cx43
ECFP/+ (C2). In the
thalamus, different astrocyte populations were observed according to their connexin expression profile.
(C3) Colocalization of the reporters was observed in most cells (yellow in merge), but single-labelled
cells expressing only one reporter gene were also present (red or green). (D) Quantification of connexin
reporter expression revealed three different astrocyte populations in the thalamus (β-Gal+/ECFP+,
78.1 ± 2.6%; β-Gal+/ECFP−, 20.4 ± 2.4%; β-Gal−/ECFP+, 1.5 ± 0.7%, n = 9 from 3 mice). Aster-
isks indicate statistical significance. Number of mice is given in parentheses. Scale bar, 20 µm. See also
Griemsmann et al., 2014.
The quantified overlap of ECFP and β-Gal signal revealed that almost all (98.5%,
43,051 ± 1,627 β-Gal+ cells/mm3 of 43,719 ± 1,457 total cells/mm3) of the astro-
cytes expressed Cx30, while one fifth lacked Cx43 (20%, 8,904 ± 1,117 β-Gal+/ECFP−
cells/mm3; Fig. 5.3D). The uncoupled cells found in the thalamus of Cx30LacZ/LacZ mice
probably belong to this group (see Section 5.2.1). Furthermore, a minor proportion of
1.5% only expressed Cx43 (667 ± 309 β-Gal−/ECFP+ cells/mm3; ANOVA and post-hoc
Tukey, p<0.01 (∗∗); see also Griemsmann et al., 2014).
Summarizing, Western blot analysis and reporter gene expression verified the prominent
expression of Cx30 in the thalamus, although Cx43 is also widely expressed.
5.2.3 The role of Cx26 in glial networks
Astrocytes express three connexins: Cx26, Cx30 and Cx43. While the latter 2 have been
extensively studied in many brain regions (Wallraff et al., 2006; Houades et al., 2008;
Pannasch et al., 2011; Roux et al., 2011), the influence of Cx26 on network formation is
highly debated in the field. In the hippocampus of Cx30/43 DKO mice, astrocytes were
uncoupled and also in the thalamus coupling was mostly abolished (see Section 5.2.1). A
recent study revealed a negative impact of the Cx30 knock-out on Cx26 expression (Lynn
et al., 2011). Hence, it was of major interest to study the effect of Cx26 on network size
directly by taking advantage of the Cx26fl/fl:Nestin-Cre mouse line (Tronche et al., 1999;
Cohen-Salmon et al., 2002).
Astrocytes were identified by SR101 labelling in acute slices. Tracer-filled cells dis-
played similar resting membrane potentials in both genotypes in the thalamus(control,
-71 ± 1.5 mV, n = 9; Cx26fl/fl:Nestin-Cre, -70 ± 1.6 mV, n = 11) and hippocampus
(control, -73 ± 1.6 mV, n = 8; Cx26fl/fl:Nestin-Cre, -69.4 ± 2.3 mV, n = 9; ANOVA).
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Figure 5.4 Cx26 does not contribute to astrocyte networks. (A, B) The impact of Cx26 deletion
on coupling was analysed in Cx26+/+ and Cx26fl/fl:Nestin-Cre mice. In both thalamus (A, TH) and
hippocampus (B, HC) large networks were observed in Cx26+/+ (A1, B1) and Cx26
fl/fl:Nestin-Cre mice
(A2, B2). (C) Network sizes were equal between all genotypes and brain regions analysed (ANOVA).
Number of experiments is given in parentheses. Scale bar, 50 µm.
Biocytin diffusion and subsequent visualization revealed large networks in the thala-
mus of both control and conditional knock-out mice (Fig. 5.4A1−2). Similar results
were obtained when analysing hippocampal networks (Fig. 5.4B1−2). Equal network
sizes were observed in control and Cx26 knock-out mice (TH, control, 150 ± 23 cells,
n = 9; Cx26fl/fl:Nestin-Cre, 112 ± 17 cells, n = 11; HC, control, 91 ± 9 cells, n = 8;
Cx26fl/fl:Nestin-Cre, 118 ± 14 cells, n = 9; Fig. 5.4C; ANOVA; see also Griemsmann
et al., 2014). Hence, Cx26 is not involved in GJN formation in these brain areas.
The Cx26fl/fl:Nestin-Cre mouse line does not express a reporter gene, when the floxed
gene is deleted. It is very important to closely monitor Cre activity to obtain the re-
quired conditional knock-out. Both an inactive Cre and an ectopic Cre activity have
been described earlier (Requardt et al., 2009; Zhang et al., 2013). Therefore, the
genotype of all animals used for the tracer study described above were re-genotyped.
The PCR strategy applied here involved three PCRs, a first Cx26fl PCR to detect
the Cx26wt and Cx26fl allele, a second PCR to detect the Nestin-Cre gene and fi-
nally a third Cx26del PCR to confirm the deletion of Cx26fl in the presence of Cre
(Fig. 5.5). In Figure 5.5 four genotypes are depicted, #1 is a Cx26+/+:Nestin-Cre
mouse which expresses the wt Cx26 protein. Mouse #2 is Cx26+/fl, but lacks Cre re-
combinase, #3 is a Cx26+/fl:Nestin-Cre mouse with deletion of the floxed allele and
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Figure 5.5 Genotyping PCR of the Cx26fl/fl:Nestin-Cre mouse line. The conditional deletion
of the floxed Cx26 allele was monitored by genotyping PCR. Animals were tested for the presence of
a wt or a fl Cx26 allele (upper row), the presence of the Nestin-Cre transgene and additionally the
deletion of the Cx26fl allele by a new Cx26del PCR. Mouse #1 has a Cx26+/+:Nestin-Cre genotype,
#2 is a Cx26+/fl, #3 is a Cx26+/fl:Nestin-Cre with Cx26 deletion, and #4 is a Cx26fl/fl:Nestin-Cre
with Cx26 deletion. The mouse #4 is a conditional Cx26 knock-out.
therefore heterozygous for Cx26. Mouse #4 has a Cx26fl/fl:Nestin-Cre genotype, also
containing the deletion of Cx26fl and is a conditional knock-out of Cx26. A deletion
of Cx26fl was only observed in the presence of Nestin-Cre, as shown for mouse #3
and #4 (10 litters of 4 matings were analysed). Noticeably, in the tail tip PCR both
the deleted and the floxed Cx26 allele were detected. Nestin is expressed in neural
precursor cells, but also in vascular endothelial cells, at the neuromuscular junction
and many precursor cells, e.g. in kidney, muscle, testis and heart (Klein et al., 2003;
Mohseni et al., 2011).
The Cx26fl/fl:Nestin-Cre mouse line proved to be a reliable tool to study the physiologi-
cal role of Cx26 in the brain. An influence of Cx26 on GJN formation was not observed,
indicating that inter-cellular GJs in astrocytes are composed of Cx30 and Cx43.
5.2.4 Cx43 variants reveal impact on RG-like cell networks
RG-like cells are neuronal precursor cells which still reside in the mature brain in neuro-
genic niches. They share many properties with astrocytes and express a similar pattern
of connexins (Kunze et al., 2009). Here, the impact of Cx43 mutations on RG-like cell
coupling was investigated.
Earlier studies showed that Cx30 has no influence on adult neurogenesis (Liebmann et
al., 2013). Therefore, all knock-out mice used in the network analysis were Cx30 knock-
outs and additionally carried different Cx43 modifications to study the influence of the
Cx43 channel vs. regulatory effects influencing Cx43 localization. Wild-type (C57/Bl6)
animals were compared to mice carrying a floxed point mutation Cx43G138R leading
to closure of the channel pore. Additionally, a mouse line carrying a truncation of the
cytoplasmic C-terminal tail was analysed. Adult mice between p90-120 were used for
the study.
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RG-like cells display rather small networks compared to astrocytes, the average net-
work size was 12 ± 1 in Cx30+/+;Cx43+/+ mice (wt, n = 5). Mice carrying the point
mutation Cx43G138R displayed smaller network sizes compared to wild-type animals
(Mann-Whitney U -test, p<0.05 (∗)). No difference was observed between animals with
Nestin-Cre (Cx30−/−;Cx43flG138R/flG138R:Nestin-Cre, 8 ± 2, n = 4) which expressed the
point mutation, and those without Cre (Cx30−/−;Cx43flG138R/flG138R, 8 ± 1, n = 3;
Mann-Whitney U -test; Fig. 5.6A). Compared to Cx30+/+;Cx43+/+ mice the occurrence
of networks was equal for RG-like cells carrying the point mutation Cx43G138R (wt,
83%, n = 5 coupled cells and n = 1 single cell; Cx30−/−;Cx43flG138R/flG138R:Nestin-Cre,
50% coupled cells, n = 4 coupled cells and n = 4 single cells; X 2-test). Mice negative for
Nestin-Cre displayed an equal network/single cell ratio compared to wild-type and point
mutation mice (60% coupled cells; n = 3 coupled cells and n = 2 single cells; X 2-test;
Fig. 5.6B).
Mice with a truncation of the cytoplasmic tail were heterozygous for this knock-out
(Cx43K258stop) and carried a floxed Cx43 on the other allele, otherwise the truncation is
lethal (Maass et al., 2007). The floxed Cx43 was deleted employing a hGFAP-Cre recom-
binase. These Cx30−/−;Cx43fl/K258stop:GFAP-Cre animals displayed significantly smaller
networks compared to Cx30+/+;Cx43+/+ animals (5 ± 1, n = 5; Mann-Whitney U -test,
p<0.05 (∗)), but were equal to GFAP-Cre negative mice (Cx30−/−;Cx43fl/K258stop, 8 ± 2,
n = 4; Mann-Whitney U -test). Analysing the ratio of networks vs. single cells when
patching an RG-like cell, the truncated Cx43K258stop did not differ from wild-type,
GFAP-Cre negative mice or Cx43G138R mice. RG-like cells in Cx30−/−;Cx43fl/K258stop
mice were coupled in 80% of the experiments (n = 4 coupled cells and n = 1 single
cell) and in Cx30−/−;Cx43fl/K258stop:GFAP-Cre mice 63% of the tracer filled RG-like
cells were coupled (n = 5 coupled cells and n = 3 single cells; X 2-test; Fig. 5.6B). The
RG-like cell networks were analysed in collaboration with Jiong Zhang, who stained and
co-counted the networks. Part of the data were published in the PhD thesis by Zhang,
2013.
In conclusion, RG-like cells in the subgranular zone of adult mice were coupled to other
cells. The networks were however much smaller compared to astrocyte networks in the
CA1 st. rad. (Fig. 5.6A, 5.1C). Modifications of the Cx43 protein led to changes in
RG-like networks. The point mutation in the pore domain often led to uncoupling, while
the truncation of the cytoplasmic tail with its regulatory phosphorylation sites decreased
network sizes compared to wild-type mice.
74
Results
Figure 5.6 Impact of Cx43 modifications on gap junctions in RG-like cells. (A) Network sizes
of RG-like cells in five different genotypes, in Cx30+/+;Cx43+/+ the average number of coupled cells was
12 ± 1. Mice expressing the Cx43G138R point mutation have smaller networks. Also cells containing
a C-terminal truncated Cx43K258stop on one allele and a floxed wt allele displayed decreased network
sizes. Mice expressing only the truncated Cx43K258stop displayed the smallest networks compared to
Cx30+/+;Cx43+/+ animals. (B) Most RG-like cells are coupled, though some cells were not connected
to other cells. No difference between genotypes was observed. Asterisks indicate statistical significance.
Number of experiments is given in parentheses.
5.3 Astrocytes and oligodendrocytes form a panglial
network in the murine brain
5.3.1 Indications for panglial networks from immunohistochemistry
The differential connexin expression between hippocampus and thalamus, and even
within thalamic astrocytes, revealed a considerable astrocyte heterogeneity. Further-
more, the network analysis revealed tracer diffusion into myelinated fibre tracts. The
latter observation led to the question how the tracer could diffuse into the myelin sheath
and questioned the concept of a pure astrocytic network. In the following experiments
the cell-type composition of these physiological networks was investigated by immuno-
histochemistry.
The membrane potential of tracer-filled astrocytes was equal between brain regions (TH,
-76.55 ± 1.34 mV, n = 11; HC, 78.7 ± 1.34 mV, n = 10), while the membrane resistance
was slightly lower in the thalamus (TH, 1.58 ± 0.23 MΩ, n = 11; HC, 3.28 ± 0.46 MΩ,
n = 10).
Characterization of cell identity in GJNs was performed employing hGFAP-EGFP mice
and subsequent antibody staining. Many EGFP+ cells were observed in both thalamus
and hippocampus (Nolte et al., 2001), although GFAP antibody staining in the thalamus
labels only very few cells (not shown; see Frassoni et al., 2000; Parri and Crunelli, 2002).
Instead of GFAP the enzyme GS was used as a marker for astrocytes (Norenberg, 1979;
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Sonnewald et al., 1997; Coulter and Eid, 2012). Glutamine synthetase is an enzyme in-
volved in detoxification of ammonia, metabolises glutamate to glutamine and is located
in the cytoplasm of astrocytes (Norenberg, 1979). Antibody staining revealed many GS+
cells in both thalamus and hippocampus and was therefore considered a good astrocyte
marker for GJN analysis. Immunostaining of tracer-coupled networks revealed many co-
labelled cells, but some biocytin filled cells were not stained for GS (Fig. 5.7A1−3, B1−3).
This marker was expressed by less than half of the biocytin-coupled cells in the thalamus
(TH, 49 ± 8 of 100 ± 13 cells, n = 10), while most of the coupled cells in the hippocam-
pal CA1 region were GS+ (HC, 106 ± 10 of 129 ± 11 cells, n = 7; Fig. 5.7). The amount
of GS+ cells differed significantly (by 35%) between networks in the two brain regions.
In the thalamus 46.4 ± 5.4% and in the hippocampus 81.6 ± 2% of the tracer filled cells
were GS+ (ANOVA and post-hoc Tukey’s test, p<0.01 (∗∗); Fig. 5.7C1−2). In summary,
glial networks contain distinct amounts of GS+ cells in the thalamus and hippocampus
(see also Griemsmann et al., 2014).
A marker for oligodendrocytes was employed in a second study to investigate the cell-
identity of GS− cells in these networks. The transcription factor Olig2 is expressed
in cells of the oligodendrocyte lineage (Marshall et al., 2005; Nishiyama et al., 2009;
Trotter et al., 2010) and was therefore considered a suitable tool to look for mature
and immature oligodendrocytes. Thalamic networks abundantly contained Olig2+ cells
(49 ± 8 of 75 ± 7 cells, n = 10; Fig. 5.8A1−3). In contrast, in hippocampal GJNs Olig2
labelling was much less prevalent (19 ± 4 of 129 ± 18 cells, n = 7; Fig. 5.8B1−3). The
fraction of Olig2+ cells differed significantly between the two brain regions. While in
the thalamus a majority of cells expressed Olig2 (62.2 ± 8.4%, n = 10), in the hip-
pocampus only a minor fraction of cells displayed Olig2 (17.5 ± 4.6%, n= 7; ANOVA
and post-hoc Tukey’s test, p<0.01 (∗∗); Fig. 5.8C1−2). Immunostainings suggested par-
ticipation of astrocytes and oligodendrocytes in GJNs in both brain regions, though at
variable amounts. While GS and Olig2 label distinct cell populations in the hippocam-
pus (Fig. 5.7C2, 5.8C2), they were not cell-type specific in the thalamus. There was a
considerable overlap in staining as derived from cell counting (Fig. 5.7C1, 5.8C1; see
also Griemsmann et al., 2014).
Recent observations in white matter areas of the brain described NG2 cells as part of
glial networks (Maglione et al., 2010). The Olig2 labelling might include NG2 cells as
the transcription factor Olig2 labels the entire oligodendrocytes lineage, including NG2+
cells (Trotter et al., 2010). A potential role of these cells in grey matter areas of the
hippocampus and thalamus was investigated in the next set of experiments. In contrast
to recent findings in the corpus callosum (Maglione et al., 2010), we never observed
NG2+ cells within thalamic or hippocampal GJNs (TH, 0 of 117 ± 11 cells, n = 8;
HC, 0 of 136 ± 18 cells, n = 8; Fig. 5.9A1−3, B1−3). In conclusion, GJNs in both brain
regions did not contain NG2+ cells and indicate differences between grey and white mat-
ter areas (see also Griemsmann et al., 2014).
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Figure 5.7 GS expressing cells in tracer-coupled networks. (A, B) Immunostainings of GJNs
(A1, B1) in the thalamus (TH) and hippocampus (HC) with the astrocyte marker GS (A2, B2). Merged
images (A3, B3) show colocalization of biocytin (red) and GS staining (green) in yellow. (C) Thalamic
networks contained less than 50% GS+ cells (C1, 46.4 ± 5.4%, n = 10), while most cells in hippocampal
GJNs were GS+ (C2, 81.6 ± 2%, n = 7). Scale bar, 20 µm. See also Griemsmann et al., 2014.
77
Results
Figure 5.8 Glial networks contain differential amounts of Olig2 expressing cells. (A, B)
Immunostainings of thalamic (TH) and hippocampal (HC) networks (A1, B1) in hGFAP-EGFP mice
using antibodies against Olig2 (A2, B2). Merged images in the thalamus (A3) display many Olig2
+ cells
in tracer coupled networks, while in the hippocampus only few Olig2+ and biocytin double labelled cells
were observed (B3). (C) Most coupled cells in the thalamus were Olig2
+ (C1, 62.2 ± 8.4 %, n = 10).
In the hippocampus only a few Olig2+ cells (C2, 17.5 ± 4.6 %, n= 7) were observed in GJNs. Scale
bar, 20 µm. See also Griemsmann et al., 2014.
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Microglia express Cx43 under certain conditions, e.g. inflammation, and are dye-coupled
in vitro (Eugen´ın et al., 2001). To check whether microglia participate in GJNs, net-
works were stained for Iba1. In both brain regions Iba1+ microglia (TH, n = 9; HC, n
= 8) were never part of the tracer-filled networks (Fig. 5.9C1−3, D1−3; see also Griems-
mann et al., 2014).
In the thalamus and the hippocampal CA3 region Cx45 mediated gap junction coupling
between neurons has been described in adulthood (Maxeiner et al., 2003). Accordingly,
a potential contribution of neurons was investigated immunohistochemically study by la-
belling neuronal nuclei (NeuN). In the ventrobasal thalamus no NeuN+ cells were found
in GJNs, when patching an astrocyte, and also in the hippocampal CA1 region no indi-
cations for a neuronal contribution to glial GJNs was observed (TH, n = 9; HC, n = 6;
Fig. 5.9E1−3, F1−3; see also Griemsmann et al., 2014).
Thus, the immunohistochemical study of physiological tracer-coupled networks in situ
revealed a heterogeneous cell population in both brain regions. GJNs are not exclusively
formed by astrocytes, but also include oligodendrocytes. While in the hippocampus the
networks contain around 80% GS+ astrocytes and 20% Olig2+ oligodendrocytes, the
thalamic networks differ in their properties regarding GS+(46%) and Olig2+(62%) cells.
Furthermore, thalamic networks contain a population of cells that, according to cell
counting, expresses both astrocytic and oligodendrocytic markers.
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Figure 5.9 (previous page) Biocytin-filled networks are devoid of NG2 cells, microglia
and neurons. Immunostainings of GJNs (A1-F1)in the thalamus (TH) and hippocampus (HC) using
antibodies against NG2 (A2, B2), Iba1 (C2, D2) and NeuN (E2, F2). The merged images (A3-F3)
show no overlap of biocytin with the cell-type specific antibody staining for NG2 cells (A3, B3), Iba1
+
microglia (C3 and D3) or NeuN
+ neurons (E3, F3) in any of the analysed brain regions. (A3, B3) show
only one optical section, the other images are projections of 10 µm z-stacks. Scale bar, 20 µm.
5.3.2 Tracer diffusion is bidirectional in panglial networks
The prevalence of both GS+ and Olig2+ cells in glial networks in the thalamus and hip-
pocampus challenged the concept of pure astrocytic networks (Section 5.3.1; Blomstrand
et al., 2004; Houades et al., 2008). It is known from in vitro studies that astrocytic con-
nexins form heterotypic channels with oligodendrocytic connexins (Orthmann-Murphy
et al., 2007b; Magnotti et al., 2011b).
Putative astrocyte-oligodendrocyte coupling was further investigated using PLP-GFP
mice. In these mice mature oligodendrocytes expressing the myelin protein phospho-
lipoprotein (PLP) also express the reporter GFP (see Section 3.10). Networks were
analysed in juvenile and adult mice.
In juvenile mice, panglial coupling was investigated before the expected onset of Cx30
protein expression (Kunzelmann et al., 1999). Thalamic SR101+ astrocytes in p9-11
PLP-GFP mice were abundantly coupled to other cells, including PLP-GFP+ cells
(total, 87 ± 18 coupled cells, among them 34% GFP+ cells, n = 14; Fig. 5.10; Griems-
mann et al., 2014). Still, at this age prior to onset of myelination only few PLP-GFP+
cells can be observed, the amount of oligodendrocytes might thus be underestimated.
Figure 5.10 Panglial tracer diffusion in juvenile (p9-11) mice. SR101+ astrocytes were filled
with biocytin (A1, indicated by AC) and subsequently co-immunostained for GFP (A2) revealing diffu-
sion from astrocytes to PLP-GFP+ oligodendrocytes (A3) in the thalamus. Scale bar, 20 µm. See also
Griemsmann et al., 2014.
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In adult mice (p30-60) either PLP-GFP+ oligodendrocytes or SR101+ astrocytes were
tracer-filled in both brain regions. In Figure 5.11 tracer-coupled networks are shown for
the 4 experimental conditions. Always large networks were observed when patching an
astrocyte or an oligodendrocyte (Fig. 5.11A1-D1). Filling of SR101
+ astrocytes with
biocytin in the thalamus and hippocampus revealed abundant coupling (TH, 118 ± 15,
n = 16; HC, 133 ± 16, n = 16; Fig. 5.12A). Network sizes were equal, when filling oligo-
dendrocytes with the tracer (TH, 87 ± 14, n = 6; HC, 82 ± 15, n = 8), and coupling
did not differ between brain regions (ANOVA; Fig. 5.12A; see also Griemsmann et al.,
2014). Biocytin diffusion is therefore bidirectional in the panglial network.
The proportion of PLP-GFP+ cells was assessed in the four groups and significant dif-
ferences between brain regions were observed. The GFP reporter fluorescence was en-
hanced by immunostaining and visualized many GFP+ cells in the ventrobasal thalamus
(Fig. 5.11A2, B2). In contrast, only few PLP-GFP
+ cells were observed in the hip-
pocampus (Fig. 5.11C2, D2). The merged images show colocalization of biocytin and
PLP-GFP in all experimental settings (Fig. 5.11A3-D3). Thalamic networks contained
more than 50% GFP+ cells, while in the hippocampus only a minor proportion stained
for GFP (<14%; ANOVA and post-hoc Tukey, p<0.01 (∗∗)). Interestingly, the contri-
bution of GFP+ cells was equal in one brain region irrespective of the patched cell-type
(TH-AC, 53.1 ± 6.4%, n = 16; TH-OL, 66.5 ± 8.4%, n = 6; HC-AC, 12.4 ± 1, n = 16;
HC-OL, 13.4 ± 1.4, n = 8; ANOVA and post-hoc Tukey; Fig. 5.12B; see also Griems-
mann et al., 2014). The tracer spread is therefore not unidirectional from astrocytes to
oligodendrocytes, but diffuses in both directions in the panglial network regardless of
the brain region. The proportions of PLP-GFP+ cells in GJNs differs between thalamus
and hippocampus and might reflect the different densities of PLP-GFP+ cells observed
in the PLP-GFP images (Fig. 5.11A2-D2; Fig. 5.12B).
In summary, astrocytes and oligodendrocytes form panglial GJNs in the thalamus and
hippocampus. The diffusion of the tracer biocytin is bidirectional as indicated by equal
network sizes and similar proportions of PLP-GFP cells in these networks in each re-
gion. Molecules can therefore pass in both directions through channels between the two
cell-types. Furthermore, panglial networks are already prevalent during early postnatal
development.
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Figure 5.11 Tracer diffusion in adult (p30-60) PLP-GFP mice reveals panglial networks.
(A-D) SR101+ astrocytes (A, C; indicated by AC) and PLP-GFP+ oligodendrocytes (B, D; as indicated
by OL) in the thalamus and hippocampus of PLP-GFP mice were tracer-filled. Immunostaining for GFP
(A2-D2) always revealed biocytin spread into PLP-GFP
+ oligodendrocytes (A3-D3). Tracer-injected
PLP-GFP+ cells always exhibited inter-cellular coupling in thalamus and hippocampus (B3, D3). Scale
bar, 20 µm. See also Griemsmann et al., 2014.
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Figure 5.12 Quantification of panglial networks in adult PLP-GFP mice. (A) Graph summa-
rizing the network sizes in the thalamus (TH) and hippocampus (HC) for injected astrocytes (AC) and
oligodendrocytes (OL). Network sizes were equal between the four groups. (B) Thalamic networks con-
tained more PLP-GFP+ cells, irrespective of the cell-type initially filled with biocytin (TH, 53.1 ± 6.4%
and 66.5 ± 8.4%, HC: 12.4 ± 1 and 13.4 ± 1.4, injection into AC or OL respectively). Number of ex-
periments is given in parentheses. Asterisks indicate statistical significance. See also Griemsmann et
al., 2014.
5.3.3 Heterotypic channels containing Cx30 are mainly responsible
for panglial coupling
Astrocytes and oligodendrocytes express a distinct set of connexins (see Section 1.4).
In vitro studies confirmed functional heterotypic channels composed of Cx30 and Cx32,
while Cx47 forms GJCs with Cx43 (Orthmann-Murphy et al., 2007b; Theis and Gi-
aume, 2012). The experiments so far confirmed the presence of panglial networks in
both regions (see Sections 5.3.1 and 5.3.2). The molecular basis of these networks was
investigated in mice with deletion of Cx30 and Cx47 (Tress et al., 2012).
Networks were analysed by tracer injection in SR101-labelled astrocytes from Cx30+/LacZ ;
Cx47EGFP/EGFP , Cx30LacZ/LacZ ;Cx47EGFP/EGFP and Cx30LacZ/LacZ ;Cx47+/EGFP mice
in the thalamus (Fig. 5.13A-C) and hippocampus (Fig. 5.13D-F).
The cell-type specific reporter gene expression provided an insight into panglial net-
work composition. Antibody staining for β-Gal+ astrocytes and Cx47-EGFP+ oligo-
dendrocytes revealed abundant panglial GJC between both cell-types in the thalamus
of Cx30+/LacZ ; Cx47EGFP/EGFP mice (Fig. 5.13A1−4).
Unexpectedly, in double knock-out Cx30LacZ/LacZ ;Cx47EGFP/EGFP mice astroglial net-
works were almost completely abolished (Fig. 5.13B1, 5.14A). In addition, no panglial
networks were observed in these mice, only β-Gal+ astrocytes were found (Fig. 5.13B1−4).
This observation led to the question whether an oligodendrocytic connexin might rescue
the glial network. Therefore, we tested mice expressing on one allele Cx47, but com-
pletely lacking Cx30 expression (Cx30LacZ/LacZ ;Cx47+/EGFP ). Tracer coupling in these
mice revealed panglial networks when patching SR101+ astrocytes (Fig. 5.13C1−4).
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In the hippocampus panglial coupling was less abundant compared to thalamic networks
(see Section 5.3.2). Though, as observed in thalamic networks, mice expressing one of
the connexins on one allele displayed panglial coupling in the CA1 region (Fig. 5.13D1−3,
F1−3). The double knock-out of Cx30 and Cx47 displayed no panglial coupling and no
or only small networks (Fig. 5.13E1−3, 5.14A).
Deletion of one Cx30 allele and both Cx47 alleles resulted in large networks (TH,
166 ± 16, n = 11; HC, 79 ± 14 coupled cells, n = 10; Fig. 5.14A). In double knock-out
Cx30LacZ/LacZ ; Cx47EGFP/EGFP mice many biocytin-filled cells lacked coupling (TH, 43%,
3 of 7 cells; HC, 60%, 6 of 10; Fig. 5.14C), and the remaining filled cells showed only
small networks (TH, 5 ± 1, n = 4; HC, 5 ± 2 coupled cells, n = 4; Fig. 5.14A). Mice
being heterozygous for Cx47 and lacking Cx30 (Cx30LacZ/LacZ ;Cx47+/EGFP ) displayed
only small networks (TH, 28 ± 11, n = 10; HC, 39 ± 19 coupled cells, n = 7; Fig. 5.14A;
see also Griemsmann et al., 2014). Differences in network size and proportions of Cx47-
EGFP cells were tested by ANOVA and post-hoc Tukey, p<0.01 (∗∗).
Analysing the proportions of networks vs. single cells no difference between brain
regions was observed (X 2-test). In the thalamus these proportions differed between
Cx30LacZ/LacZ ;Cx47+/EGFP (100% coupled cells) and Cx30LacZ/LacZ ;Cx47EGFP/EGFP mice
(57% coupled cells), while in the hippocampus Cx30+/LacZ ;Cx47EGFP/EGFP (100% cou-
pled cells) displayed more networks compared to Cx30LacZ/LacZ ;Cx47EGFP/EGFP mice
(40% coupled cells; X 2-test, p<0.05 (∗)).
Panglial coupling was quantified by determining the proportion of Cx47-EGFP+ oligo-
dendrocytes. As Cx30-LacZ is not expressed in the hippocampus, astrocytes were not
quantified. The amount of oligodendrocytes varied considerably in GJNs of different
genotypes (Fig. 5.14B). Networks in Cx30 and Cx47 double knock-out mice did not
contain any Cx47-EGFP+ cells (n = 4, each brain region). In the thalamus and hip-
pocampus of Cx30+/LacZ ;Cx47EGFP/EGFP (TH, 60 ± 8.5%, n = 11; HC, 29 ± 3.3%,
n = 10) and Cx30LacZ/LacZ ;Cx47+/EGFP mice (TH, 19 ± 5.9%, n = 10; HC, 19.9 ± 6.8%,
n = 7) panglial coupling was always present, though less abundant in the thalamus of
the latter genotype (see also Griemsmann et al., 2014).
Interestingly, one allele of either connexin was sufficient to promote panglial coupling,
while the double knock-out of Cx30 and Cx47 was mainly devoid of any glial networks.
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Figure 5.13 (previous page) Cx30 and Cx47 reporter gene expression in thalamic
networks. SR101+ astrocytes in the TH and HC were tracer filled for 20 min (A1-F1) in
3 genotypes Cx30+/LacZ ;Cx47EGFP/EGFP (A, D), Cx30LacZ/LacZ ;Cx47EGFP/EGFP (B, E) and
Cx30LacZ/LacZ ;Cx47+/EGFP (C, F). Cx47-EGFP+ oligodendrocytes are displayed in green (A2-F2)
and β-Gal+ astrocytes (A3-C3) in blue in the merged images (A4-C4; D3-F3). Notice that Cx30LacZ is
not expressed in the hippocampus and β-Gal is therefore only displayed for thalamic networks. Colo-
calization of biocytin and Cx47-EGFP was observed in networks of heterozygous animals (A4, C4, D3,
F3) and overlap with β-Gal was observed in all genotypes in the thalamus (A4-C4). Cx30/47 double
knock-outs were devoid of Cx47-EGFP cells (B4, E3). Scale bar, 20 µm.
Figure 5.14 Summary of Cx30 and Cx47 impact on network properties. (A) Network sizes
differed considerably between genotypes. Only minimal tracer spread was observed in Cx30/Cx47
deficient mice, in contrast to heterozygous mice. (B) The proportion of coupled vs. single cells
was assessed in all genotypes both in hippocampus and thalamus. (C) Cx47-EGFP+ oligodendro-
cytes were quantified in all networks. Many oligodendrocytes were observed in thalamic networks
of Cx30+/LacZ ;Cx47EGFP/EGFP mice. The hippocampal networks contained less Cx47-EGFP+ cells.
Oligodendrocytes were absent in GJNs of Cx30/Cx47 deficient mice and panglial coupling was reduced
in the thalamus of Cx30LacZ/LacZ ;Cx47+/EGFP mice. Asterisks indicate statistical significance. Num-
ber of experiments is given in parentheses. See also Griemsmann et al., 2014.
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5.4 Expression profile of classical astrocyte markers in
the thalamus
5.4.1 A cell-type marker study in PLP-GFP mice
The immunohistochemical analysis of glial networks revealed abundant GS expression
in the thalamus, but the calculated overlap of GS and Olig2 questioned the concept of
marker specificity in this brain region (see Section 5.3.1). Hence, GS expression and
other markers were further analysed by immunofluorescence.
Brain slices from PLP-GFP mice were stained against GS. In the thalamus abundant
overlap of GS and PLP-GFP was observed in confocal images (94.5%, 129,333 ± 8,616
GFP+ and GS+ cells/mm3 from a total of 136,911 ± 9,363 GFP+ cells/mm3, n = 9
from 3 mice), while only few cells displaying weak GS immunoreactivity were visible
(indicated with a star in Figure 5.15A1−3; Griemsmann et al., 2014). Furthermore,
the strongly GS fluorescent cells (Fig. 5.15A1) possessed the typical morphology of
PLP-GFP+ oligodendrocytes (Fig. 5.15A2), while the weakly fluorescent cells show GS
immunoreactivity also in their main processes (see star-labelled cells in Figure 5.15A).
In the green channel myelinated fibre bundles were visible, a characteristic property
of the VB which was never observed in the CA1 region. In the hippocampus of the
same slices the GS staining pattern was distinct from the thalamus. Many star-like
cells, resembling astrocytes, with GS staining in their cytoplasm and main processes
were observed. Notice that only in few cases PLP-GFP cells expressed GS (17.8%,
4,067 ± 692 GFP+ and GS+ cells/mm3 from a total of 22,644 ± 1,573 GFP+ cells/mm3,
n = 9 from 3 mice; Fig. 5.15B1−3, 5.17A; see also Griemsmann et al., 2014). Some of
the processes of PLP-GFP cells can be observed in the GFP staining (Fig. 5.15B2).
The density of PLP cells in the thalamus is significantly higher, by sixfold, compared
to the hippocampus. In the CA1 region the population of GS+ cells was significantly
larger than the PLP-GFP+ population (Fig. 5.17A). A complete list of cell densities
obtained by immunohistochemistry is shown in table 9.1 in the appendix. Differences
in cell densities in this and the following immunostainings were statistically analysed by
ANOVA and post-hoc Tukey or Student’s t-test as appropriate, p<0.05 (∗).
PLP-GFP expression in mice has been described to exclusively label oligodendrocytes
in selected brain areas including hippocampus, while the thalamus was not analysed
(Fuss et al., 2000). Therefore, in addition to astrocyte markers also other cell-type spe-
cific markers were analysed for potential co-labelling with PLP-GFP. In a first set of
experiments, GFP staining was analysed in neurons. Both, in the thalamus and hip-
pocampus no co-staining with NeuN was observed (n = 3 from 3 mice; Fig. 5.15C1−3,
D1−3; Fig. 5.17B).
The commonly used astrocyte marker GFAP was applied in another series of stainings,
along with the microglia marker Iba1. GFAP antibodies only sparsely labelled cells
in the thalamus (Fig. 5.16A1), confirming earlier observations (Frassoni et al., 2000;
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Figure 5.15 Immunohistochemical analysis reveals GS staining, but not NeuN in PLP-
GFP cells. (A) Staining with antibodies against GS (A1) in the thalamus (TH) revealed abundant
colocalization with PLP-GFP (A2)in the merged images (yellow cells in A3). Few cells were only GS
+
(labelled with a star in A). (B) GS staining in the hippocampus (HC) of the same brain slices displayed
the typical star-like morphology of astrocytes (B1). Rarely colocalization of PLP-GFP (B2) with GS
was observed (inset in B3). (C, D) Analysis of PLP-GFP expression (C2, D2) revealed no colocalization
with neuronal nuclei (NeuN; C1, D1) in the overlay (C3, D3). Scale bar, 20 µm.
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Parri and Crunelli, 2002). Interestingly, some of the GFAP+ processes were arranged
parallel to myelinated fibre bundles. In contrast, CA1 stratum radiatum GFAP+ cells
stretch their main processes perpendicular to stratum pyramidale (Fig. 5.16B1). Mi-
croglia in both brain regions had similar morphologies (Fig. 5.16A3,B3) No colocalization
of GFAP (Fig. 5.16A1,B1), nor Iba1 (Fig. 5.16A3,B3) with PLP-GFP (Fig. 5.16A2,B2)
were observed in the merged images (n = 3 from 3 mice; Fig. 5.16A4,B4) in any of the
two brain regions (Fig. 5.17C).
Another astrocyte marker, S100β (Ogata and Kosaka, 2002; Parri et al., 2010), was
analysed in conjunction with NG2, a marker for oligodendrocyte precursor cells (Trotter
et al., 2010). Images showed that in the thalamus S100β was not restricted to astrocytes,
but some of the PLP-GFP cells also expressed this marker (17.5%, indicated with a ∧ in
Fig. 5.16C1−4). Colocalization of S100β with NG2 was a rare event in the VB (22 ± 31
cells/mm3), also neither triple labelling (0.014%) nor overlap of PLP-GFP with NG2
(0.2% from 158,844 ± 4,092 GFP+ cells/mm3, n = 9 slices from 3 mice; Fig. 5.17D)
was observed. In the hippocampal CA1 region only a minor fraction of PLP-GFP cells
were labelled for S100β (18.1%, indicated with a ”∧” in Fig. 5.16D1−4). Interestingly, in
this region NG2 cells were sometimes PLP-GFP+ (17.9% from a total of 26,447 ± 1,434
GFP+ cells/mm3, n = 9 slices from 3 mice; indicated with a star in Fig. 5.16D1−4).
Some S100β+ cells were NG2+ (622 ± 227 cells/mm3) and furthermore in rare cases
triple labelling was detected (1.6%, indicated with an arrowhead in Fig. 5.16D1−4). The
population of PLP-GFP, S100β and NG2 labelled cells was significantly smaller than
the PLP-GFP+ population. Additionally, the cell density of PLP-GFP and S100β co-
labelled cells was significantly larger in the thalamus, though ratios were similar (Fig.
5.17D; see also Griemsmann et al., 2014). In this region, a fraction of 25.1 ± 3.1% of
S100β+ cells was PLP-GFP+, while in the hippocampus only 5.1 ± 1.9% of the S100β+
cells expressed PLP-GFP.
Finally, we used the astrocyte marker Aldh1L1 which was described as a more global
marker in a transcriptome study (Cahoy et al., 2008). Aldh1L1 was abundantly ex-
pressed in the thalamus of PLP-GFP mice. Extensive overlap of Aldh1L1 staining and
PLP-GFP (52.2% overlap from a total of 65,422 ± 6,242 cells/mm3; n = 9 slices from
3 mice; Fig. 5.16E1−4, Fig 5.17E) was observed. Almost all of these cells also expressed
Olig2 (97.2%). Only a minority of Aldh1L1+ and PLP-GFP+ cells lacked the tran-
scription factor Olig2 (444 ± 522 cells/mm3). The other half of the Aldh1L1 cells lacked
PLP-GFP: 22.4% of all Aldh1L1 cells only expressed this marker and 25.3% co-expressed
Olig2 (see also Griemsmann et al., 2014). An overlapping expression profile of astrocyte
and oligodendrocyte markers was observed earlier in the immunohistochemical study of
GJNs (see Section 5.3.1).
In summary, classical astrocyte markers are not expressed by oligodendrocytes in the
hippocampus, though S100β is partially expressed in NG2 cells, while in the thalamus
most markers are not astrocyte specific. The results indicate S100β as the most reliable
astrocyte marker of all analysed proteins in the VB thalamus.
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Figure 5.16 (previous page) Astrocyte markers are expressed by PLP-GFP cells. (A, B)
Stainings for GFAP (A1, B1) and Iba1 (A3, B3) revealed no overlap with PLP-GFP (A2, B2) in the
merged images (A4, B4). There are only few GFAP labelled cells in the TH, displaying a distinct
morphology from those in the HC. (C, D) Antibodies against S100β (C1, D1) were used along with
NG2 (C3, D3). In some cases colocalization of S100β with PLP-GFP (C2, D2) was observed in merged
images (yellow cells in C4, D4, labelled with ∧). No colocalization of S100β with NG2 or PLP-GFP
with NG2 was observed in the TH, while in the HC some cells were triple labelled (arrowhead) or
PLP-GFP was co-expressed with NG2 (star). (E) Aldh1L1 antibody staining (E1) in the TH revealed
that almost half of these cells were PLP-GFP+ (E2) and also Olig2
+ (arrowhead, E3) in the merged
images (E4). Some cells were only Aldh1L1
+ (*), and some cells expressed Aldh1L1 and Olig2 (∧),
though at variable amounts. Scale bar, 20 µm.
Figure 5.17 Graphs summarizing the immunohistochemical analysis in PLP-GFP mice.
(A) Quantification of GS and PLP-GFP in the HC (n = 9 for each region from 3 mice). There are
fourfold more GS cells than PLP-GFP cells. (B) PLP-GFP cells were never NeuN+ (n = 3 for each
region from 3 mice). There are almost sixfold more oligodendrocytes in TH compared to HC. (C)
PLP-GFP never colocalized with GFAP nor Iba1 in both brain regions (n = 3 for each region from 3
mice). (D) Some of the PLP-GFP cells were S100β+ in both TH and HC. Furthermore only in HC a
few PLP-GFP cells were also NG2+ and in rare cases triple labelled (n = 9 for each region from 3 mice).
(E) Aldh1L1 is a more global astrocyte marker. In the TH four groups of cells were observed. Almost
half of the cells were triple labelled for AldhL1, PLP-GFP and Olig2. Almost one fourth was only
AldhL1+, one fourth was AldhL1+ and Olig2+ and a minor population was AldhL1+ and PLP-GFP+
(n = 9 from 3 mice). Asterisks indicate statistical significance.
92
Results
5.4.2 Immunohistochemical identification of thalamic glial cells
The results presented in the previous Section questioned the concept of cell markers in
the thalamus as the observed co-expression of astrocyte and oligodendrocyte markers
was unexpected. Employing the Cx43-ECFP knock-in mouse, the expression of Olig2
was studied. In these mice the reporter ECFP is expressed under the control of Cx43
regulatory elements (see also Section 3.10). Due to the similarities of ECFP with GFP
it can be visualized using GFP antibodies.
Immunostaining of ECFP and Olig2 in the thalamus revealed that about half of the
Cx43-ECFP+ cells co-expressed the transcription factor Olig2 (20,267 ± 2,917 cells/mm3
from a total of 38,563 ± 1,723 ECFP+ cells/mm3; Fig. 5.18A1−3, C1).
The total density of ECFP+ cells was slightly higher in the hippocampus than in the tha-
lamus, but in the latter ECFP+ cells mostly lacked Olig2 (3,155 ± 1,107 ECFP+/Olig2+
cells/mm3 from a total of 52,217 ± 3,215 ECFP+ cells/mm3; Fig. 5.18B). The two pop-
ulations of ECFP+ cells with or without Olig2 differed significantly in size (Fig. 5.18C2).
Furthermore, the cell density of solely ECFP+ cells was significantly higher in the hip-
pocampus, while the population of ECFP+ and Olig2+ cells was significantly increased
in the thalamus (see also Griemsmann et al., 2014). All cell densities are listed in table
9.1 in the appendix. Differences in cell densities were analysed by ANOVA and post-hoc
Tukey, p<0.05 (∗).
Overlap of astrocyte (Cx43-ECFP, Degen et al., 2012) and oligodendrocyte markers
(Olig2, Trotter et al., 2010) in these immunostainings and in PLP-GFP mice indicate
the existence of an ”intermediate” glial cell-type in the thalamus.
In a next step, the antigen expression profile in biocytin labelled networks in Cx43-
ECFP mice was analysed in the thalamus. The ”intermediate” glial cell-type was also
part of glial networks in the thalamus (see merged image in Fig. 5.19). Tracer injection
of a Cx43-ECFP expressing cell and subsequent visualisation confirmed the presence of
a small population of ECFP+ and Olig2+ cells in these networks (14% of 58 ± 6 coupled
cells, n =10; see also Griemsmann et al., 2014).
The immunohistochemical study in Cx43-ECFP knock-in mice confirmed the findings
in PLP-GFP mice of an overlapping marker profile in the thalamus. Interestingly, the
observed ”intermediate” glial cells were gap junction coupled, a hallmark of mature cells.
93
Results
Figure 5.18 Cx43-ECFP cells express Olig2. (A) Immunostaining of Olig2 (A1) in the thalamus
(TH) revealed abundant co-labelling with Cx43-ECFP (A2). These cells appear yellow in the merged
image (A3). (B) In contrast, in the hippocampus (HC) most ECFP
+ cells (B2) lacked expression of the
transcription factor Olig2 (B1) in the merged image (B3). (C) Quantification of the cell populations
revealed significant differences between brain regions. In the thalamus the two populations were almost
equal in size (52.2 ± 6% ECFP+/Olig2+), while in the hippocampus the population of ECFP cells
outnumbered the population of ECFP+ and Olig2+ cells (5.9 ± 1.8% ECFP+/Olig2+; n = 9 from 3
mice for each region). Scale bar, 20 µm. See also Griemsmann et al., 2014.
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Figure 5.19 Thalamic glial networks include Cx43-ECFP+ and Olig2+ cells. Biocytin-filled
networks (A1) in the thalamus (TH) contained Cx43-ECFP
+ (A2) and Olig2
+ cells (A3), when patching
an ECFP+ astrocyte. Furthermore, in the merged image (A4) triple-labelled cells are visible (white
cells, centre). Scale bar, 20 µm. See also Griemsmann et al., 2014.
5.5 Physiological role of panglial networks
The results documented an unexpected heterogeneity of glial cells between brain regions.
The well studied astrocytes in the hippocampus displayed known properties, while in
the thalamus glial cells differ in their network properties and their marker expression.
Here, an undocumented ”intermediate” cell-type was observed. The observation of an
extensive panglial network in the thalamus using the tracer biocytin was of special
interest, but the functional role of this network remained elusive.
5.5.1 Metabolite diffusion in panglial networks
The tracer biocytin diffused into the panglial network irrespective of the patched cell-
type and diffused along a concentration gradient into neighbouring cells. Recently, it
was observed that oligodendrocytes support axonal function by transport of metabo-
lites and therefore sustain neuronal activity (Fu¨nfschilling et al., 2012; Lee et al., 2012).
Physiologically active molecules likely diffuse to sites of local demand.
Since oligodendrocytes do not have a direct contact to blood vessels, the panglial network
is a possible route of transport for energy metabolites from blood vessels to oligodendro-
cytes. In the hippocampus, glucose diffusion has been observed in the astroglial network
(Rouach et al., 2008). Possible diffusion of glucose in thalamic panglial network was
analysed in the following experiment.
For visualization of glucose diffusion, the fluorescent glucose analogue 2-NBDG (2-(N-(7-
Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose) was applied. Taking advantage
of a confocal LSM equipped with an infrared laser, it was possible to image SR101+ cells
(excitation/absorption maxima ∼586/605 nm) and PLP-GFP+ oligodendrocytes (exci-
tation/absorption maxima ∼488/509 nm) with continuous wave lasers and isolate the
fluorescence of the 2-NBDG (excitation/absorption maxima of ∼465/540 nm) employ-
ing a pulsed 2P laser. 2-NBDG was acquired with NDDs, while SR101 and PLP-GFP
images were acquired with PMTs.
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Figure 5.20 Metabolite transport in thalamic panglial networks. (A) Employing the green
fluorescent glucose analogue 2-NBDG, it was possible to visualize glucose transport from an SR101+
astrocyte (red, centre) to PLP-GFP+ oligodendrocytes (green, labelled with a ∧) in the thalamus (A1).
Already after 3 min 2-NBDG diffusion into neighbouring cells was visible (A2). After 20 min 2-NBDG
diffused into neighbouring astrocytes (*) and oligodendrocytes (∧). Furthermore, 2-NBDG diffused
into myelinating processes of oligodendrocytes (see insets in A1, A3, showing a higher magnification of
boxed areas). Scale bar, 20 µm. (B) The 2-NBDG-filled network comprised of 40 ± 9.4% PLP-GFP+
cells, 58.4 ± 9.5% SR101+ cells and 1.6 ± 1% only 2-NBDG+ cells (n = 6).
Before starting glucose filling a z-stack of the SR101 and PLP-GFP cells (Fig. 5.20A1)
was acquired and after 3 min (Fig. 5.20A2) and 20 min (Fig. 5.20A3) z-stacks of
2-NBDG fluorescence were imaged. Already after 3 min glucose diffused into an average
of 14 ± 0.7 cells (n = 6; Fig. 5.20A2). The 2-NBDG further spread into the network
and after 20 min 36 ± 5 cells were filled (n = 6; Fig. 5.20A3). The networks were
smaller than those visualized with biocytin (see Section 5.1) which might be due to the
difference in size of the molecules. Additionally, the tracer diffused into the processes of
oligodendrocytes and into the myelin sheath (see insets in Fig. 5.20A1, A3).
Employing the images taken before tracer diffusion and the 2-NBDG images after 20 min,
the panglial diffusion was assessed (Fig. 5.20A). The networks contained 58.4 ± 9.5%
SR101+ astrocytes, 40± 9.4% PLP-GFP+ oligodendrocytes and 1.6± 1% only 2-NBDG+
cells (n = 6; Fig. 5.20B).
The experiments with the glucose-derived tracer 2-NBDG confirmed diffusion of metabo-
lites through the panglial network and moreover into the myelin sheath. The panglial
network might therefore be important for nutrient supply to neuronal axons.
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5.5.2 Cortico-thalamic pathway stimulation
The extensive panglial network in the thalamus might be crucial in sustaining neuronal
activity. A protocol for field potential recordings in the VB on nearly horizontal slices
was established. In the following experiments field potentials of neuronal activity were
recorded as it allows for monitoring the activity of entire neuronal populations.
The ventrobasal thalamus has two inputs. One is the lemniscal pathway which sends the
sensory information from the whiskers to the VB. The information is then propagated
towards the cortex via the thalamo-cortical pathway and there is a feedback circuit to
the VB, the cortico-thalamic (CT) pathway (Parri et al., 2010; Pinault, 2011; Grant et
al., 2012). For further experiments the CT pathway was stimulated and a protocol for
stimulation on horizontal slices was established.
Stimulation of the CT pathway was achieved on horizontal slices with a 30◦ angle to
the horizontal plane (Fig. 4.2A). The recording electrode was placed in the VB and
the bipolar stimulation electrode was located in the internal capsule to stimulate CT
afferents. The stimulation protocol consisted of train stimuli of 5 pulses at 20 Hz which
were repeated every 15 s. To obtain stable responses for almost 2 h the stimulation
intensity was set to 80% of the maximally elicited peak amplitude.
The recorded field potentials in the VB displayed two peaks with increasing amplitude
over 5 pulses (Fig. 5.21A). After the first pulse only one peak was observed directly
after the stimulus (indicated by arrows in Fig. 5.21). The second response displayed a
first larger and a small second peak, for the following stimuli the second peak increased
in amplitude (Fig. 5.21A). The trace shown in Figure 5.21B is a blow up of the field
potentials for the third and fourth stimulus shown in A. The first negative peak appeared
very fast directly after the stimulus (arrow). Between the two peaks the field potential
did not reach baseline levels again, but instead a positive potential was observed during
which a second negative peak appeared. Only afterwards the signal reached baseline
levels again.
The field potentials were recorded in the presence of picrotoxin to block GABAergic in-
hibitory innervation of the VB from the RTN (see Section 1.1.1; Pinault, 2011). In some
cases weak epileptiform activity was observed, as can be seen after the second stimulus
in Figure 5.21A. In case epileptiform activity interfered with the stimulation responses,
the experiments were excluded from further analysis.
The stimulation parameters of the recorded field potentials were designed to avoid meta-
plasticity. The train stimulation proved to be a reliable tool to record neuronal activity
in the VB thalamus.
The field potentials were further characterized by applying blockers to inhibit neuronal
excitation. Therefore the CT pathway was stimulated and fEPSPs recorded in normal
ACSF for 20 min. Afterwards D-AP5 and NBQX were applied to block NMDA and
AMPA receptors (Fig. 5.22A). Blockers were applied for 20 min and the field potential
was continuously recorded. At the end of the experiment the voltage-gated Na+ chan-
nel blocker TTX was applied. The application of D-AP5 and NBQX led to loss of the
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Figure 5.21 Field potentials in the ventrobasal thalamus. (A) The CT pathway was stimulated
in the internal capsule and the neuronal activity was recorded in the VPL and VPM nuclei. Stimulation
trains of 5 pulses at 20 Hz (indicated with arrows) were applied and repeated every 15 s. Traces show
averages of 10 recordings. Field potentials in the VB displayed increasing responses over 5 stimuli. The
first peak slightly increased in amplitude during the train, while the second peak only appeared after
the second stimulus and then increased in amplitude. Scale bar, 20 ms, 0.5 mV. (B) Blow up of the
third and fourth response shown in A. Scale bar, 10 ms, 0.5 mV.
second peak of the field potential, while the first peak was still present. The remaining
amplitude is therefore induced by presynaptic neuronal excitation. Application of TTX
completely blocked action potentials and led to loss of both pre- and postsynaptic re-
sponses. The residual signals were stimulation artefacts (Fig. 5.22A).
Field potentials were analysed using a custom written Igor tool (by Ronald Jabs). Fig-
ures 5.22B1 and B2 illustrate the field potential analysis for the third pulse. In Figure
5.22B1 the raw data of one response are displayed, a recording in ACSF (black), after
blocker application (blue) and after TTX application (red). The overlay nicely shows
the loss of the second peak after D-AP5 and NBQX application and the complete loss
of both peaks after TTX application. In Figure 5.22B2 two methods to compensate
for the artefact are displayed. The blue trace displays the resulting field potential after
subtraction of the D-AP5 and NBQX recording from the ACSF recording. The red trace
indicates the subtraction of the TTX recording. In the following analysis, the artefact
was eliminated by subtraction of the TTX recording.
Quantification of the field potentials revealed fast changes in fEPSPs upon blocker
application. Data were normalized to the average amplitudes and delay in ACSF
(t−20min−t0min). Analysing the amplitude of the postsynaptic peak a slight increase in
normalized amplitude was observed during the first 20 min of recording to 127.1 ± 5.2%.
Shortly after bath application of the blockers the amplitude decreased, 4 min after incu-
bation the amplitude size dropped to 53.9 ± 6.3% and further diminished to 14.9 ± 2%
at 6.5 min. After 14 min the second peak completely disappeared (n = 4; Fig. 5.22C1).
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Figure 5.22 (previous page) Properties of field potentials in the ventrobasal thalamus. (A)
fEPSPs were sensitive to blocker application. The upper trace is a recording in ACSF supplemented
with picrotoxin. The middle trace was recorded after bath application of D-AP5 and NBQX which
inhibit synaptic transmission. The lower trace shows a recording after TTX application which blocks
action potentials. The residual signals are stimulation artefacts. Scale bar, 20 ms, 0.2 mV. (B) Signals
before and after analysis with the Igor tool are shown. In B1 the raw data for one stimulus are displayed,
an ACSF recording (black), a response after D-AP5 and NBQX application (blue) and a recording in the
presence of TTX (red). In B2 the ACSF recording was separated by subtracting recordings in the pres-
ence of blockers, to either isolate the fEPSP (blue), or the pre- and postsynaptic responses (red). Scale
bar, 5 ms, 0.1 mV. (C1) The normalized fEPSP amplitudes during ACSF recordings (t−20min−t0min)
and during D-AP5 and NBQX application (t0min−t20min) are displayed. The fEPSP amplitude slightly
increased during the first 20 min and rapidly decreased after blocker application (n = 4). (C2) The
normalized delay of the postsynaptic potential was constant prior to blocker application and afterwards
the delay increased (n = 4). After 14 min fEPSPs completely disappeared. Traces show averages of 10
recordings.
In addition to the amplitude the time interval from the stimulus to the amplitude peak
of the postsynaptic response was measured, termed the delay of the fEPSP. The nor-
malized data show a constant delay of the fEPSP. At the end of recording in normal
ACSF the normalized delay amounted to 93 ± 1.4% of the average delay in ACSF.
After 4 min blocker application the delay was constant at 109 ± 6%, afterwards the
delay increased to 132.4 ± 5.6% after 6.5 min. After 14 min the fEPSP was completely
abolished (n = 4; Fig. 5.22C2). Changes in fEPSP amplitude and delay were analysed
by ANOVA and post-hoc Tukey, p<0.05 (∗).
In summary, field potentials on nearly horizontal slices in the VB consist of pre- and post-
synaptic responses as identified by blocker application. The newly established method
is a reliable tool to monitor neuronal activity in the VB.
5.5.3 Impact of glucose deprivation on neuronal activity
The experiments so far demonstrated extensive panglial networks in the thalamus and
a potential role in metabolite supply to neurons.
Neuronal activity is sensitive to extracellular glucose deprivation (GD) and has been
extensively studied in optic nerve and hippocampus (Wender et al., 2000; Brown et al.,
2001; An et al., 2008; Rouach et al., 2008). In the following experiments a method
to monitor neuronal glucose sensitivity in the thalamus in acute horizontal slices was
established. Therefore, experiments were conducted in the VB to analyse the effects
of long-time GD. At the beginning a recording in ACSF with picrotoxin was recorded
for 10 min and subsequently glucose-free ACSF with picrotoxin was applied for 1 h.
Afterwards, field potentials were recorded during 20 min re-perfusion with ACSF, see
also timeline in Figure 4.2D. Additionally, control experiments in ACSF with picrotoxin
over the same time period were performed on slices from the same animals. Three GD
and three control experiments were recorded in n = 3 animals.
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At the beginning, the fEPSP was recorded in ACSF and displayed the typical two peaks
in response to the stimulus. Already 20 min after the start of GD the postsynaptic am-
plitude decreased. After 62 min the postsynaptic response was almost abolished (Fig.
5.23A).
Data were normalized to the mean amplitude and delay in ACSF (t−10min−t0min). At
the end of recordings in ACSF the normalized fEPSP amplitude was at 92.7 ± 4.3%
(t−2.5min) of the mean signal over 20 min in ACSF. After 21 min of GD the amplitude
decreased to 50.3 ± 16%, further decreased until the end of GD to 11 ± 2.2% (t62min),
and did not recover during re-perfusion with glucose (t78min, 17.1 ± 0.4%,n = 3; ANOVA
and post-hoc Tukey, p<0.05 (∗); Fig. 5.23B1). On the other hand the neuronal activity
is not completely abolished, most likely there is some glucose storage in cells. Control
experiments on another slice from the same animal over 90 min in ACSF displayed con-
stant amplitude sizes (t−2.5min, 108.2 ± 1.2; t21min, 110.6 ± 7.9; and t62min, 110.3 ± 9%;
n = 3 controls; ANOVA; Fig. 5.23B1). The fEPSP amplitudes were similar during
recordings in ACSF at the beginning of the experiments. After 16 min of GD the am-
plitude was significantly smaller compared to control fEPSPs in ACSF (ANOVA and
post-hoc Tukey,, p<0.05 (∗); Fig. 5.23B1).
The delay of the postsynaptic peak varied during GD, but did not differ from prior
recordings in ACSF (t−2.5min, 101 ± 0.4%; t62min, 148.8 ± 9.5%; ANOVA). The delay
of the postsynaptic potential did also not recover during re-perfusion (t78min, 119.3 ±
8.5%; ANOVA; Fig. 5.23B1). In control experiments on another slice from the same an-
imal the normalized delay was stable during the entire recording time in ACSF (t−2.5min,
100.6 ± 0.3%; t62min, 97 ± 0.9%; t78min, 97.6 ± 1%; n = 3 each; ANOVA; Fig. 5.23B2).
The delay in GD and control recordings was equal at the beginning of the recording in
ACSF. After 18 min the delay was increased compared to the delay in control record-
ings and remained high. Some time points were not significantly different from control
recordings, due to the higher variability of the delay during GD (ANOVA and post-hoc
Tukey, p<0.05 (∗); Fig. 5.23B2).
In conclusion, thalamic neurons are sensitive to GD. The amplitude of fEPSPs decreased
to 50% after 21 min, while the delay was unchanged. Recordings in ACSF over 90 min
were stable and differed both in amplitude and delay from recordings in glucose-free
ACSF.
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Figure 5.23 Impact of glucose deprivation on thalamic fEPSPs. (A) GD led to changes in
fEPSPs. The upper trace is a recording in ACSF supplemented with picrotoxin. The middle trace
was recorded 21 min after GD. After 62 min only presynaptic responses were observed (lower trace).
Scale bar, 20 ms, 0.4 mV. (B1) Normalized fEPSP amplitudes were sensitive to GD. After 10 min
recording in ACSF, 60 min GD was performed. Subsequently, 20 min in normal ACSF were recorded,
but no recovery was observed. In contrast, recordings in normal ACSF over 90 min showed no changes
in amplitude (n = 3 each). (B2) Additionally to the decreased amplitude the neuronal postsynaptic
response appeared later after the stimulus. In control slices in normal ACSF the delay was constant over
90 min (n = 3 each). Traces show averages of 10 recordings. Asterisks indicate statistical significance
of differences between GD and control experiments.
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5.6 Molecular analysis of ionotropic receptor expression
in thalamic astrocytes
Astrocytes express several other channels and receptors on their cell surface in addition to
connexins. In this study, we focused on AMPA and GABAA receptors and investigated
the subunit expression pattern in VB astrocytes. The cells were identified by their
bright GFAP-EGFP fluorescence, a passive current pattern and typical negative resting
membrane potentials. Subsequently, the cytoplasm was harvested for further RT-PCR
analysis performed by Gerald Seifert.
5.6.1 Astrocytic AMPA receptor subunit expression
The RNA of harvested cells was used for reverse transcription and subsequent multiplex
PCR for different AMPA receptor subunits. The typical astrocytic current pattern and
the PCR result for a cell are shown in Fig. 5.24A, B. S100β was used as an astrocytic
marker. A total of 23 cells expressed AMPA receptors in this study, 4 cells expressed the
GluA1 subunit (17%), 22 cells expressed GluA2 (96%), 10 cells expressed GluA3 (43%)
and only 8 cells expressed the GluA4 subunit (35%; Fig. 5.24C). Additionally, 5 cells
did not contain AMPA receptor subunit specific mRNAs, but expressed S100β.
All AMPA receptor subunits have different splice isoforms, termed flip and flop. The
second PCR of the two-round multiplex PCR was repeated and the cDNA used for a
restriction enzyme digest. Characteristic splice fragments were obtained and separated
by gel electrophoresis. The flip GluA1 subunit was only observed in 1 of 4 cells, the
other 3 cells contained the flop splice variant. Most astrocytes expressed both splice
variants of GluA2 (flip, 18 of 22 cells; flop, 17 of 22 cells). The GluA3 splice variants
were also often both present in the cells, all cells contained the flop variant (flip, 5 of 10
cells; flop, 10 of 10 cells). Both splice variants of GluA4 were found in most cells (flip,
6 of 8 cells; flop 6 of 8 cells; Fig. 5.24D).
In summary, single-cell RT-PCR revealed two astrocyte populations lacking or expressing
AMPA receptors. The latter group abundantly expressed the AMPA receptor GluA2
subunit.
5.6.2 Astrocytic GABAA receptor subunit expression
In the second part of the molecular analysis the GABAA receptors were analysed. The
RT-PCR study on harvested cells focused on the subunit composition of the receptors.
There are different subunit isoforms which can be further differentiated, e.g. five different
α-GABAA receptor subunits (Fig. 5.25A). In Figure 5.25A1,2 one exemplary cell is
shown. It displayed a passive current pattern and expressed four of the five α subunits.
As for the AMPA receptor study S100β was used as a cell-type marker. A total of 18
cells was analysed and 33% expressed the subunit α1 (6 of 18 cells), 50% expressed the
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Figure 5.24 Single cell RT-PCR reveals AMPA receptor subunit expression in thalamic
astrocytes. (A) Typical passive astrocyte current pattern of a harvested cell. Scale bar, 20 ms, 5 nA.
(B) Reverse transcription and subsequent multiplex PCR for different AMPA receptor subunits. The
exemplary cell expressed the subunits GluA2, GluA3 and GluA4, but lacked GluA1. Additionally, the
astrocyte specific S100β was expressed and used as a control. (C) Summary of the data of the RT-
PCR, almost 20% of the cells expressed GluA1, almost all cells expressed GluA2, the GluA3 subunit
was expressed by 40% and GluA4 was found in 30% of the cells. (D) The subunits exist as splice
variants flip and flop, therefore the PCR product of the second PCR round was digested. Except for
GluA1, cells mostly contained both splice variants. White bars indicate flip variants and black bars
indicate flop variants.
α2 subunit (9 of 18 cells) and no cell expressed the α3 subunit. The GABAA α4 subunit
was expressed in 39% of the cells (7 of 18 cells) and the α5 subunit was detected in 56%
(10 of 18 cells; Fig. 5.25A3).
Furthermore, the RT-PCR study revealed expression of β1 in 86% of the cells (6 of
7 cells) and β2/3 in 43% (3 of 7 cells; Fig. 5.25B). The GABAA δ subunit was less
expressed in astrocytes (14%, 1 of 7 cells; Fig. 5.25B).
A total of 9 cells were used for γ subunit expression. All of the cells expressed the
γ1 subunit(100%, 9 of 9 cells), γ2 was rarely expressed (11%, 1 of 9 cells) and the γ3
subunit was abundantly expressed in 89% of the cells (8 of 9 cells).
In conclusion, all VB astrocytes expressed GABAA receptors and abundantly expressed
the γ1 subunit and lacked the α3 subunit.
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Figure 5.25 Thalamic astrocytes express different GABAA receptor subunits as revealed
by single cell RT-PCR. (A) α subunit expression in astrocytes. (A1) Typical passive astrocyte
current pattern of a harvested cell. Scale bar, 20 ms, 2 nA. (A2) The astrocyte shown in A1 expressed
all α subunits, except for α3. S100β served as a control for astrocyte specific expression. (A3) Summary
of the data of the RT-PCR. Almost 33% of the cells expressed α1, 50% expressed α2, no cell expressed
α3. The subunit α4 was expressed by 39% of the analysed cells and α5 was found in 56% of the cells
(n= 18 cells). (B) GABAA receptor subunit β and δ expression in astrocytes. (B1) Current pattern
of an astrocyte. Scale bar, 20 ms, 2 nA. (B2) The passive cell was an S100β
+ astrocyte expressing the
subunit β1, but lacked the other isoforms. (B3) In summary, 86% of the analysed cells expressed the
β1 isoform, 43% expressed β2/3 subunit and only 14% expressed the δ subunit (n = 7). (C) GABAA
receptor subunit γ expression in astrocytes. (C1) Typical passive astrocyte current pattern. Scale bar,
20 ms, 5 nA. (C2) The S100β positive cell expressed the subunits γ1 and γ3. (C3) Quantification of
single-cell RT-PCRs of 9 cells showed expression of γ1 in all cells, γ2 was only present in 11% and γ3
in 89% of the cells.
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Glial cells were seen as the passive glue, ”Nervenkitt”, between neurons for a long time
(Virchow, 1846). Today we know that these cells fulfil a variety of functions in the brain.
The present study aimed at characterizing glial cells in a subcortical brain structure, the
thalamus, often referred to as the ”gate to consciousness”. The ventrobasal thalamus
receives somatosensory input and relays information to the cortex. It consists of grey
matter and myelinated fibres extending to and arriving from the cortex and brain stem.
Glial cells are active partners in neuronal signalling and were analysed in this study for
their protein and ionotropic receptor expression profile and network properties. Further-
more, a method to analyse neuron-glia interactions on a network level was established in
this study. The results of the present study revealed heterogeneous expression profiles
and properties within and between brain regions, enhancing our understanding of glial
heterogeneity.
6.1 Properties of glial networks in the VB
Astrocytes were widely studied in the hippocampus and cortex, but little is known about
thalamic glial cells. In a previous study by Parri et al. (2001) astrocytes lacked gap junc-
tion coupling. This surprising observation initialised a first set of experiments to study
glial networks in the VB. In adult mice biocytin-filled networks revealed large GJN with
a round shape as observed in the hippocampus (Fig. 5.1A2; Wallraff et al., 2004). Fur-
thermore, network sizes were similar to hippocampal networks (Section 5.3.1). GJNs
close to myelinated fibres often displayed tracer spread into the myelin sheath with the
GJs responsible for this tracer spread being unknown (Fig. 5.1B2). This aspect will be
further discussed in the following Section.
For network analysis astrocytes were identified by their bright fluorescence in transgenic
hGFAP-EGFP mice (Nolte et al., 2001; Matthias et al., 2003), or labelled with the flu-
orescent dye SR101. This marker is specifically taken up by astrocytes in acute slices
and in vivo (Nimmerjahn et al., 2004; Kafitz et al., 2008). It is taken up by the thyroid
hormone transporter, an organic anion transporter protein (OATP1C1), expressed in
astrocytes in several brain regions like cortex and hippocampus, but not in the ven-
trolateral medulla (Schnell et al., 2012; Schnell et al., 2013). This expression profile
reveals a heterogeneous astrocyte population in the brain. A study performed earlier in
the lab confirmed the specific uptake of SR101 by thalamic astrocytes, but not oligo-
dendrocytes which is in contrast to findings in the cortex (Wasseff and Scherer, 2011;
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Griemsmann et al., 2014). Recently, an in vivo study by Hill and Grutzendler (2014)
reported SR101 uptake by oligodendrocytes, but this study employed 200x more SR101
than applied by Nimmerjahn et al. (2004) and 50-100x more SR101 than Kafitz et
al. (2008), Schnell et al. (2012) and Griemsmann et al. (2014). This high concentra-
tion of SR101 might have caused non-specific oligodendrocyte staining. In the cortex a
time dependent diffusion of SR101 through panglial GJCs was described (Wasseff and
Scherer, 2011). Another study revealed an impact of SR101 on neuronal activity (Kang
et al., 2010). In the present study, a potential influence of the marker SR101 on astro-
cytic networks was analysed in SR101 incubated slices vs. control slices. Tracer diffusion
revealed no impact of SR101 on GJ mediated tracer transfer, and is therefore a reliable
astrocyte marker in this brain region (Fig. 5.1D).
The tracer biocytin was employed as it was shown to diffuse furthest into the network
compared to other dyes like Sulforhodamine B or Lucifer yellow (Rouach et al., 2008).
In vitro studies confirmed reliable diffusion of a structurally similar molecule, neurobi-
otin, through astrocytic GJCs (Yum et al., 2007). Thus, the absence of coupling in the
thalamus in a previous study by Parri et al. (2001) is likely due to distinct properties of
the channel pore resulting in a selective permeability for tracers regarding size, structure
and charge. Likewise, the tracer Lucifer yellow employed by Parri et al. (2001) does not
diffuse through Cx30 channels (Yum et al., 2007). Selective permeability was observed
for both Cx30 and Cx43 channels, while Cx26 seems to form non-selective channels (Elf-
gang et al., 1995; Yum et al., 2007).
Glial networks in the VB were analysed during development and further experiments
were performed in adult mice between p30-60. Astrocytic networks were already present
at p9-11 and increased in size until the end of the second postnatal week (Fig. 5.1C).
All astrocytes showed GJ mediated tracer diffusion. In comparison, hippocampal net-
works were found already shortly after birth and reached their maximum size at the end
of the second postnatal week, though the frequency of coupling was highly variable in
rat brain (Schools et al., 2006). In the cortex a similar timeline was described at p5
small networks were observed which increased until the age of p10 in the mouse brain
(Houades et al., 2008).
In conclusion, thalamic astrocytes form glial networks in contrast to previous obser-
vations by Parri et al. (2001). The frequency of coupling is higher in the thalamus
compared to hippocampus during postnatal development. The maximum network size
is established later in the thalamus compared to the cortex.
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6.2 The role of connexins in astroglial networks
6.2.1 Cx30 is the main gap junction protein in thalamic astrocytes
The time course of network formation likely reflects the high impact of Cx30 observed in
thalamic networks (Fig. 5.2A1−3, B1−2) and its late upregulation in the second postnatal
week (Kunzelmann et al., 1999). In the thalamus loss of Cx30 resulted in dramatically
reduced networks compared to wild-type littermates (Fig. 5.2B1). In the hippocampus
the Cx30 knock-out had a weaker impact between 22% and 50% (Gosejacob et al., 2011;
Pannasch et al., 2014). In the olfactory glomeruli Cx43 was more important than Cx30
for network sizes (Roux et al., 2011). Cx43 expression starts already during embryonal
development and remains high after birth (Dermietzel et al., 1989). Brain regions mainly
expressing Cx43 might therefore establish large glial network earlier than brain regions
expressing mainly Cx30, although not all cells are part of a network at early develop-
mental stages. The impact of Cx30 and Cx43 on network formation is region dependent
and reflects the heterogeneous properties of these cells in the brain. The VB contains a
somatotopic map of the whisker field. Mice use their whiskers for exploration of new ter-
ritories (Erzurumlu et al., 2010). These signals arrive in the VB before they are relayed
to the somatosensory cortex. Interestingly, Cx30 levels increased in animals exposed to
enriched environment (Rampon et al., 2000). This is in line with the high impact of Cx30
in the thalamus (Fig. 5.2A1−3, B1−2). As reported for hippocampal networks (Wallraff
et al., 2006), the Cx30/43 DKOs mostly lacked GJC in the thalamus (Fig. 5.2C1−2, D).
Residual coupling is likely mediated by cells devoid of hGFAP-Cre activity as GFAP
is only weakly expressed in the thalamus (Frassoni et al., 2000; Wallraff et al., 2006;
Requardt et al., 2009; Pannasch et al., 2011).
Likewise, these small networks might be mediated by another connexin, Cx26, which
is also expressed by astrocytes and was reported to be abundantly present in thalamic
nuclei (Nagy et al., 2011). On the other hand, it was reported that the Cx30LacZ mouse
line additionally lacks Cx26, probably due to the Cx30 knock-out strategy and the close
proximity of the two loci on one chromosome (Lynn et al., 2011). Concluding, the 30/43
DKO mice additionally lack Cx26 expression. Employing the mouse line Cx26fl:Nestin-
Cre used by Nagy et al. (2011), biocytin diffusion did not reveal any functional impact
of Cx26 on intercellular coupling in thalamus nor hippocampus in the present study
(Fig. 5.4). Therefore Cx30 and Cx43 are the main GJ proteins in astrocytes required
for network formation in the hippocampus and thalamus, although with a different im-
pact. The role of Cx26 expression in the thalamus remains elusive. Nagy et al. (2011)
reported an immunohistochemical colocalization of Cx26 with Cx43 and Cx47. This
is in contrast to the findings of the present study. The immunohistochemically iden-
tified channels seem to be non-functional as loss of Cx26 did not influence network
sizes (Fig. 5.4C). Similarly, in vitro studies found no functional channels between Cx26
and Cx43, nor Cx26 and Cx47 (Elfgang et al., 1995; Magnotti et al., 2011b). Cx26
might be located at autologous GJs between processes of one cell. Another explanation
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might be that potential intercellular GJ between different cells were replaced by Cx30
and Cx43 in Cx26fl/fl:Nestin-Cre mice in the present study. Cx26 formed functional
channels with Cx26, Cx30 and Cx32 in vitro (Elfgang et al., 1995; Yum et al., 2007;
Magnotti et al., 2011b). A comparative study by Nagy et al. (2011) revealed higher
Cx26 protein levels in the rat brain compared to mouse brain. Thus, a functional role in
brains with morphologically more complex astrocytes (Nedergaard et al., 2003) cannot
be excluded and requires further analysis. The secondary effect caused by the Cx30LacZ
knock-out strategy can be circumvented by using the new Cx30 knock-out mouse line
generated by Boulay et al. (2013).
It is unlikely that the results in Cx26fl/fl:Nestin-Cre mice were due to incomplete recom-
bination. Unfortunately, the Cx26fl:Nestin-Cre mouse line lacks a reporter to confirm
successful excision of the floxed gene. In the present study, Cre recombinase activ-
ity was confirmed by a newly generated Cx26Del PCR detecting the deleted floxed
Cx26 in tail tip PCRs (Fig. 5.5). Due to Nestin expression in other tissues like en-
dothelial cells, it was possible to determine the deleted genotype (Klein et al., 2003;
Mohseni et al., 2011). These control PCRs were required as several reports demon-
strated both the inactivity of Cre and the ectopic Cre activity (Requardt et al., 2009;
Zhang et al., 2013). For future studies it would be advantageous to use reporter genes
to confirm the status of the floxed gene.
The relevance of Cx30 in the thalamus was further supported by increased protein lev-
els in Western blot analysis compared to hippocampus and reporter gene expression
in the thalamus. Interestingly, the Cx43 protein levels did not differ between thala-
mus and hippocampus in the adult brain, but a substantial astrocyte population lacked
Cx43 reporter gene expression (Fig 5.3). This observation is in line with the observa-
tion of a subpopulation of uncoupled cells in Cx30LacZ/lacZ mice in the thalamus (Fig
5.2B2). Another study performed in the lab employing heterozygous Cx43-ECFP mice
confirmed the strong impact of Cx43 on network size in the hippocampus, but no change
in network size was observed in cortex nor thalamus. In addition, the ECFP expres-
sion in glial networks was higher in the hippocampus compared to thalamus and cor-
tex (Griemsmann et al., 2014). The different expression levels of Cx43 might reflect
functional differences and regional specializations of astrocytes which adapted to their
environment and local requirements. Cx30 was shown to mediate astrocyte process ex-
tension into synaptic clefts by a non-channel adhesive function, while Cx43 hemichannels
play a role in presynaptic glutamate release (Pannasch et al., 2014; Chever et al., 2014;
Chever et al., 2014).
Biocytin is a widely used tracer for network analysis. Due to its good diffusion proper-
ties it passes equally well through most connexin GJC. On the other hand, the analysis
by counting biocytin-labelled cells has its limitations. No information about the pref-
erential direction of the tracer diffusion in glial networks nor about the quantity of gap
junctions between adjacent cells is gained. For further analysis of spatial properties of
glial networks a diffusion model was simulated and analysed in the hippocampus. Quan-
tifying network sizes by the coupling length constant and network anisotropy revealed a
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temperature dependence in dye diffusion which could not be detected by cell counting
(Anders et al., 2014). For future network studies it would be advantageous to analyse
diffusion parameters based on fluorescence intensities in addition to cell counting.
In summary, connexin expression in astroglial cells differs between all brain regions
analysed so far, revealing considerable heterogeneity between astrocytes throughout the
brain. The impact of Cx30 and Cx43, the main connexins for GJC formation, differs
between brain regions. In the present study, a predominating role for Cx30 in thalamic
glial networks was observed. In addition, some astrocytes in the thalamus express only
one connexin. This is in contrast to previous assumptions of general Cx43 expression in
all astrocytes (Giaume et al., 1991). Most likely these differences reflect functional and
regional specializations of these cells.
6.2.2 The role of Cx43 in RG-like cell proliferation
The functional role of Cx43 was further studied in neural stem cells in the mature brain.
A study by Elias et al. (2007) demonstrated the importance of extracellular adhesive
functions of Cx26 and Cx43 GJC expressed in neuronal precursors migrating along the
radial scaffold during embryonal development. This effect did not depend on connexin
expression and intracellular scaffolding in RG-like cells as shown by transplantation of
Cx26-shRNA or Cx43-shRNA treated neuronal precursors into wild-type brains (Elias
et al., 2007). In contrast, a study by Cina et al. (2009) showed that the intracellular
C-terminal domain is essential for neuronal migration. In the mature brain neuronal
precursors were not coupled to RG-like cells (Kunze et al., 2009).
The present study aimed at identifying the key function, adhesion or gap junction cou-
pling, of Cx43 for proliferation in adult neurogenesis. RG-like cells are neuronal precur-
sors which reside in neurogenic niches, the SVZ and the SGZ, in the adult brain. They
share many properties with astrocytes, e.g. they express GFAP and are connected to
neighbouring cells via GJC formed by Cx30 and Cx43. Cx30/43 DKO mice displayed
reduced adult neurogenesis and uncoupled RG-like cells (Kunze et al., 2009). Though,
few RG-like cells expressed Cx26 in the above-mentioned study, a functional analysis
in Cx26fl:Nestin-Cre mice was not performed so far. Recently, a study in this lab and
by another group showed that Cx30 is not important for adult neurogenesis (Liebmann
et al., 2013; Zhang, 2013). Hence, due to the findings in RG-like cells, Cx43 is a likely
candidate to regulate proliferation and is known to be tightly regulated, e.g. by phospho-
rylation of the cytoplasmic C-terminal tail. To decide whether Cx43 mediated regulation
of adult neurogenesis relies on a channel mediated effect or adhesion to the intracellular
cytoskeleton of RG-like cells we employed mice carrying two different Cx43 mutations.
In this study, Cx43G138R mice were employed which carry a point mutation in the cy-
toplasmic loop. This mutation leads to channel closure and changes in phosphorylation
status, but Cx 43 traffic to the membrane is preserved as revealed in cardiomyocytes
(Dobrowolski et al., 2008). In addition, Cx43K258stop mice were studied. These mice
lack the entire C-terminal tail and in consequence adhesion to the cytoskeleton by ZO-
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proteins and all phosphorylation sites, but display an intact GJC pore (Maass et al.,
2007; see also3.10). Compensation of Cx43 function by Cx30 expression was circum-
vented as both genotypes additionally lacked Cx30.
The two mouse lines displayed significantly reduced network sizes compared to wild-type
mice, but not in comparison to their Cre negative controls (Fig. 5.6A). The ratio of cou-
pled to uncoupled cells was unaffected by Cx43 mutations (Fig. 5.6B). The observation
of coupled RG-like cells in Cx43G138R mice was an unexpected finding as this mutation
was shown to inhibit GJ coupling in the heart. The mutation is not located in the
channel pore itself, but in the cytoplasmic loop. The loop of Cx43G138R folds into the
channel pore, this process might be sterically hindered in brain cells in contrast to car-
diomyocytes. Another explanation would be an incomplete excision status of the floxed
Cx43G138R due to Cre inactivity in some cells or Cx26 mediated GJC (Kunze et al.,
2009; Requardt et al., 2009). Although, the latter case is unlikely due to side-effects of
the Cx30LacZ knock-out on Cx26 expression as discussed above. RG-like cells carrying
the other mutation Cx43K258stop were coupled, although network sizes were reduced
compared to wild-type mice. Due to the observed residual coupling in Cx43G138R mice,
the data do not allow for a definite conclusion on the decisive effect, adhesion or GJ cou-
pling, for adult neurogenesis. Both gap junction coupling and adhesive properties to the
intracellular cytoskeleton might play role in adult neurogenesis.
Unfortunately, both floxed Cx43 mutations displayed strongly reduced protein levels
compared to wild-type protein expression, but no further reduction upon excision of
the mutation sites (Maass et al., 2007; Dobrowolski et al., 2008). The observations on
network size level rather reflect the diminished Cx43 protein levels in the Cx43 mu-
tated mouse lines than mutation specific effects on network sizes. Regulatory effects
by phosphorylation might also play a role in regulating proliferation as the Cx43G138R
mutation showed a shift in phosphorylation in Western blots and the Cx43K258stop
mouse lacks the entire C-terminus including all phosphorylation sites.
In this context, further experiments are required to understand the role of gap junctions
in adult neurogenesis. A suitable tool would require mutated protein levels as in wild-
type mice. Employing the Cx43 mutant Cx43flD378stop, which just lacks the binding
site for ZO-1 protein, might be helpful to exclude side-effects by changes in the phospho-
rylation status (Lu¨bkemeier et al., 2013). In conclusion, Cx43 expression seems to be
required for proliferation of RG-like cells as shown by Liebmann et al. (2013), although
the mechanism remains elusive.
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6.3 Panglial networks in the brain
The initial experiments in this study often displayed tracer spread into myelinated fi-
bres in the thalamus (Fig. 5.1B2). The GJC involved in this transfer from astrocytes to
the myelin sheath were unknown and questioned the concept of a purely astrocytic net-
work. So far, studies in the hippocampus and cortex always described purely astroctyic
networks (Houades et al., 2008; Rouach et al., 2008).
6.3.1 Astrocytes and oligodendrocytes form functional networks
Analysing glial networks in the thalamus for the first time in the present study, immuno-
histochemical analysis was carried out to characterize the protein expression profile of
cells involved in tracer-coupled networks. There is only little information available for
suitable glial markers in the thalamus. A study by Frassoni et al. (2000) showed that
GFAP is only weakly expressed in the adult thalamus. Therefore GS was chosen to
identify astrocytes in GJNs which was shown to be a good marker in other areas. Olig2
was used to label the oligodendrocyte lineage. This comparative study in hippocam-
pus and thalamus revealed considerable heterogeneity regarding the expression profile
of the tracer-filled cells. Half of the cells expressed GS and over 60% expressed Olig2 in
the thalamus , while in the hippocampus the majority of cells expressed GS and only
a minority was Olig2-labelled (Fig. 5.7; 5.8). This indicated the presence of panglial
networks, though to a different extent in both brain regions. The expression of these
two proteins was further studied by immunohistochemistry on transgenic mice with as-
trocyte or oligodendrocyte specific fluorescence. A cell-type specific expression of GS
and Olig2 could not be observed in the thalamus, in contrast to the hippocampus (Fig.
5.15A1−3, B1−3 5.18). In conclusion, the immunohistochemical analysis indicated the
presence of a panglial network in both brain regions.
In contrast to white matter networks studied by Maglione et al. (2010) the presence of
NG2 cells was not observed in glial networks in the grey matter areas thalamus and
hippocampus (Fig. 5.9A1−3, B1−3). This observation was further confirmed by a pre-
vious study demonstrating that NG2 cells in the hippocampus are uncoupled (Wallraff
et al., 2004). During embryonic development neurons express connexins and possess
electrical synapses which are later on mostly replaced by chemical synapses. In some
regions, e.g. in the RTN, GJs between neurons are present throughout life (Lee et
al., 2014). Despite the presence of neuronal GJ in neighbouring thalamic nuclei, no
tracer spread from glia to neurons was observed and also microglia were not involved
in network formation (Fig. 5.9C1−3, F1−3). These findings are in line with previous
observations in the healthy and lesioned cortex and striatum (Richter et al., 2014;
Wasseff and Scherer, 2014). Hence, the network is limited to astrocytes and oligo-
dendrocytes.
The protein expression of tracer-coupled cells was indicative for a panglial network. To
further confirm this hypothesis transgenic PLP-GFP mice with fluorescence labelled
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oligodendrocytes were employed (Fuss et al., 2000). Network analysis in PLP-GFP mice
confirmed the findings of the immunohistochemical network study employing GS and
Olig2. Thalamic networks consist of almost equal numbers of astrocytes and oligoden-
drocyte, while in the hippocampus only a minor population of cells in these networks
are oligodendrocytes (Fig 5.11, 5.12B). In contrast, when injecting an oligodendrocyte
in the white matter region corpus callosum the ratio of astrocytes and oligodendrocytes
was opposite to hippocampal networks, because only a minority of astrocytes were ob-
served in these networks (Maglione et al., 2010). In the cortex similar numbers of Olig2
labelled cells were found in glial networks compared to thalamic glial networks, but fewer
Cx43-ECFP+ co-expressed Olig2 compared to the thalamus (Griemsmann et al., 2014).
Cortical glial networks comprise of an astrocyte to oligodendrocyte ratio in between
hippocampus and thalamus. The thalamus has an even cell-type ratio of astrocytes
and oligodendrocytes which corresponds well with a grey matter regions which contains
myelinated fibre bundles. The contribution of oligodendrocytes to glial networks ad-
ditionally reflects the different densities of oligodendrocytes in different brain regions,
as observed by immunohistochemistry (Fig. 5.17B). Interestingly, tracer diffusion was
independent of the cell-type initially patched, PLP-GFP+ cells or SR101+ cells. This
indicates bidirectional diffusion of biocytin through GJC between astrocytes and oligo-
dendrocytes. Further studies are required to analyse potential physiological influences
on diffusion of active molecules which likely diffuse towards sites of higher demand and
away from sites with excess concentrations.
Thalamic panglial networks were already present in the second postnatal week (Fig.
5.10). Still, the number of PLP-GFP+ cells might be an underestimation of the oligo-
dendrocyte fraction in biocytin networks as GFP fluorescence in these mice starts with
the onset of myelination in the second postnatal week (Fuss et al., 2000). Panglial net-
works in white matter were as well observed at early postnatal ages between p10-25
(Maglione et al., 2010). The early establishment of panglial connections raises the ques-
tion of their physiological function. A functional role might involve metabolite supply
from blood vessels to myelinated axons and K+ buffering away from sites underneath
the myelin sheath. These presumed functions are further supported by recent findings
of lactate transfer from oligodendrocytes to axons and vacuolizations underneath the
myelin sheath in Cx47 knock-out mice (Menichella et al., 2003; Odermatt et al., 2003;
Fu¨nfschilling et al., 2012; Lee et al., 2012).
6.3.2 Heterotypic connexin channels mediate panglial coupling
The GJC involved in panglial coupling in the thalamus and hippocampus were unknown.
Connexins are widely expressed throughout the brain and not confined to astrocytes.
Oligodendrocytes express Cx29, Cx32 and Cx47. While Cx29 is restricted to the myelin
sheath, the other two isoforms do form GJC with neighbouring cells. Cx47 was the most
important connexin for oligodendrocyte network formation in white matter (Maglione
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et al., 2010). GJC must be formed by heterotypic channels of two different connexins as
astrocytes and oligodendrocytes do not express the same set of connexins.
Cell culture studies indicated that the loss of one astrocytic and one oligodendrocytic
connexin, either Cx32 and Cx43 or Cx30 and Cx47, should abolish panglial networks.
Cx32 can only form channels with Cx30 and Cx43 forms GJC with Cx47 (see also Sec-
tion 1.4.4). Both knock-out combinations were generated in mice and displayed severe
changes including myelin abnormalities, vacuolizations and were partially lethal (Mag-
notti et al., 2011a; Tress et al., 2012).
Due to the prominent Cx30 expression in the thalamus, the Cx30/47 DKO was chosen to
study heterotypic gap junction channels involved in panglial network formation in this
study. When injecting the tracer into an astrocyte in these Cx30/47 DKO mice, diffusion
into neighbouring astrocytes should still be mediated by Cx43 channels. However, we
observed a lack of astrocyte networks (Fig. 5.13B1−4, E1−3; 5.14A, C). Recently, a pub-
lication by May et al. (2013) showed that the presence of Cx47 on the cell membrane
requires Cx43 expression in astrocytes. This is most likely a mutual effect, implying
that lack of Cx47 leads to relocation of Cx43 in astrocytes and would explain the ob-
servation of uncoupled cells in Cx30/47 DKO mice. The morphological alterations in
the brains of Cx30/47 DKO mice might as well contribute to this effect, because mi-
croglia activation and astrogliosis were reported in several brain regions (see Tress et
al., 2012). These morphological changes might have altered connexin expression (Gi-
aume et al., 2010) in Cx30/47 DKO mice and thereby influenced GJC in astrocytes.
The hypothesis of a mutual effect of Cx43 and Cx47 on their localization was tested by
tracer-injection in Cx30(LacZ/LacZ);Cx47(+/EGFP ) mice which were heterozygous for the
oligodendrocytic connexin. Indeed, panglial networks were restored, confirming a role
of Cx47 in Cx43 stabilization in the membrane and a small contribution of Cx43-Cx47
GJCs to panglial coupling in both regions (Fig. 5.13C1−4, F1−3; 5.14A, C). On the
contrary, in white matter oligodendrocyte networks displayed normal sizes, but lacked
astrocytes in Cx30/47 DKO which is most likely a Cx47 driven effect as the single knock-
out of Cx47 displayed smaller networks and lacked astrocytes (Maglione et al., 2010;
Tress et al., 2012). In the present study, employing the Cx30/47 DKO mouse line, the
proportion of Cx47-EGFP fluorescent oligodendrocytes in biocytin-filled networks (Fig.
5.14C) confirmed the findings of the immunohistochemical study (Fig. 5.7; 5.8) and the
PLP-GFP study (Fig. 5.12B). More oligodendrocytes were present in thalamic panglial
networks compared to hippocampal tracer-filled networks.
The anatomical structure of panglial networks in grey matter is unknown so far. In PLP-
GFP mice, we observed no diffusion preferences in the network because tracer injection
in oligodendrocytes or astrocytes always resulted in large GJN. From hippocampal astro-
cytes it is known that they occupy distinct spatial domains (Bushong et al., 2002). The
localization of oligodendrocytes in these domains and networks requires further analysis.
In contrast to oligodendrocytes, astrocytes contact blood vessels. Accordingly, the tight
link of both glial cells might be a fast transportation route between oligodendrocytes
and blood vessels and might play a role in brain homoeostasis.
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In the present study, the abundant prevalence of panglial networks was demonstrated
for thalamic and hippocampal glial cells. Based on findings in white matter regions and
cortex it is tempting to speculate that the formation of panglial networks is a universal
feature of glial cells in the brain, though the contribution of astrocytes and oligoden-
drocytes varies among brain regions and might depend on the density of each cell-type.
Mice lacking panglial networks display a strong phenotype and future studies should
aim at elucidating the physiological functions of these networks.
6.4 Immunohistochemical analysis reveals a unique
population of glial cells
Studying glial cells in the brain requires the reliable identification of different cell-types.
Only little is known about thalamic glia and their protein expression profile. In this
study, the initial experiments to identify glial cells in biocytin-labelled networks by im-
munohistochemistry questioned the concept of cell-type specific protein expression in
the VB. Here, GS and Olig2 were quantified in the networks and displayed an overlap-
ping expression profile, while in hippocampal networks this effect was not observed (see
Section 5.3.1). Proteins used as ”classical” cell-type markers in other brain regions were
subsequently tested in the thalamus.
Employing transgenic PLP-GFP and Cx43-ECFP knock-in mice, the observation of a
potential ”classical marker” overlap in thalamic glial networks was further investigated
by immunohistochemistry on brain slices. GFAP, a widely used astrocyte marker, was
reported to be weakly expressed in the adult thalamus (Frassoni et al., 2000). These
findings were confirmed in the present study and were in contrast to the strong, abun-
dant GFAP expression by hippocampal astrocytes (Fig. 5.16A1−4; B1−4). GFAP is an
intermediate filament found in astrocytes. PLP-GFP cells were also always devoid of
GFAP-labelling (Fig. 5.17C). In conclusion, although GFAP expression is confined to
astrocytes, only few cells can be identified and this protein is therefore not a good marker
for thalamic astrocytes.
GS was regarded as an astrocyte specific protein in many other studies (Norenberg, 1979;
Sonnewald et al., 1997; Coulter and Eid, 2012). GS is an enzyme that metabolises glu-
tamate to glutamine, postulated to be astrocyte specific due to neurotransmitter uptake
and detoxification by astrocytes in the tripartite synapse. Unexpectedly, GS was found
to be expressed by both oligodendrocytes and astroctyes in the thalamus in contrast to
astrocyte restricted expression in the hippocampus (Fig. 5.15A1−3, B1−3). The morphol-
ogy of GS stained cells differed between brain regions. In the VB, the round GS-labelled
cell somata resembled those observed in several studies describing GS expression in
oligodendrocytes (D’Amelio et al., 1987; Cammer, 1990), and colocalized with PLP-
GFP fluorescence. The role of increased GS expression in thalamic oligodendrocytes
remains elusive.
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Another widely used marker, S100β, was further investigated in another set of experi-
ments. Due to its previously described expression in NG2 cells (Karram et al., 2008),
co-labelling with PLP-GFP and NG2 was investigated. Only a subpopulation of PLP-
GFP cells expressed S100β, while most GFP+ cells were devoid of S100β (Fig. 5.16C1−4,
D1−3; 5.17D). It is therefore the most reliable marker to distinguish astrocytes from
oligodendrocytes by immunohistochemistry in the thalamus. Additionally, dense S100β
staining can be used to macroscopically identify the VB. As shown in an immunohisto-
chemical study by Muneoka et al. (2012) it was possible to identify the ventroposterior
nucleus in the thalamus by S100β immunohistochemistry.
In contrast to hippocampal NG2 cells, thalamic NG2 cells mostly lacked S100β ex-
pression (Fig. 5.16C1−4, D1−4; 5.17D). This is in line with previous findings by Parri
et al. (2010). Additionally, they were devoid of PLP-GFP expression in the thalamus.
This might indicate that thalamic NG2 cells in the adult brain do not enter the oligoden-
drocyte lineage. In white matter regions NG2 cells differentiate into oligodendrocytes,
while in grey matter they persist as NG2 cells (Dimou et al., 2008). In contrast, in
the hippocampus sparse PLP expression in NG2 cells was described in reporter mice in
a previous study (Mallon et al., 2002) and was also observed in the present study. In
conclusion, the concept of glial heterogeneity needs to be extended to the fourth type of
glia the NG2 cells.
A transcriptome study by Cahoy et al. (2008) described Aldh1L1 as a global astro-
cyte marker throughout the brain. Accordingly, Aldh1L1 expression was investigated in
the thalamus (Fig. 5.16E1−4; 5.17E). Many Aldh1L1 cells with a typical star-like mor-
phology of astrocytes were identified, but half of the Aldh1L1-labelling colocalized with
PLP-GFP. These cells displayed the typical round somata of oligodendrocytes. Hence,
Aldh1L1 is a possible astrocyte marker, when additionally selecting for cell morphology.
Still, further analysis is required to analyse how many astrocytes can be identified by
Aldh1L1.
The network analysis individually revealed an overlap of GS and Olig2 in the VB. Cx43-
ECFP knock-in mice were employed to reliably identify astrocytes and investigate Olig2
expression. Unexpectedly, half of the thalamic Cx43-ECFP expressing cells expressed
Olig2, while in the hippocampus only a small subpopulation expressed Olig2 (Fig. 5.18).
The proportion of Olig2 expressing astrocytes might even underestimate the extent
of Olig2 expression in astrocytes as 20% of thalamic astrocytes lack Cx43 expression
(Fig. 5.3C4). So far, Olig2 expression in astrocytes was only described in the juvenile
brain (Fukuda et al., 2004; Marshall et al., 2005; Cai et al., 2007). In the present study,
abundant astrocytic Olig2 expression in the thalamus of the mature brain was observed.
This population might represent an ”intermediate” cell-type between astrocytes and
oligodendrocytes. The functional role of these cells requires further investigation.
Similarly, Aldh1L1 colocalized with Olig2 in cells with and without PLP-GFP fluo-
rescence (Fig. 5.16E1−4). Cells co-labelled for Aldh1L1 and Olig2 likely account for
this ”intermediate” cell-type. To exclude that the Olig2 expressing astrocytes are im-
mature astrocytes, their gap junction coupling was analysed in Cx43-ECFP mice with
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co-staining of Olig2 (Fig. 5.19). Indeed, the ”intermediate” cell-type was observed in
glial networks and indicates the mature state of these cells.
Immunohistochemical analysis further confirmed the oligodendrocyte-specific PLP-GFP
expression. Their round morphology differed from the star-like morphology of astro-
cytes. GFP+ cells were devoid of GFAP labelling and never expressed Iba1 or NeuN
(Fig. 5.151−3C, D1−3; 5.16A1−4-E1−4; 5.17B, C, D). Olig2 staining always colocalized
with PLP-GFP in the thalamus (Fig. 5.17E). Additionally, in the hippocampus PLP-
GFP cells mostly lacked astrocytic protein expression.
In summary, transgenic and knock-in mice with cell-type specific PLP-GFP and Cx43-
ECFP fluorescence can be employed to identify astrocytes and oligodendrocytes. For
immunohistochemical analysis S100β is the most reliable marker to distinguish between
astrocytes and oligodendrocytes. As it is not an exclusive marker for astrocytes, the
morphology of S100β+ cells should be analysed as a second criterion. Still, for future
immunohistochemical studies the identification of a reliable astrocyte marker will be
advantageous.
6.5 Neuron-glia interactions in the thalamus
6.5.1 Metabolite diffusion in panglial networks
Astrocytes have been known for a long time as key players in neuronal synaptic trans-
mission by taking up neurotransmitter from the synaptic cleft, releasing gliotransmitters
and controlling local homoeostasis. These functions were summarized in the concept of
the tripartite synapse (Araque et al., 1999). The extent of panglial networks in the VB
questioned this concept and it might have to be extended to oligodendrocyte participa-
tion in brain homoeostasis.
Metabolite supply is regarded to be an astrocytic function in the brain and is sum-
marized in the ANLS concept (see also Fig. 1.4). Astrocytes take up glucose from
the blood vessels and by glycolysis produce lactate which is shuffled into neuronal
boutons. Increased activity at glutamatergic synapses leads to increased glycolysis
in astrocytes. Panglial networks between astrocytes and oligodendrocytes might be a
transportation route for metabolites or ions. Indeed, employing the fluorescent glucose
analogue 2-NBDG the diffusion of glucose through heterotypic channels from astro-
cytes to oligodendrocytes was confirmed in the present study. In addition to metabo-
lite transport in astrocytic networks (Rouach et al., 2008), this experiment confirmed
the transport of metabolites in panglial networks (Fig. 5.20B). Interestingly, like in
the initial biocytin experiments 2-NBDG fluorescence was observed in myelinated fibre
tracts (Fig. 5.1B2; 5.20A1,3). A transportation via the extracellular space is unlikely, as
2-NBDG fluorescence was never observed in the extracellular space (Fig. 5.20A1−2).
2-NBDG can enter gylcolysis like glucose and is rapidly phosphorylated by hexoki-
nases. Phosphorylation of glucose molecules inhibits diffusion through glucose trans-
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porters to the extracellular space and glucose and 2-NBDG are trapped inside cells.
In the present study, network sizes were smaller employing 2-NBDG compared to bio-
cytin. The fluorescent glucose molecule is larger than biocytin and consists of two ring
structures. Its diffusion through GJCs might be sterically limited. Glucose without
a fluorescent tag supposedly diffuses further into the network. As described in the
ANLS model, astrocytes metabolise glucose and provide lactate to neurons in vivo. In
addition, they might transfer lactate to neighbouring oligodendrocytes which in turn
transport it to myelinated axons. Recent publications reported the oligodendrocytic
support of axons with lactate to sustain neuronal activity (Fu¨nfschilling et al., 2012;
Lee et al., 2012). The origin of lactate in oligodendrocytes was unclear as oligoden-
drocytes do not contact blood vessels. Lactate might be derived from the extracellular
space, or from astrocytes via panglial GJC as described in the present study.
6.5.2 Neuronal activity requires energy supply
The interactions of glial networks and neurons was further investigated in the present
study. As glial networks support several neurons, these effects were analysed on neuronal
network scale by recording extracellular field potential recordings. The extent of panglial
coupling in the hippocampus was lower compared to the thalamus. It would therefore
be advantageous to study glia-neuron interactions in the thalamus. For this reason a
method to monitor neuronal activity in the VB was established in the present study. The
thalamus receives synaptic input from the lemniscal pathway and the cortico-thalamic
pathway. Cortical fibre tracts could be easily identified in DIC optics on acute brain
slices and were chosen for stimulation experiments.
A protocol was developed to stimulate the CT pathway on nearly horizontal slices. Field
potential responses were small in the VB and therefore trains of five stimuli were applied,
while induction of LTP or LTD was avoided. Control recordings for 90 min confirmed
the reliability of the designed input parameters for long term recordings (Fig. 5.23).
Stimulation of the CT pathway resulted in pre- and postsynaptic responses in the VB
as identified by block of synaptic transmission (Fig. 5.22). In contrast to hippocampal
field potentials (An et al., 2008), in the thalamus also the presynaptic signal displays a
large amplitude which is blocked by TTX application (Fig. 5.22).
Recorded fEPSPs were analysed with a custom made Igor tool. Ten traces were averaged
and analysed for the delay and the amplitude of the postsynaptic response. During slow
application of receptor blockers NBQX and D-AP5 the amplitude decreased, while the
delay increased (Fig. 5.22C). Synaptic transmission was slower and elicited postsynap-
tic responses in fewer neurons leading to a decrease in amplitude of the fEPSP. After a
few minutes, the synaptic transmission was completely blocked. Similar responses were
obtained in a study employing coronal slices with a lateral angle when stimulating the
CT pathway (Castro-Alamancos and Calcagnotto, 1999).
For studying the effects of panglial networks on neuronal activity, changes in fEPSP in
response to extracellular glucose deprivation (GD) were investigated. In a first experi-
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mental approach GD was applied after 10 min of recording in ACSF. After 60 min of
GD, re-perfusion with ACSF was performed for 20 min, but the fEPSPs could not be
restored. Most likely long-time GD leads to neuronal inactivity and cell death which
cannot be rescued. In the optic nerve GD cells recovered completely from 45 min of GD,
but not from 65 min GD (Ransom and Fern, 1997). In the thalamus the postsynaptic
response started to decrease after 16 min of GD. After 21 min the signal decreased to
50% of the normalized maximum amplitude and further decreased over the recording
time. In comparison, in the hippocampus the signal decreased to 50% after 30 min of
GD (Rouach et al., 2008). Control recordings on another brain slice from the same ani-
mals displayed stable fEPSPs in response to the stimulation parameters which confirms
a specific effect of GD on fEPSP amplitudes. A previous experimental study tested
different glucose concentrations and found optimal responses with 10 mM extracellular
glucose. Lower concentrations decreased hippocampal popspike amplitudes, while the
paired-pulse-ratio was maintained (An et al., 2008). GD also affects axonal signalling in
white matter areas, changes in compound action potentials were only observed after half
an hour of GD, followed by a rapid decline in signal (Wender et al., 2000). The delayed
changes in white matter compound action potentials compared to the fEPSP changes in
VB might indicate a higher energy consumption by synaptic transmission compared to
axonal action potential propagation in the optic nerve. hippocampal fEPSP were stable
for a longer time during GD compared to thalamic fEPSPs indicating a higher energy
consumption in the thalamus. Probably, the thalamus requires high energy supply to
sustain both synaptic transmission and axonal signal propagation. Long axons from
cortical neurons arrive in the VB and require more local metabolite supply, in contrast
to shorter hippocampal Schaffer collaterals. Another possible explanation would be that
glycogen storage is increased in the hippocampus compared to the VB.
Astrocytes are the glycogen storage place in the brain (Pellerin and Magistretti, 2012). In
the present study the hypothesis of glucose uptake from the blood by astrocytes and the
subsequent transfer of energy metabolites in the panglial network was investigated. In
conclusion, glucose indeed diffused into panglial networks and neuronal activity in acute
slices is sensitive to extracellular GD. In future studies it would be interesting to analyse
changes in both, synaptic transmission and axonal signal propagation, during GD. For
further analysis of the glial metabolic support mice lacking panglial networks should
be employed. It is also of further interest, whether it is possible to rescue the fEPSPs
during GD by glucose filling of panglial networks. Understanding panglial metabolite
supply will be advantageous to find treatments to rescue energy deprived neuronal tissue
in diseases, e.g. ischemia.
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6.6 Ionotropic receptor expression in VB astrocytes
Astrocytes have been shown to express ionotropic receptors in several brain regions.
Here, a detailed analysis of the AMPA and GABAA receptor subunit expression profile
of astrocytes in the VB was performed. Therefore, functionally characterized and fluo-
rescently identified astrocytes in the VB of juvenile mice were harvested for subsequent
RNA analysis.
6.6.1 AMPA receptor expression analysis identifies two astrocyte
populations
The RT-PCR results identified two astrocyte populations which could be distinguished
by the presence or absence of AMPA receptor subunit expression, revealing astrocyte
heterogeneity on receptor expression level. Cells expressing AMPA receptors revealed
abundant GluA2 expression, while GluA1 was least expressed. Both splice variants, flip
and flop, were found for all four subunits. GluA1 and GluA3 mainly occurred in the flop
isoform (Fig. 5.24). The other two receptor subunits were found to a similar proportion
as flip or flop. Indeed, astrocytes with and without AMPA receptor currents were also
found in the functional receptor study on acutely isolated cells (Ho¨ft et al., 2014). In
contrast, hippocampal astrocytes lack AMPA receptors, but express glutamate trans-
porters. Instead, another group of glia, hippocampal NG2 cells, were shown to have func-
tional AMPA receptors and abundantly expressed GluA1 and GluA2 subunits (Bergles
et al., 2000; Matthias et al., 2003; Seifert et al., 2003; Jabs et al., 2005). Heterogeneous
AMPA expression was also reported for striatal astrocytes and NG2 cells (Wang et al.,
2008). Thalamic NG2 cells express functional AMPA receptors which were blocked by
CNQX (Parri et al., 2010). Radial-glia like cells are neuronal precursors in the SGZ of
the dentate gyrus and displayed a heterogeneous AMPA receptor localization on their
cell surface. The radial process contained many AMPA receptors, while the cell soma
was devoid of AMPA receptors (Renzel et al., 2013). They often expressed the GluA2
subunit, like thalamic astrocytes. In the supraoptic nucleus most astrocytes lacked
any glutamate uptake currents and were devoid of glutamate receptors, while a mor-
phologically identified subpopulation expressed glutamate transporters (Matyash and
Kettenmann, 2010). In contrast, cerebellar Bergmann glia have functional AMPA re-
ceptors with high Ca2+ permeabilities lacking the GluA2 subunit (Burnashev et al., 1992;
Mu¨ller et al., 1992).
VB astrocytes respond to neuronal activity with increased [Ca2+]i levels, mediated by
mGluR5 G-protein coupled receptors, but not AMPA receptors (Parri et al., 2010).
These Ca2+ elevations in turn lead to gliotransmitter release of glutamate which induces
slow inward currents in neurons (Pirttimaki and Parri, 2012). The absence of AMPA
receptors mediated [Ca2+]i (Parri et al., 2010) is in line with the high GluA2 expression
level in thalamic astrocytes observed in the present study. AMPA receptors containing
the GluA2 subunit are impermeable for Ca2+ (Burnashev et al., 1992).
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In summary, astrocytic responses to glutamate vary among brain regions, some astro-
cytes express AMPA receptors, while others express transporters or do not respond at all
to glutamate application. The AMPA receptor subunit composition is also highly vari-
able among brain regions and even within a given region, e.g. some thalamic astrocytes
lack AMPA receptors.
6.6.2 Astrocytic GABAA receptor subunit expression
The GABAA receptor expression profile was assessed by RT-PCR analysis. As observed
in other brain regions (Fraser et al., 1995; Israel et al., 2003), all thalamic astrocytes
expressed GABAA receptor subunits (Fig. 5.25). Only in 1 of 9 cells the γ2 subunit of
the GABAA receptor was expressed. This subunit is indicative of synaptic localization
of the receptor in neurons and in another group of glia, NG2 cells (Essrich et al., 1998;
Passlick et al., 2013). Instead, VB astrocytes abundantly expressed the γ1 and γ3 sub-
units and also prominently expressed β1. In contrast, hippocampal NG2 cells expressed
β3 more often than β1, while all γ subunits were found in most cells (Passlick et al.,
2013). Radial-glia like cells which share many properties with astrocytes, also express
GABAA receptors in the adult SGZ. Similarly to thalamic astrocytes, RG-like cells often
expressed the β1 subunit, but less often the γ1 and γ3 subunits (Renzel et al., 2013).
Astrocytes in the supraoptic nucleus and hippocampus also express GABAA receptors,
the latter often contained the subunits α1, α3 and β1 among others (Fraser et al., 1995;
Israel et al., 2003).
Functional studies on acutely isolated VB astrocytes always displayed GABAA recep-
tor currents in response to muscimol (Ho¨ft et al., 2014). They respond to GABA with
depolarization in the VB and hippocampus (Meier et al., 2008; Ho¨ft et al., 2014), and
increases in [Ca2+]i (Meier et al., 2008). Though, [Ca
2+]i responses seem to be mediated
mainly by mGluR5 in the VB and were not reduced by a combined block of AMPA,
NMDA and GABAA receptors (Parri et al., 2010). In contrast to neurons, astrocytes re-
spond to GABA with depolarization due to the expression of the NKCC1 cotransporter
and the resulting higher [Cl−]i concentrations. GABA-signalling on astrocytes might
therefore be required to buffer [Cl−]o and thereby controls neuronal inhibitory signalling
(Losi et al., 2014). Additionally, astrocytes lack the KCl cotransporter KCC2 expressed
in mature neurons (Stein et al., 2004). So far, the role of GABAA receptor activation in
astrocytes is not well understood. Additionally, only few studies are available on GABA
mediated neuron-astrocyte interactions (Ve´lez-Fort et al., 2012).
Interestingly, thalamic astrocytes completely lacked the α3 subunit (Fig. 5.25). α3
knock-out mice suffered longer from alcohol induced incoordination (Blednov et al.,
2013). Furthermore, this subunit is abundantly expressed by RTN, but not VB neurons
(Mozrzymas et al., 2007; Christian and Huguenard, 2013). The GABAA receptor subunit
α3 contains a benzodiazepine-binding site (Christian and Huguenard, 2013). Astrocytes
enhance GABAA receptor mediated currents via endozepine actions in the RTN, but
not in the VB (Mozrzymas et al., 2007; Christian and Huguenard, 2013). Astrocytes
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negatively modulate GABAA receptor currents via GABA transporter mediated uptake
from the synaptic cleft (Christian and Huguenard, 2013). Physiologically, the absence
of this subunit in VB astrocytes, in the present study, might prevent feedback signalling
to astrocytes. The expression of GABAA receptors in RTN astrocytes requires further
analysis to confirm this hypotheses.
Benzodiazepines are used to treat neuropsychiatric diseases and seizures. Thalamic
dysfunctions are associated with schizophrenia and absence epilepsy (Pinault, 2011;
Christian and Huguenard, 2013). Glial cells might play a role in these diseases as
increased GS and S100β levels in the thalamus were reported in schizophrenia (Rother-
mundt et al., 2004; Bruneau et al., 2005). Apparently, benzodiazepine treatment cannot
target astrocytes, but these cells modulate neuronal GABAA receptor signalling in the
RTN. For future studies it might be beneficial to identify potential astrocytic targets for
new treatments.
GABA-signalling on astrocytes increased GFAP levels and astrocytic branching in the
rat forebrain (Runquist and Alonso, 2003). Only few VB astrocytes express GFAP
(Frassoni et al., 2000) and it is probably a less important mechanism in the VB.
In summary, VB astrocytes display a heterogeneous AMPA receptor expression profile
and abundantly express GABAA receptors. The impact of this heterogeneous AMPA
receptor expression profile on brain function requires further analysis. Astrocytes re-
spond to glutamate with gliotransmitter release and might modulate neuronal activity
in the VB. Additionally, the role of GABA receptors on VB astrocytes remains elusive
so far, but likely plays an important role in thalamic neuronal circuits which are highly
regulated by GABAergic signalling.
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7 Summary
Increasing evidence over the past decades revealed the importance of glia in the brain.
In this study, astrocytes in the ventrobasal thalamus were characterized in detail for the
first time. Glial heterogeneity was investigated by comparing their properties with those
of astrocytes in the hippocampus, a brain region in which glial cells have been widely
studied.
During development, astrocytes establish gap junction channels with each other. In
this study, the networks in the ventrobasal thalamus increased in size until the end of
the second postnatal week. Cx30 expression was strongly upregulated during postnatal
development and had a predominating role in glial network formation in the mature
thalamus. Cx30 and Cx43, but not Cx26, mediated gap junction coupling in the hip-
pocampus and thalamus. Strikingly, some astrocytes were devoid of Cx43. Expression
of Cx43 in RG-like cells influences proliferation. The effect of two Cx43 mutations on
network sizes were studied to identify the key function, gap junction coupling or adhe-
sion, for proliferation. The function remained elusive. In summary, connexin expression
differs among brain regions revealing glial heterogeneity throughout the brain.
Tracer diffusion from astrocytes into the myelin sheath was observed in the ventrobasal
thalamus. Such functional gap junction channels between astrocytes and oligodendro-
cytes were so far unknown. In this study, a panglial network formed by oligodendro-
cytes and astrocytes was discovered in the hippocampus and the thalamus. Employing
Cx30/47 DKO mice, a major impact of Cx30 on panglial network formation was ob-
served in the thalamus. Cx30 and Cx47 do not form functional channels in vitro. This
leads to the conclusion that panglial coupling is mainly mediated by Cx30:Cx32 chan-
nels.
Immunohistochemical analysis in PLP-GFP and Cx43-ECFP mice identified overlapping
protein expression of ”classical” markers in thalamic astrocytes and oligodendrocytes
in contrast to hippocampal glia. S100β was the most reliable marker to distinguish
astrocytes and oligodendrocytes in the ventrobasal thalamus. Unexpectedly, an ”inter-
mediate” cell-type was identified co-expressing Cx43 and Olig2. It is a mature cell-type
which is part of thalamic glial networks and has been described for the first time in this
study.
The functional role of panglial networks in metabolite supply to neurons was anal-
ysed in the present study. Glucose diffusion from astrocytes to oligodendrocytes was
demonstrated in the thalamus employing the fluorescent glucose analogue 2-NBDG in
PLP-GFP mice with SR101 labelled astrocytes. For further investigation of glia-neuron
interactions, a method to analyse neuronal field potentials in the ventrobasal thalamus
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was established and characterized. Extracellular glucose deprivation abolished neuronal
postsynaptic field potentials, thereby confirming the neuronal requirement of glial en-
ergy supply.
In addition to connexin mediated gap junction channels, the expression of ionotropic
AMPA and GABAA receptors was studied in thalamic astrocytes. In the juvenile thala-
mus, two astrocyte populations were distinguished by the presence or absence of AMPA
receptor expression. The GluA2 subunit was abundantly expressed when AMPA re-
ceptors were expressed. All astrocytes expressed GABAA receptors. They were devoid
of the α3 subunit and rarely expressed the γ2 subunit required for synaptic GABAA
receptor localization. Instead, all cells expressed the γ1 subunit. These data indicate
that glial heterogeneity occurs even within a given brain regions.
The present study describes panglial networks in grey matter and their distinct proper-
ties among brain regions for the first time. In addition, glial heterogeneity was observed
between and within brain regions and enhanced our understanding of glial specializa-
tions. In addition, a new ”intermediate” cell-type was discovered which is abundantly
present in the ventrobasal thalamus.
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8 Perspective
The thalamus is the ”gate to conciousness” and many studies focused on neurons in
this brain region. In the present study, glial cells were extensively characterized in
the ventrobasal thalamus and many exciting new properties of glial cells were discov-
ered. Among all results, two major findings challenge our current understanding of glial
cells and their function in the brain: Unravelling the role of panglial networks between
astrocytes and oligodendrocytes, and the role of the ”intermediate” cell-type in the ven-
trobasal thalamus should be objectives of future studies.
Panglial networks are already established in the second postnatal week and present
in both thalamus and hippocampus. Due to the higher number of oligodendrocytes in
thalamic glial networks, it will be advantageous to perform functional studies in the
ventrobasal thalamus. In this study, a newly established method to assess neuronal ac-
tivity and neuron-glia interactions in the ventrobasal thalamus was established and can
be employed to unravel the function of panglial networks. These networks might play
a role in many physiological functions previously attributed to astrocytic networks, e.g.
metabolite supply, gliotransmission and K+ homoeostasis. The experiments performed
in the present study suggest a role in metabolite supply to neurons and hence this func-
tion should be further investigated. In addition, it might be interesting to analyse the
influence of panglial networks on somatosensory input.
Excitingly, the immunohistochemical study identified an ”intermediate” cell-type which
is abundantly present in the ventrobasal thalamus. The co-expression of previously
known ”classical” cell-type markers in one cell-type raises the question of their cellular
identity and function. Moreover, studying ionotropic receptor expression, two popu-
lations of astrocytes were identified by the presence or absence of AMPA receptors.
These two populations might account for the ”intermediate” cell-type and astrocytes
in the ventrobasal thalamus. To answer this question, functional, molecular and im-
munohistochemical approaches should be combined in future studies. To enhance our
understanding of this ”intermediate” cell-type, also local specializations of these cells
should be considered, as the thalamus is subdivided into several nuclei with highly
specific functions. The ventrobasal thalamus contains barreloids which receive signals
from the whiskers. Hence, the ”intermediate” cell-type might be involved in modulating
neuronal activity between barreloids.
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Table 9.1 Cell densities obtained from immunohistochemical analysis in PLP-GFP mice, data are
displayed as mean ± SEM cells/mm3.
Region total PLP-GFP only PLP-GFP GFP+GS only GS
TH 136,911 ± 9,363 7,578 ± 1,978 129,333 ± 8,616 n.a.
HC 22,644 ± 1,573 18,578 ± 1,288 4,067 ± 692 74,175 ± 4,278
Region total PLP-GFP only PLP-GFP GFP+NeuN
TH 140,867 ± 7,661 140,867 ± 7,661 0
HC 20,200 ± 1,030 20,200 ± 1,030 0
Region total PLP-GFP only PLP-GFP GFP+GFAP GFP+Iba1
TH 135,600 ± 8,674 135,600 ± 8,674 0 0
HC 24,267 ± 1,957 24,267 ± 1,957 0 0
Region total PLP-GFP only PLP-GFP GFP+S100β GFP+NG2
TH 158,844 ± 4,092 130,600 ± 2,865 27,933 ± 2,556 289 ± 136
HC 26,447 ± 1,434 16,489 ± 1,184 4,889 ± 785 4,644 ± 408
Region S100β+NG2 GFP+S100β
+NG2
TH 22 ± 31 22 ± 31
HC 622 ± 227 444 ± 116
Region total Aldh1L1 only Aldh1L1 Aldh1L1+GFP Aldh1L1+Olig2
TH 65,422 ± 6,242 13,978 ± 3,649 444 ± 522 17,022 ± 4,388
Region Aldh1L1+GFP
+Olig2
TH 33,533 ± 5,111
Region total Cx43-ECFP only Cx43-ECFP Cx43-ECFP+Olig2
TH 38,563 ± 1,723 18,293 ± 2,066 20,267 ± 2,917
HC 52,217 ± 3,215 49,062 ±2,784 3,155 ± 1,107
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